(+)-albicanol multiple interactions ISO RGD:62159 6480464 albicanol inhibits the reaction [Galactose results in increased expression of CASP9 mRNA] CTD PMID:33761044 (+)-alpha-viniferin increases activity ISO RGD:69147 6480464 alpha-viniferin analog results in increased activity of CASP9 protein, alpha-viniferin results in increased activity of CASP9 protein CTD PMID:16158945 (+)-catechin increases activity ISO RGD:69147 6480464 Catechin results in increased activity of CASP9 protein CTD PMID:20206613 (+)-catechin increases expression ISO RGD:69147 6480464 Catechin results in increased expression of CASP9 mRNA CTD PMID:23706674 (+)-dexrazoxane decreases expression ISO RGD:62159 6480464 Dexrazoxane results in decreased expression of CASP9 mRNA CTD PMID:26873546 (+)-pilocarpine increases expression ISO RGD:62159 6480464 Pilocarpine results in increased expression of CASP9 protein CTD PMID:18708038 (+)-taxifolin decreases activity EXP 6480464 taxifolin results in decreased activity of CASP9 protein CTD PMID:24269735 (+)-Tetrandrine multiple interactions ISO RGD:69147 6480464 tetrandrine results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:26822499 (+)-Tetrandrine increases cleavage ISO RGD:69147 6480464 tetrandrine results in increased cleavage of CASP9 protein CTD PMID:25266202 (+)-trans-(S)-allethrin multiple interactions ISO RGD:69147 6480464 Vitamin E inhibits the reaction [bioallethrin results in increased cleavage of CASP9 protein] CTD PMID:35511042 (+)-trans-(S)-allethrin increases cleavage ISO RGD:69147 6480464 bioallethrin results in increased cleavage of CASP9 protein CTD PMID:35511042 (-)-anisomycin multiple interactions ISO RGD:69147 6480464 Anisomycin promotes the reaction [Indomethacin results in increased activity of CASP9 protein] CTD PMID:17341418 (-)-anisomycin multiple interactions EXP 6480464 Anisomycin inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP9 protein]] CTD PMID:34767868 (-)-Arctigenin increases expression ISO RGD:69147 6480464 arctigenin results in increased expression of CASP9 mRNA CTD PMID:25922263 (-)-citrinin increases activity ISO RGD:62159 6480464 Citrinin results in increased activity of CASP9 protein CTD PMID:21622943 (-)-citrinin increases expression EXP 6480464 Citrinin results in increased expression of CASP9 protein modified form CTD PMID:22564900 (-)-epigallocatechin 3-gallate increases activity ISO RGD:69147 6480464 epigallocatechin gallate results in increased activity of CASP9 protein CTD PMID:15764647 (-)-epigallocatechin 3-gallate increases cleavage ISO RGD:62159 6480464 epigallocatechin gallate results in increased cleavage of CASP9 protein CTD PMID:34600025 (-)-epigallocatechin 3-gallate increases expression ISO RGD:69147 6480464 epigallocatechin gallate results in increased expression of CASP9 protein CTD PMID:32512070 (-)-epigallocatechin 3-gallate affects activity ISO RGD:69147 6480464 epigallocatechin gallate affects the activity of CASP9 protein CTD PMID:23954321 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:69147 6480464 epigallocatechin gallate inhibits the reaction [Nitroprusside binds to and results in increased activity of CASP9 protein] CTD PMID:23665936 (-)-epigallocatechin 3-gallate increases cleavage ISO RGD:69147 6480464 epigallocatechin gallate analog results in increased cleavage of CASP9 protein CTD PMID:16115949 (-)-gambogic acid multiple interactions ISO RGD:69147 6480464 [gambogic acid co-treated with Bortezomib] results in increased activity of CASP9 protein more ... CTD PMID:24291039 , PMID:24373880 (-)-gambogic acid decreases expression ISO RGD:69147 6480464 gambogic acid results in decreased expression of CASP9 protein alternative form CTD PMID:19464570 (-)-matairesinol increases expression ISO RGD:69147 6480464 matairesinol results in increased expression of CASP9 mRNA CTD PMID:25922263 (-)-noscapine multiple interactions ISO RGD:69147 6480464 Noscapine promotes the reaction [Cisplatin results in increased expression of and results in increased cleavage of CASP9 protein], Noscapine results in increased expression of and results in increased cleavage of CASP9 protein CTD PMID:20674069 (20R)-protopanaxadiol affects expression ISO RGD:69147 6480464 protopanaxadiol affects the expression of CASP9 protein CTD PMID:31805304 (20R)-protopanaxadiol increases expression ISO RGD:69147 6480464 protopanaxadiol results in increased expression of CASP9 mRNA CTD PMID:31805304 (20S)-ginsenoside Rg3 multiple interactions ISO RGD:69147 6480464 ginsenoside Rg3 inhibits the reaction [cagA protein, Helicobacter pylori results in decreased cleavage of CASP9 protein] CTD PMID:26427350 (20S)-ginsenoside Rh2 decreases expression ISO RGD:69147 6480464 ginsenoside Rh2 results in decreased expression of CASP9 protein CTD PMID:32762018 (aminomethyl)phosphonic acid increases expression ISO RGD:69147 6480464 1-aminomethylphosphonic acid results in increased expression of CASP9 protein CTD PMID:23983455 (aminomethyl)phosphonic acid multiple interactions ISO RGD:69147 6480464 [1-aminomethylphosphonic acid co-treated with methoxyacetic acid] results in increased expression of CASP9 protein CTD PMID:26006246 (R)-carnitine multiple interactions EXP 6480464 Carnitine inhibits the reaction [Ifosfamide results in increased expression of CASP9 mRNA] CTD PMID:23213347 (R)-carnitine multiple interactions ISO RGD:69147 6480464 Carnitine inhibits the reaction [quinone results in increased activity of CASP9 protein] CTD PMID:32478940 (R)-lipoic acid increases activity ISO RGD:69147 6480464 Thioctic Acid results in increased activity of CASP9 protein CTD PMID:16990509 (R)-lipoic acid multiple interactions ISO RGD:69147 6480464 Thioctic Acid inhibits the reaction [Zinc Oxide analog results in increased activity of CASP9 protein] CTD PMID:27544635 (R)-lipoic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of CASP9 mRNA more ... CTD PMID:19951573 more ... (R)-noradrenaline multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP9 protein], Ascorbic Acid inhibits the reaction [Norepinephrine results in increased activity of CASP9 protein] CTD PMID:15158148 (R)-noradrenaline affects activity EXP 6480464 Norepinephrine affects the activity of CASP9 protein CTD PMID:25437044 (R)-noradrenaline increases cleavage EXP 6480464 Norepinephrine results in increased cleavage of CASP9 protein CTD PMID:16338971 (R)-noradrenaline increases activity EXP 6480464 Norepinephrine results in increased activity of CASP9 protein CTD PMID:14732211 , PMID:15158148 (R,R,R)-alpha-tocopherol increases cleavage ISO RGD:69147 6480464 alpha-Tocopherol analog results in increased cleavage of CASP9 protein CTD PMID:20686688 (R,R,R)-alpha-tocopherol multiple interactions ISO RGD:62159 6480464 alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP9 protein] CTD PMID:31712109 (R,R,R)-alpha-tocopherol multiple interactions ISO RGD:69147 6480464 alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP9 protein], alpha-Tocopherol results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:21869839 , PMID:36058301 (S)-colchicine increases activity ISO RGD:69147 6480464 Colchicine results in increased activity of CASP9 protein CTD PMID:22342440 (S)-naringenin increases activity ISO RGD:69147 6480464 naringenin results in increased activity of CASP9 protein CTD PMID:19124070 (S)-naringenin increases expression ISO RGD:69147 6480464 naringenin metabolite results in increased expression of CASP9 mRNA more ... CTD PMID:27838343 , PMID:36235125 (S)-naringenin multiple interactions ISO RGD:69147 6480464 [naringenin co-treated with bisphenol A] results in increased expression of CASP9 mRNA more ... CTD PMID:31254498 , PMID:36235125 (S)-naringenin multiple interactions EXP 6480464 naringenin inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of CASP9 protein], naringenin inhibits the reaction [Glucose results in increased expression of CASP9 mRNA] CTD PMID:23192364 (S)-nicotine multiple interactions ISO RGD:62159 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of CASP9 protein CTD PMID:29972271 (S)-nicotine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [Nicotine results in increased expression of CASP9 protein] CTD PMID:29972271 (S)-nicotine multiple interactions ISO RGD:69147 6480464 Nicotine inhibits the reaction [[Cisplatin co-treated with Etoposide] results in increased activity of CASP9 protein] CTD PMID:18676776 (S)-nicotine decreases expression ISO RGD:69147 6480464 Nicotine results in decreased expression of CASP9 mRNA CTD PMID:16949557 (S)-ropivacaine decreases expression ISO RGD:69147 6480464 Ropivacaine results in decreased expression of CASP9 protein CTD PMID:20194319 (Z)-3-butylidenephthalide increases cleavage EXP 6480464 butylidenephthalide results in increased cleavage of CASP9 protein CTD PMID:16987298 (Z)-3-butylidenephthalide increases cleavage ISO RGD:69147 6480464 butylidenephthalide results in increased cleavage of CASP9 protein CTD PMID:16987298 (Z)-ligustilide increases cleavage ISO RGD:69147 6480464 ligustilide results in increased cleavage of CASP9 protein CTD PMID:31765699 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o, p'-DDT analog results in decreased expression of CASP9 mRNA CTD PMID:22937105 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:69147 6480464 o, p'-DDT results in increased expression of CASP9 protein modified form CTD PMID:35122929 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions ISO RGD:69147 6480464 Quercetin inhibits the reaction [o, p'-DDT results in increased expression of CASP9 protein modified form] CTD PMID:35122929 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO RGD:62159 6480464 o, p'-DDT affects the expression of CASP9 mRNA CTD PMID:18925944 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o, p'-DDT results in increased expression of CASP9 mRNA CTD PMID:22937105 1,2-dichloroethane decreases expression ISO RGD:62159 6480464 ethylene dichloride results in decreased expression of CASP9 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of CASP9 protein CTD PMID:29108773 1,2-dimethylhydrazine decreases expression ISO RGD:62159 6480464 1, 2-Dimethylhydrazine results in decreased expression of CASP9 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 asiatic acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of CASP9 protein] CTD PMID:29108773 1,4-benzoquinone multiple interactions ISO RGD:69147 6480464 Carnitine inhibits the reaction [quinone results in increased activity of CASP9 protein], Cyclosporine inhibits the reaction [quinone results in increased expression of CASP9 protein] CTD PMID:29567065 , PMID:32478940 1,4-benzoquinone increases activity ISO RGD:69147 6480464 quinone results in increased activity of CASP9 protein CTD PMID:32478940 1,4-benzoquinone increases expression ISO RGD:69147 6480464 quinone results in increased expression of CASP9 protein CTD PMID:29567065 1,4-dithiothreitol multiple interactions ISO RGD:62159 6480464 Dithiothreitol inhibits the reaction [2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP9 protein] CTD PMID:11226294 1-(4-methoxybenzyl)-3-(5-nitro-1,3-thiazol-2-yl)urea multiple interactions ISO RGD:69147 6480464 [N-(4-methoxybenzyl)-N'-(5-nitro-1, 3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of CASP9 protein] CTD PMID:20540935 1-chloro-2,4-dinitrobenzene decreases expression ISO RGD:62159 6480464 Dinitrochlorobenzene results in decreased expression of CASP9 mRNA CTD PMID:28219650 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:62159 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases cleavage ISO RGD:62159 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:23201480 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:62159 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 more ... 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO RGD:69147 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:15498850 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Gossypol co-treated with Methyltestosterone co-treated with Ethinyl Estradiol] results in increased expression of CASP9 mRNA CTD PMID:15451339 17beta-estradiol multiple interactions EXP 6480464 [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP9 mRNA, ABCC8 protein promotes the reaction [Estradiol results in increased activity of CASP9 protein] CTD PMID:19095654 , PMID:20732338 17beta-estradiol increases expression ISO RGD:69147 6480464 Estradiol analog results in increased expression of CASP9 mRNA, Estradiol analog results in increased expression of CASP9 protein CTD PMID:36460128 17beta-estradiol affects expression ISO RGD:69147 6480464 Estradiol affects the expression of CASP9 mRNA CTD PMID:24481588 17beta-estradiol decreases expression ISO RGD:69147 6480464 Estradiol results in decreased expression of CASP9 mRNA, Estradiol results in decreased expression of CASP9 protein CTD PMID:23373633 more ... 17beta-estradiol multiple interactions ISO RGD:69147 6480464 [Estradiol co-treated with EGF protein] results in decreased expression of CASP9 mRNA more ... CTD PMID:24758408 more ... 17beta-estradiol increases activity ISO RGD:69147 6480464 Estradiol results in increased activity of CASP9 protein CTD PMID:19095654 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 estradiol 3-benzoate results in increased expression of and results in increased activity of CASP9 protein more ... CTD PMID:24316378 17beta-estradiol 3-benzoate increases expression EXP 6480464 estradiol 3-benzoate results in increased expression of CASP9 mRNA CTD PMID:24316378 2,2',4,4',5,5'-hexachlorobiphenyl increases activity ISO RGD:62159 6480464 2 more ... CTD PMID:19362103 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:69147 6480464 2 more ... CTD PMID:20638727 2,2',4,4',5,5'-hexachlorobiphenyl decreases activity EXP 6480464 2 more ... CTD PMID:24726520 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:24726520 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [2 more ... CTD PMID:24726520 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:62159 6480464 2 more ... CTD PMID:25462306 2,2',4,4'-Tetrabromodiphenyl ether decreases activity ISO RGD:69147 6480464 2 more ... CTD PMID:27589474 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:69147 6480464 2 more ... CTD PMID:27060917 , PMID:27589474 2,2',4,5-tetrachlorobiphenyl increases activity ISO RGD:62159 6480464 2 more ... CTD PMID:19362103 2,2,2-tetramine increases activity ISO RGD:69147 6480464 Trientine results in increased activity of CASP9 protein CTD PMID:14513838 2,3',4,4',5-Pentachlorobiphenyl increases activity ISO RGD:62159 6480464 2 more ... CTD PMID:19362103 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62159 6480464 Tetrachlorodibenzodioxin results in increased expression of CASP9 mRNA, Tetrachlorodibenzodioxin results in increased expression of CASP9 protein CTD PMID:15667827 , PMID:15972635 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:69147 6480464 Tetrachlorodibenzodioxin results in decreased expression of CASP9 mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:62159 6480464 Tetrachlorodibenzodioxin affects the expression of CASP9 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CASP9 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CASP9 mRNA CTD PMID:19520675 , PMID:33387578 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CASP9 protein modified form CTD PMID:30503585 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 Hydroxamic Acids analog promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP9 protein modified form], Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP9 protein modified form] CTD PMID:30503585 2,4-D multiple interactions EXP 6480464 [2 more ... CTD PMID:36085217 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases activity ISO RGD:69147 6480464 2 more ... CTD PMID:23124135 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CASP9 mRNA CTD PMID:21346803 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions ISO RGD:69147 6480464 [Verapamil co-treated with gambogic acid] results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:24373880 2-(tert-butylimino)-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one increases activity ISO RGD:69147 6480464 buprofezin results in increased activity of CASP9 protein CTD PMID:36287832 2-acetamidofluorene increases activity EXP 6480464 2-Acetylaminofluorene results in increased activity of CASP9 protein CTD PMID:23665045 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of CASP9 protein CTD PMID:26364502 2-acetamidofluorene multiple interactions EXP 6480464 Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP9 protein], geraniol inhibits the reaction [2-Acetylaminofluorene results in increased expression of CASP9 protein] CTD PMID:23665045 , PMID:26364502 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO RGD:62159 6480464 3-Hydroxybutyric Acid promotes the reaction [[lipopolysaccharide more ... CTD PMID:20558151 more ... 2-amino-2-deoxy-D-galactopyranose increases expression EXP 6480464 Galactosamine results in increased expression of CASP9 protein CTD PMID:22118634 2-amino-2-deoxy-D-galactopyranose multiple interactions EXP 6480464 mangiferin inhibits the reaction [Galactosamine results in increased expression of CASP9 protein] CTD PMID:22118634 2-deoxy-D-glucose multiple interactions ISO RGD:69147 6480464 [Deoxyglucose co-treated with Cisplatin] results in increased activity of CASP9 protein more ... CTD PMID:20138251 , PMID:23041229 2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid multiple interactions ISO RGD:69147 6480464 [anacardic acid co-treated with TNF protein] results in increased cleavage of CASP9 protein CTD PMID:18349320 2-hydroxyethyl methacrylate multiple interactions ISO RGD:69147 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of CASP9 mRNA] more ... CTD PMID:28184909 2-hydroxyethyl methacrylate increases expression ISO RGD:69147 6480464 hydroxyethyl methacrylate results in increased expression of CASP9 mRNA CTD PMID:28184909 2-methoxy-17beta-estradiol increases expression ISO RGD:69147 6480464 2-Methoxyestradiol results in increased expression of CASP9 protein modified form CTD PMID:23967052 2-methoxy-17beta-estradiol increases expression ISO RGD:62159 6480464 2-Methoxyestradiol results in increased expression of CASP9 protein CTD PMID:36414027 2-pyridylethylamine multiple interactions ISO RGD:69147 6480464 [Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased cleavage of CASP9 protein CTD PMID:17327230 25-hydroxycholesterol multiple interactions EXP 6480464 6-hydroxy-2 more ... CTD PMID:25845326 25-hydroxycholesterol increases activity EXP 6480464 25-hydroxycholesterol results in increased activity of CASP9 protein CTD PMID:25845326 28-deoxonimbolide increases activity ISO RGD:69147 6480464 28-deoxonimbolide results in increased activity of CASP9 protein CTD PMID:21381696 3',4',7-trihydroxyisoflavone multiple interactions ISO RGD:69147 6480464 3' more ... CTD PMID:22914566 3',4',7-trihydroxyisoflavone increases expression ISO RGD:69147 6480464 3' more ... CTD PMID:22914566 3',4',7-trihydroxyisoflavone increases activity ISO RGD:69147 6480464 3' more ... CTD PMID:22914566 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:62159 6480464 3 more ... CTD PMID:31563530 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:69147 6480464 tetrabromobisphenol A results in increased expression of CASP9 mRNA CTD PMID:30951941 3,3',5,5'-tetraiodothyroacetic acid multiple interactions ISO RGD:69147 6480464 tetraiodothyroacetic acid inhibits the reaction [heteronemin results in increased expression of CASP9 protein modified form] CTD PMID:35151786 3,3',5,5'-tetraiodothyroacetic acid decreases expression ISO RGD:69147 6480464 tetraiodothyroacetic acid results in decreased expression of CASP9 protein CTD PMID:35151786 3,3'-Dichlorobenzidine increases activity ISO RGD:69147 6480464 3, 3'-Dichlorobenzidine results in increased activity of CASP9 protein CTD PMID:24604609 3,4-dihydroxybenzoic acid multiple interactions EXP 6480464 protocatechuic acid inhibits the reaction [furan results in increased activity of CASP9 protein] CTD PMID:32758512 3,4-methylenedioxymethamphetamine increases activity EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased activity of CASP9 protein CTD PMID:27255387 3-aminobenzamide multiple interactions EXP 6480464 3-aminobenzamide inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] CTD PMID:16505238 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of CASP9 mRNA CTD PMID:30107153 3-chloropropane-1,2-diol multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased cleavage of CASP9 protein] more ... CTD PMID:30107153 , PMID:33651226 3-chloropropane-1,2-diol increases activity ISO RGD:69147 6480464 alpha-Chlorohydrin results in increased activity of CASP9 protein CTD PMID:28070108 , PMID:35149085 3-chloropropane-1,2-diol decreases expression ISO RGD:69147 6480464 alpha-Chlorohydrin results in decreased expression of CASP9 mRNA CTD PMID:27732882 3-chloropropane-1,2-diol multiple interactions ISO RGD:69147 6480464 3-methyladenine inhibits the reaction [Diosgenin inhibits the reaction [alpha-Chlorohydrin results in increased activity of CASP9 protein]] more ... CTD PMID:27732882 more ... 3-chloropropane-1,2-diol increases cleavage ISO RGD:69147 6480464 alpha-Chlorohydrin results in increased cleavage of CASP9 protein CTD PMID:33651226 3-chloropropane-1,2-diol increases cleavage EXP 6480464 alpha-Chlorohydrin results in increased cleavage of CASP9 protein CTD PMID:33651226 3-hydroxybutyric acid multiple interactions ISO RGD:69147 6480464 3-Hydroxybutyric Acid inhibits the reaction [Rotenone results in increased activity of CASP9 protein] CTD PMID:16917840 3-hydroxybutyric acid multiple interactions ISO RGD:62159 6480464 3-Hydroxybutyric Acid promotes the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased expression of CASP9 protein] CTD PMID:31332890 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases expression ISO RGD:69147 6480464 2-amino-3-methylimidazo(4, 5-f)quinoline results in increased expression of CASP9 mRNA CTD PMID:35985368 3-methyladenine multiple interactions ISO RGD:69147 6480464 3-methyladenine inhibits the reaction [Acrolein results in increased cleavage of CASP9 protein] more ... CTD PMID:20104024 more ... 3-methyladenine multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP9 protein], 3-methyladenine promotes the reaction [Staurosporine results in increased cleavage of CASP9 protein] CTD PMID:16497721 , PMID:20426806 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of CASP9 mRNA CTD PMID:23273579 , PMID:29094188 3-methylcholanthrene increases methylation EXP 6480464 Methylcholanthrene results in increased methylation of CASP9 promoter CTD PMID:29094188 3-methylcholanthrene multiple interactions EXP 6480464 [alpha-naphthoflavone co-treated with Methylcholanthrene] results in decreased acetylation of CASP9 promoter more ... CTD PMID:29094188 3-Nitrofluoranthene increases activity ISO RGD:62159 6480464 3-nitrofluoranthene results in increased activity of CASP9 protein CTD PMID:19041363 3-nitropropanoic acid increases activity EXP 6480464 3-nitropropionic acid results in increased activity of CASP9 protein CTD PMID:15571979 3-phenoxybenzoic acid increases expression ISO RGD:69147 6480464 3-phenoxybenzoic acid results in increased expression of CASP9 mRNA CTD PMID:29945211 3-phenoxybenzoic acid multiple interactions ISO RGD:69147 6480464 Acetylcysteine inhibits the reaction [3-phenoxybenzoic acid results in increased expression of CASP9 mRNA] CTD PMID:29945211 3-phenylprop-2-enal decreases expression ISO RGD:62159 6480464 cinnamaldehyde results in decreased expression of CASP9 mRNA CTD PMID:28219650 4'-epidoxorubicin multiple interactions ISO RGD:69147 6480464 3' more ... CTD PMID:22914566 more ... 4'-epidoxorubicin increases expression ISO RGD:69147 6480464 Epirubicin results in increased expression of CASP9 mRNA CTD PMID:22914566 more ... 4'-epidoxorubicin increases activity ISO RGD:69147 6480464 Epirubicin results in increased activity of CASP9 protein CTD PMID:23867903 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid multiple interactions ISO RGD:69147 6480464 4 more ... CTD PMID:14766669 , PMID:28343033 4,4'-sulfonyldiphenol increases activity EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased activity of CASP9 protein CTD PMID:23458715 4,5,6,7-TETRABROMOBENZOTRIAZOLE multiple interactions ISO RGD:69147 6480464 [4 more ... CTD PMID:16489027 4-aminopyridine increases activity EXP 6480464 4-Aminopyridine results in increased activity of CASP9 protein CTD PMID:24378259 4-hydroperoxycyclophosphamide increases activity ISO RGD:62159 6480464 perfosfamide results in increased activity of CASP9 protein CTD PMID:16488414 4-hydroxy-TEMPO decreases expression EXP 6480464 tempol results in decreased expression of CASP9 protein CTD PMID:18714161 4-hydroxynon-2-enal increases activity EXP 6480464 4-hydroxy-2-nonenal results in increased activity of CASP9 protein CTD PMID:21187080 4-hydroxynon-2-enal increases activity ISO RGD:69147 6480464 4-hydroxy-2-nonenal results in increased activity of CASP9 protein CTD PMID:24825450 4-hydroxynon-2-enal multiple interactions ISO RGD:62159 6480464 pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein], resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein] CTD PMID:16322078 4-hydroxynon-2-enal increases activity ISO RGD:62159 6480464 4-hydroxy-2-nonenal results in increased activity of CASP9 protein CTD PMID:16322078 , PMID:17263905 4-hydroxyphenyl retinamide multiple interactions ISO RGD:69147 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Fenretinide results in increased cleavage of CASP9 protein] more ... CTD PMID:16407847 , PMID:17273769 4-Nerolidylcatechol multiple interactions ISO RGD:69147 6480464 1 more ... CTD PMID:22372875 4-Nerolidylcatechol increases cleavage ISO RGD:69147 6480464 4-nerolidylcatechol results in increased cleavage of CASP9 protein CTD PMID:22372875 4-nitrophenol increases expression ISO RGD:62159 6480464 4-nitrophenol results in increased expression of CASP9 mRNA CTD PMID:34673133 4-nonylphenol increases cleavage ISO RGD:62159 6480464 4-nonylphenol results in increased cleavage of CASP9 protein CTD PMID:22056370 4-nonylphenol decreases expression EXP 6480464 4-nonylphenol results in decreased expression of CASP9 mRNA CTD PMID:27109770 4-nonylphenol increases expression EXP 6480464 4-nonylphenol results in increased expression of CASP9 mRNA CTD PMID:27087316 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased cleavage of CASP9 protein] CTD PMID:33651226 4-phenylbutyric acid multiple interactions ISO RGD:69147 6480464 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased cleavage of CASP9 protein] more ... CTD PMID:29306025 more ... 4-vinylcyclohexene dioxide affects expression ISO RGD:62159 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of CASP9 mRNA CTD PMID:20829426 5-aminolevulinic acid multiple interactions ISO RGD:69147 6480464 pyrazolanthrone inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP9 protein] CTD PMID:21138480 5-aminolevulinic acid increases activity ISO RGD:69147 6480464 Aminolevulinic Acid analog results in increased activity of CASP9 protein CTD PMID:17245620 , PMID:21138480 5-aminolevulinic acid increases activity EXP 6480464 Aminolevulinic Acid analog results in increased activity of CASP9 protein CTD PMID:20426806 5-aminolevulinic acid multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP9 protein] CTD PMID:20426806 5-aza-2'-deoxycytidine increases cleavage ISO RGD:69147 6480464 Decitabine results in increased cleavage of CASP9 protein CTD PMID:18636160 5-aza-2'-deoxycytidine multiple interactions ISO RGD:69147 6480464 [Decitabine affects the methylation of CASP9 gene] which affects the expression of CASP9 protein more ... CTD PMID:18636160 more ... 5-azacytidine increases expression ISO RGD:62159 6480464 Azacitidine results in increased expression of CASP9 mRNA CTD PMID:23395740 5-fluorouracil multiple interactions ISO RGD:69147 6480464 [Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of CASP9 mRNA more ... CTD PMID:12414664 more ... 5-fluorouracil multiple interactions EXP 6480464 Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 mRNA], Fluorouracil inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein] CTD PMID:31129132 5-fluorouracil multiple interactions ISO RGD:62159 6480464 Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP9 protein] more ... CTD PMID:28025107 , PMID:32270916 5-fluorouracil increases activity ISO RGD:62159 6480464 Fluorouracil results in increased activity of CASP9 protein CTD PMID:28025107 , PMID:32270916 5-fluorouracil increases activity ISO RGD:69147 6480464 Fluorouracil results in increased activity of CASP9 protein CTD PMID:10779637 more ... 5-fluorouracil decreases expression ISO RGD:69147 6480464 Fluorouracil results in decreased expression of CASP9 mRNA CTD PMID:23941782 5-fluorouracil increases expression ISO RGD:69147 6480464 Fluorouracil results in increased expression of CASP9 protein CTD PMID:16803524 5-fluorouracil increases cleavage ISO RGD:69147 6480464 Fluorouracil results in increased cleavage of CASP9 protein CTD PMID:17498489 , PMID:19816940 5-methoxypsoralen increases cleavage ISO RGD:69147 6480464 5-Methoxypsoralen results in increased cleavage of CASP9 protein CTD PMID:30576070 5-methoxypsoralen multiple interactions ISO RGD:69147 6480464 pifithrin inhibits the reaction [5-Methoxypsoralen results in increased cleavage of CASP9 protein] CTD PMID:30576070 6-(cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine multiple interactions ISO RGD:69147 6480464 4-cyclohexylmethoxy-5-nitrosopyrimidine-2, 6-diamine promotes the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP9 protein] CTD PMID:26208482 7,12-dimethyltetraphene decreases expression ISO RGD:62159 6480464 9 more ... CTD PMID:25478867 , PMID:33347706 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:30101532 7,12-dimethyltetraphene multiple interactions EXP 6480464 Taurine inhibits the reaction [9 more ... CTD PMID:30101532 7,12-dimethyltetraphene decreases activity ISO RGD:62159 6480464 9 more ... CTD PMID:25478867 7,12-dimethyltetraphene multiple interactions ISO RGD:62159 6480464 [9 more ... CTD PMID:25478867 more ... 7,8-Diacetoxy-4-methylcoumarin increases activity ISO RGD:69147 6480464 7, 8-diacetoxy-4-methylcoumarin results in increased activity of CASP9 protein CTD PMID:19061872 7-ketocholesterol multiple interactions EXP 6480464 6-hydroxy-2 more ... CTD PMID:25845326 7-ketocholesterol increases activity EXP 6480464 7-ketocholesterol results in increased activity of CASP9 protein CTD PMID:25845326 8-Br-cAMP increases expression ISO RGD:69147 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CASP9 mRNA CTD PMID:22079614 9'-cis-neoxanthin multiple interactions ISO RGD:69147 6480464 neoxanthin results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:17186379 9,10-anthraquinone increases activity ISO RGD:69147 6480464 9, 10-anthraquinone analog results in increased activity of CASP9 protein CTD PMID:26915975 9,10-phenanthroquinone increases activity ISO RGD:69147 6480464 9, 10-phenanthrenequinone results in increased activity of CASP9 protein CTD PMID:29108775 9,10-phenanthroquinone multiple interactions ISO RGD:69147 6480464 Acetylcysteine inhibits the reaction [9, 10-phenanthrenequinone results in increased activity of CASP9 protein] CTD PMID:29108775 9-hydroxycanthin-6-one increases cleavage ISO RGD:69147 6480464 9-hydroxycanthin-6-one results in increased cleavage of CASP9 protein CTD PMID:29225138 [6]-Shogaol multiple interactions ISO RGD:69147 6480464 shogaol results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:18384088 ABT-737 increases cleavage ISO RGD:69147 6480464 ABT-737 results in increased cleavage of CASP9 protein CTD PMID:20104024 , PMID:33662508 ABT-737 multiple interactions ISO RGD:69147 6480464 3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]] more ... CTD PMID:20104024 , PMID:23353698 ABT-737 increases activity ISO RGD:69147 6480464 ABT-737 results in increased activity of CASP9 protein CTD PMID:30461186 acadesine increases cleavage ISO RGD:62159 6480464 acadesine results in increased cleavage of CASP9 protein CTD PMID:22137261 acetochlor multiple interactions ISO RGD:69147 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [acetochlor results in increased cleavage of CASP9 protein] CTD PMID:25291404 acetochlor increases cleavage ISO RGD:69147 6480464 acetochlor results in increased cleavage of CASP9 protein CTD PMID:25291404 acetylsalicylic acid multiple interactions ISO RGD:69147 6480464 [TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP9 protein more ... CTD PMID:14753751 more ... acetylsalicylic acid increases activity ISO RGD:62159 6480464 Aspirin results in increased activity of CASP9 protein CTD PMID:16880202 acetylsalicylic acid increases activity ISO RGD:69147 6480464 Aspirin results in increased activity of CASP9 protein CTD PMID:11034327 aconitine increases expression EXP 6480464 Aconitine results in increased expression of CASP9 protein CTD PMID:24840785 acrolein increases activity ISO RGD:69147 6480464 Acrolein results in increased activity of CASP9 protein CTD PMID:19596284 acrolein increases cleavage ISO RGD:69147 6480464 Acrolein results in increased cleavage of CASP9 protein CTD PMID:29902662 , PMID:29964147 acrolein multiple interactions ISO RGD:69147 6480464 3-methyladenine inhibits the reaction [Acrolein results in increased cleavage of CASP9 protein] more ... CTD PMID:29902662 , PMID:29964147 acrolein decreases activity ISO RGD:62159 6480464 Acrolein results in decreased activity of CASP9 protein CTD PMID:11803030 acrylamide increases expression ISO RGD:69147 6480464 Acrylamide results in increased expression of CASP9 mRNA CTD PMID:28159594 , PMID:32763439 acrylamide multiple interactions ISO RGD:69147 6480464 salvin inhibits the reaction [Acrylamide results in increased expression of CASP9 mRNA] CTD PMID:28159594 actinomycin D multiple interactions ISO RGD:69147 6480464 [Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP9 protein CTD PMID:17707539 actinomycin D increases cleavage ISO RGD:62159 6480464 Dactinomycin results in increased cleavage of CASP9 protein CTD PMID:26670606 adenosine increases activity ISO RGD:69147 6480464 Adenosine results in increased activity of CASP9 protein CTD PMID:11570579 adenosine increases activity EXP 6480464 Adenosine results in increased activity of CASP9 protein CTD PMID:16469385 adenosine multiple interactions ISO RGD:69147 6480464 Thymidine inhibits the reaction [Adenosine results in increased activity of CASP9 protein] CTD PMID:11570579 aflatoxin B1 increases cleavage ISO RGD:69147 6480464 Aflatoxin B1 results in increased cleavage of CASP9 protein CTD PMID:22743290 aflatoxin B1 increases cleavage ISO RGD:62159 6480464 Aflatoxin B1 results in increased cleavage of CASP9 protein CTD PMID:34396909 aflatoxin B1 multiple interactions ISO RGD:69147 6480464 Zearalenone promotes the reaction [[Aflatoxin B1 co-treated with deoxynivalenol] results in increased expression of CASP9 mRNA] CTD PMID:30668976 aflatoxin B1 increases expression ISO RGD:69147 6480464 Aflatoxin B1 results in increased expression of CASP9 mRNA CTD PMID:27017951 , PMID:30668976 AICA ribonucleotide increases activity EXP 6480464 AICA ribonucleotide results in increased activity of CASP9 protein CTD PMID:16469385 alantolactone increases cleavage ISO RGD:69147 6480464 alantolactone results in increased cleavage of CASP9 protein CTD PMID:22721982 alantolactone increases activity ISO RGD:69147 6480464 alantolactone results in increased activity of CASP9 protein CTD PMID:24252419 alborixin increases activity ISO RGD:69147 6480464 alborixin results in increased activity of CASP9 protein CTD PMID:27378626 aldehydo-D-glucose multiple interactions ISO RGD:69147 6480464 [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein more ... CTD PMID:17309078 , PMID:30431688 aldehydo-D-glucose increases cleavage ISO RGD:69147 6480464 Glucose results in increased cleavage of CASP9 protein CTD PMID:30431688 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of CASP9 mRNA CTD PMID:23192364 aldehydo-D-glucose multiple interactions EXP 6480464 [Glucose co-treated with IGF2R protein modified form] results in increased expression of CASP9 protein more ... CTD PMID:18791325 more ... aldehydo-D-glucose increases activity EXP 6480464 Glucose results in increased activity of CASP9 CTD PMID:18791325 aldrithiol increases activity EXP 6480464 2, 2'-dipyridyl disulfide results in increased activity of CASP9 protein CTD PMID:11331359 alendronic acid multiple interactions ISO RGD:69147 6480464 TNFSF11 inhibits the reaction [Alendronate results in increased expression of CASP9 protein] CTD PMID:19405951 alginic acid increases expression ISO RGD:62159 6480464 Alginic Acid results in increased expression of CASP9 protein CTD PMID:35066102 all-trans-acitretin increases activity ISO RGD:69147 6480464 Acitretin results in increased activity of CASP9 protein CTD PMID:18624760 all-trans-neoxanthin multiple interactions ISO RGD:69147 6480464 neoxanthin results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:17186379 all-trans-retinoic acid multiple interactions ISO RGD:69147 6480464 [IFNB1 protein co-treated with Tretinoin] results in increased cleavage of and results in increased activity of CASP9 protein more ... CTD PMID:16166294 more ... all-trans-retinoic acid increases expression ISO RGD:69147 6480464 Tretinoin results in increased expression of CASP9 mRNA CTD PMID:15498508 more ... all-trans-retinoic acid decreases expression ISO RGD:62159 6480464 Tretinoin results in decreased expression of CASP9 mRNA CTD PMID:22498432 all-trans-retinoic acid increases expression ISO RGD:62159 6480464 Tretinoin results in increased expression of CASP9 protein CTD PMID:16764683 all-trans-retinoic acid increases activity ISO RGD:62159 6480464 Tretinoin results in increased activity of CASP9 protein CTD PMID:16291826 all-trans-retinoic acid multiple interactions ISO RGD:62159 6480464 benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Tretinoin results in increased activity of CASP9 protein] CTD PMID:16291826 all-trans-retinoic acid increases activity ISO RGD:69147 6480464 Tretinoin results in increased activity of CASP9 protein CTD PMID:16568081 allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP9 mRNA more ... CTD PMID:33396045 more ... alloxan increases activity EXP 6480464 Alloxan results in increased activity of CASP9 protein CTD PMID:21982801 alloxan increases expression EXP 6480464 Alloxan results in increased expression of CASP9 protein, Alloxan results in increased expression of CASP9 protein modified form CTD PMID:22138235 , PMID:23092809 alloxan multiple interactions EXP 6480464 D-Glucaric acid more ... CTD PMID:21982801 more ... Aloe emodin increases activity ISO RGD:69147 6480464 aloe emodin results in increased activity of CASP9 protein CTD PMID:19928967 Aloe emodin increases expression ISO RGD:69147 6480464 aloe emodin results in increased expression of CASP9 protein modified form CTD PMID:19928967 Aloe emodin multiple interactions ISO RGD:69147 6480464 [Fluorouracil co-treated with aloe emodin] affects the expression of CASP9, Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP9 protein modified form] CTD PMID:19928967 aloxistatin multiple interactions ISO RGD:69147 6480464 aloxistatin inhibits the reaction [syringic acid analog results in increased secretion of CASP9 protein] CTD PMID:34523043 alpha-D-galactose multiple interactions EXP 6480464 [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] CTD PMID:25997894 alpha-D-galactose multiple interactions ISO RGD:62159 6480464 albicanol inhibits the reaction [Galactose results in increased expression of CASP9 mRNA] CTD PMID:33761044 alpha-D-galactose increases expression ISO RGD:62159 6480464 Galactose results in increased expression of CASP9 mRNA CTD PMID:33761044 alpha-D-galactose increases expression EXP 6480464 Galactose results in increased expression of CASP9 protein CTD PMID:32295448 alpha-mangostin increases activity ISO RGD:69147 6480464 mangostin results in increased activity of CASP9 protein CTD PMID:23954321 , PMID:24480042 alpha-naphthoflavone increases activity ISO RGD:62159 6480464 alpha-naphthoflavone results in increased activity of CASP9 protein CTD PMID:18334599 alpha-naphthoflavone multiple interactions EXP 6480464 [alpha-naphthoflavone co-treated with Methylcholanthrene] results in decreased acetylation of CASP9 promoter more ... CTD PMID:29094188 alpinumisoflavone multiple interactions ISO RGD:69147 6480464 [alpinumisoflavone results in increased expression of FAS protein] which results in increased cleavage of CASP9 protein CTD PMID:23850732 alpinumisoflavone increases cleavage ISO RGD:69147 6480464 alpinumisoflavone results in increased cleavage of CASP9 protein CTD PMID:23850732 alternariol increases activity ISO RGD:69147 6480464 alternariol results in increased activity of CASP9 protein CTD PMID:22542754 aluminium atom multiple interactions ISO RGD:69147 6480464 [aluminum chlorhydrate results in increased abundance of Aluminum] which results in decreased expression of CASP9 protein, Fulvestrant inhibits the reaction [[aluminum chlorhydrate results in increased abundance of Aluminum] which results in decreased expression of CASP9 protein] CTD PMID:31945389 aluminium(0) multiple interactions ISO RGD:69147 6480464 [aluminum chlorhydrate results in increased abundance of Aluminum] which results in decreased expression of CASP9 protein, Fulvestrant inhibits the reaction [[aluminum chlorhydrate results in increased abundance of Aluminum] which results in decreased expression of CASP9 protein] CTD PMID:31945389 alvocidib multiple interactions ISO RGD:69147 6480464 [alvocidib co-treated with ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate] results in increased cleavage of CASP9 protein, BCL2 protein mutant form inhibits the reaction [alvocidib results in increased activity of CASP9 protein] CTD PMID:12170773 , PMID:15634644 alvocidib affects cleavage ISO RGD:69147 6480464 alvocidib affects the cleavage of CASP9 protein CTD PMID:10896673 alvocidib increases activity ISO RGD:69147 6480464 alvocidib results in increased activity of CASP9 protein CTD PMID:12170773 amiloride multiple interactions ISO RGD:69147 6480464 Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP9 protein] CTD PMID:16059913 aminoguanidine multiple interactions ISO RGD:62159 6480464 pimagedine inhibits the reaction [Cardiotoxins results in increased cleavage of CASP9 protein] CTD PMID:17786558 aminoguanidine multiple interactions ISO RGD:69147 6480464 pimagedine inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP9 protein] more ... CTD PMID:19556603 , PMID:33930484 amiodarone increases expression ISO RGD:69147 6480464 Amiodarone results in increased expression of CASP9 mRNA CTD PMID:19774075 amiodarone multiple interactions ISO RGD:62159 6480464 [Amiodarone co-treated with TNF protein] results in increased activity of CASP9 protein CTD PMID:23042730 amiodarone multiple interactions ISO RGD:69147 6480464 [TNFSF10 co-treated with Amiodarone] results in increased cleavage of CASP9 protein CTD PMID:21292685 ammonium chloride multiple interactions EXP 6480464 (1 more ... CTD PMID:14535961 ammonium chloride increases activity EXP 6480464 Ammonium Chloride results in increased activity of CASP9 protein CTD PMID:14535961 , PMID:18722528 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CASP9 mRNA CTD PMID:16483693 ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of CASP9 protein CTD PMID:16483693 amosite asbestos multiple interactions ISO RGD:69147 6480464 4 more ... CTD PMID:12540492 , PMID:14766669 amosite asbestos multiple interactions EXP 6480464 pifithrin inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein] CTD PMID:16357363 amosite asbestos increases activity EXP 6480464 Asbestos, Amosite results in increased activity of CASP9 protein CTD PMID:12540492 , PMID:16357363 amosite asbestos increases activity ISO RGD:69147 6480464 Asbestos, Amosite results in increased activity of CASP9 protein CTD PMID:12540492 , PMID:14766669 amphetamine increases activity EXP 6480464 Amphetamine results in increased activity of CASP9 protein CTD PMID:16638611 andrographolide increases activity ISO RGD:69147 6480464 andrographolide results in increased activity of CASP9 protein CTD PMID:19097688 andrographolide increases expression ISO RGD:69147 6480464 andrographolide results in increased expression of CASP9 mRNA CTD PMID:24563380 andrographolide multiple interactions EXP 6480464 andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein] more ... CTD PMID:20946909 andrographolide multiple interactions ISO RGD:69147 6480464 [andrographolide co-treated with Cisplatin] results in increased expression of CASP9 mRNA more ... CTD PMID:19097688 , PMID:24563380 anethole multiple interactions EXP 6480464 anethole inhibits the reaction [Isoproterenol results in increased cleavage of CASP9 protein] CTD PMID:35430261 anthocyanin multiple interactions EXP 6480464 Anthocyanins inhibits the reaction [Streptozocin results in increased expression of CASP9 protein] CTD PMID:28856781 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:69147 6480464 pyrazolanthrone inhibits the reaction [5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone results in increased cleavage of CASP9 protein] more ... CTD PMID:15501958 more ... anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP9 protein] more ... CTD PMID:16310883 more ... anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:62159 6480464 pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein], pyrazolanthrone inhibits the reaction [Cardiotoxins results in increased cleavage of CASP9 protein] CTD PMID:16322078 , PMID:17786558 anthra[1,9-cd]pyrazol-6(2H)-one increases activity ISO RGD:69147 6480464 pyrazolanthrone results in increased activity of CASP9 protein CTD PMID:15034932 antimycin A decreases expression ISO RGD:69147 6480464 Antimycin A results in decreased expression of CASP9 mRNA CTD PMID:33512557 antimycin A multiple interactions ISO RGD:69147 6480464 Acetylcysteine inhibits the reaction [Antimycin A results in increased cleavage of CASP9 protein] CTD PMID:32662599 antimycin A increases cleavage ISO RGD:69147 6480464 Antimycin A results in increased cleavage of CASP9 protein CTD PMID:32662599 antirheumatic drug decreases expression ISO RGD:69147 6480464 Antirheumatic Agents results in decreased expression of CASP9 mRNA CTD PMID:24449571 apigenin increases cleavage ISO RGD:69147 6480464 Apigenin results in increased cleavage of CASP9 protein CTD PMID:15486995 , PMID:19397994 apigenin increases activity ISO RGD:62159 6480464 Apigenin results in increased activity of CASP9 protein CTD PMID:28025107 apigenin multiple interactions ISO RGD:62159 6480464 Apigenin promotes the reaction [Fluorouracil results in increased activity of CASP9 protein], Fluorouracil promotes the reaction [Apigenin results in increased activity of CASP9 protein] CTD PMID:28025107 apigenin multiple interactions EXP 6480464 (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP9 protein modified form] more ... CTD PMID:25557508 more ... apigenin multiple interactions ISO RGD:69147 6480464 [Polylactic Acid-Polyglycolic Acid Copolymer co-treated with Apigenin] results in increased expression of CASP9 mRNA more ... CTD PMID:24070738 , PMID:29247770 arachidonic acid increases activity ISO RGD:69147 6480464 Arachidonic Acid results in increased activity of CASP9 protein CTD PMID:19540902 , PMID:19720122 arachidonyl-2'-chloroethylamide multiple interactions ISO RGD:62159 6480464 arachidonyl-2-chloroethylamide inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] CTD PMID:31256211 arecoline increases cleavage EXP 6480464 Arecoline results in increased cleavage of CASP9 protein CTD PMID:33929070 aristolochic acid A increases expression ISO RGD:62159 6480464 aristolochic acid I results in increased expression of CASP9 protein modified form CTD PMID:26656393 aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of CASP9 mRNA, aristolochic acid I results in increased expression of CASP9 protein CTD PMID:34167444 more ... aristolochic acid A multiple interactions EXP 6480464 aristolochic acid I results in increased expression of and results in increased cleavage of CASP9 protein more ... CTD PMID:35850572 , PMID:36037877 arjunolic acid multiple interactions ISO RGD:62159 6480464 arjunolic acid inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] CTD PMID:21420465 Aroclor 1254 multiple interactions EXP 6480464 Quercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of CASP9 mRNA] CTD PMID:23281070 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CASP9 mRNA CTD PMID:23281070 arsane increases expression ISO RGD:69147 6480464 Arsenic results in increased expression of CASP9 mRNA CTD PMID:11134558 arsane multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CASP9 protein, sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CASP9 protein] CTD PMID:30835071 arsanilic acid increases activity EXP 6480464 Arsanilic Acid results in increased activity of CASP9 protein CTD PMID:23848144 arsenic atom increases expression ISO RGD:69147 6480464 Arsenic results in increased expression of CASP9 mRNA CTD PMID:11134558 arsenic atom multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CASP9 protein, sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CASP9 protein] CTD PMID:30835071 arsenite(3-) affects expression ISO RGD:69147 6480464 arsenite affects the expression of CASP9 protein CTD PMID:20083129 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of CASP9 mRNA CTD PMID:29324385 arsenite(3-) multiple interactions EXP 6480464 Selenium inhibits the reaction [arsenite results in increased expression of CASP9 mRNA] CTD PMID:29324385 arsenite(3-) multiple interactions ISO RGD:69147 6480464 [arsenite results in decreased activity of PARP1 protein] which results in decreased cleavage of and results in decreased activity of CASP9 protein, arsenite results in decreased cleavage of and results in decreased activity of CASP9 protein CTD PMID:22387748 arsenite(3-) increases cleavage ISO RGD:69147 6480464 arsenite results in increased cleavage of CASP9 protein CTD PMID:17553788 arsenous acid increases cleavage EXP 6480464 Arsenic Trioxide results in increased cleavage of CASP9 protein CTD PMID:24634002 arsenous acid increases cleavage ISO RGD:69147 6480464 Arsenic Trioxide results in increased cleavage of CASP9 protein CTD PMID:12480548 more ... arsenous acid increases activity ISO RGD:62159 6480464 Arsenic Trioxide results in increased activity of CASP9 protein CTD PMID:21565247 , PMID:24157283 arsenous acid multiple interactions ISO RGD:62159 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CASP9 protein] more ... CTD PMID:15688020 more ... arsenous acid increases activity EXP 6480464 Arsenic Trioxide results in increased activity of CASP9 protein CTD PMID:21145380 arsenous acid multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [CASP9 protein binds to CYCS protein]] more ... CTD PMID:21145380 , PMID:24634002 arsenous acid increases expression ISO RGD:62159 6480464 Arsenic Trioxide results in increased expression of CASP9 protein modified form CTD PMID:28587418 arsenous acid increases cleavage ISO RGD:62159 6480464 Arsenic Trioxide results in increased cleavage of CASP9 protein CTD PMID:24801902 arsenous acid increases activity ISO RGD:69147 6480464 Arsenic Trioxide results in increased activity of CASP9 protein CTD PMID:12148893 more ... arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CASP9 mRNA CTD PMID:19730151 arsenous acid increases expression ISO RGD:69147 6480464 Arsenic Trioxide results in increased expression of CASP9 protein CTD PMID:23980369 arsenous acid multiple interactions ISO RGD:69147 6480464 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein] more ... CTD PMID:17237268 more ... arsenous acid decreases expression ISO RGD:69147 6480464 Arsenic Trioxide results in decreased expression of CASP9 protein CTD PMID:22963400 , PMID:29164574 arsenous acid decreases expression ISO RGD:62159 6480464 Arsenic Trioxide results in decreased expression of CASP9 protein CTD PMID:18336854 artesunate affects expression ISO RGD:69147 6480464 artesunate affects the expression of CASP9 protein CTD PMID:24704559 asbestos increases activity EXP 6480464 Asbestos results in increased activity of CASP9 protein CTD PMID:15618436 asbestos multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [FGF10 protein inhibits the reaction [Asbestos results in increased activity of CASP9 protein]] more ... CTD PMID:15618436 asiatic acid multiple interactions EXP 6480464 asiatic acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of CASP9 protein] CTD PMID:29108773 aspartame multiple interactions ISO RGD:62159 6480464 [Fats more ... CTD PMID:23783067 astilbin multiple interactions ISO RGD:69147 6480464 astilbin inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] CTD PMID:29471006 atorvastatin calcium increases activity EXP 6480464 Atorvastatin results in increased activity of CASP9 protein CTD PMID:18339080 atorvastatin calcium increases activity ISO RGD:69147 6480464 Atorvastatin results in increased activity of CASP9 protein CTD PMID:15705602 more ... atorvastatin calcium multiple interactions ISO RGD:69147 6480464 [Atorvastatin co-treated with Celecoxib] results in increased cleavage of CASP9 protein CTD PMID:18172863 atorvastatin calcium multiple interactions EXP 6480464 Mevalonic Acid inhibits the reaction [Atorvastatin results in increased activity of CASP9 protein], U 0126 inhibits the reaction [Atorvastatin results in increased activity of CASP9 protein] CTD PMID:18339080 atrazine increases expression EXP 6480464 Atrazine results in increased expression of CASP9 mRNA, Atrazine results in increased expression of CASP9 protein CTD PMID:26075868 , PMID:30084861 atrazine decreases expression ISO RGD:69147 6480464 Atrazine results in decreased expression of CASP9 mRNA CTD PMID:22378314 atrazine multiple interactions EXP 6480464 kolaviron inhibits the reaction [Atrazine affects the expression of CASP9] CTD PMID:21726175 atrazine affects expression EXP 6480464 Atrazine affects the expression of CASP9 CTD PMID:21726175 atrazine increases expression ISO RGD:69147 6480464 Atrazine results in increased expression of CASP9 mRNA CTD PMID:21333729 atrazine multiple interactions ISO RGD:69147 6480464 kolaviron inhibits the reaction [Atrazine results in increased expression of CASP9 mRNA] CTD PMID:21333729 aucubin multiple interactions ISO RGD:62159 6480464 aucubin inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] CTD PMID:32504734 Augmentin increases activity EXP 6480464 Amoxicillin-Potassium Clavulanate Combination results in increased activity of CASP9 protein CTD PMID:30273099 auranofin multiple interactions ISO RGD:69147 6480464 Auranofin results in decreased expression of and results in increased cleavage of CASP9 protein CTD PMID:20542334 Auriculasin multiple interactions ISO RGD:69147 6480464 [auriculasin co-treated with TNFSF10 protein] results in increased expression of CASP9 protein, TNFRSF10B protein affects the reaction [[auriculasin co-treated with TNFSF10 protein] results in increased expression of CASP9 protein] CTD PMID:30817944 azadirachtin A increases expression ISO RGD:69147 6480464 azadirachtin results in increased expression of CASP9 mRNA, azadirachtin results in increased expression of CASP9 protein CTD PMID:20429769 azadiradione increases activity ISO RGD:69147 6480464 azadiradione results in increased activity of CASP9 protein CTD PMID:21381696 azilsartan multiple interactions ISO RGD:69147 6480464 [Zinc Sulfate binds to azilsartan] which results in increased expression of CASP9 protein CTD PMID:29408668 bafilomycin A1 multiple interactions EXP 6480464 bafilomycin A1 inhibits the reaction [manganese chloride results in increased cleavage of CASP9 protein] CTD PMID:28378122 bafilomycin A1 multiple interactions ISO RGD:69147 6480464 bafilomycin A1 inhibits the reaction [Soot analog results in increased expression of CASP9 protein] CTD PMID:30240709 beauvericin increases expression ISO RGD:69147 6480464 beauvericin results in increased expression of CASP9 mRNA CTD PMID:29203277 beclomethasone increases activity ISO RGD:69147 6480464 Beclomethasone results in increased activity of CASP9 protein CTD PMID:11734450 belinostat increases cleavage ISO RGD:69147 6480464 belinostat results in increased cleavage of CASP9 protein CTD PMID:18223231 , PMID:25537862 belinostat multiple interactions ISO RGD:69147 6480464 Bortezomib promotes the reaction [belinostat results in increased cleavage of CASP9 protein] CTD PMID:18223231 benzene increases expression EXP 6480464 Benzene results in increased expression of CASP9 protein CTD PMID:17171516 benzene multiple interactions ISO RGD:62159 6480464 shikonin inhibits the reaction [Benzene results in increased cleavage of CASP9 protein], shikonin inhibits the reaction [Benzene results in increased expression of CASP9 mRNA] CTD PMID:36306860 benzene increases expression ISO RGD:62159 6480464 Benzene results in increased expression of CASP9 mRNA CTD PMID:36306860 benzene increases cleavage ISO RGD:62159 6480464 Benzene results in increased cleavage of CASP9 protein CTD PMID:36306860 benzene increases expression ISO RGD:69147 6480464 Benzene results in increased expression of CASP9 mRNA CTD PMID:19162166 benzene-1,2,4-triol increases activity ISO RGD:69147 6480464 hydroxyhydroquinone results in increased activity of CASP9 protein CTD PMID:23776099 benzo[a]pyrene multiple interactions ISO RGD:69147 6480464 Nitrogen Oxides inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP9 protein] CTD PMID:16041517 benzo[a]pyrene decreases activity ISO RGD:62159 6480464 Benzo(a)pyrene results in decreased activity of CASP9 protein CTD PMID:28681665 benzo[a]pyrene multiple interactions ISO RGD:62159 6480464 [Phytol co-treated with Benzo(a)pyrene] results in decreased expression of CASP9 protein more ... CTD PMID:28681665 , PMID:30520250 benzo[a]pyrene affects methylation ISO RGD:69147 6480464 Benzo(a)pyrene affects the methylation of CASP9 exon CTD PMID:27901495 benzo[a]pyrene increases activity ISO RGD:62159 6480464 Benzo(a)pyrene results in increased activity of CASP9 protein CTD PMID:27208085 benzo[a]pyrene increases expression ISO RGD:69147 6480464 Benzo(a)pyrene results in increased expression of CASP9 mRNA CTD PMID:21393351 , PMID:24239969 benzo[a]pyrene multiple interactions EXP 6480464 Glycyrrhizic Acid inhibits the reaction [Benzo(a)pyrene results in increased activity of CASP9 protein] CTD PMID:22051199 benzo[a]pyrene increases activity EXP 6480464 Benzo(a)pyrene results in increased activity of CASP9 protein CTD PMID:22051199 benzo[a]pyrene increases cleavage ISO RGD:69147 6480464 Benzo(a)pyrene results in increased cleavage of CASP9 protein CTD PMID:16041517 , PMID:30659931 benzo[a]pyrene diol epoxide I multiple interactions ISO RGD:69147 6480464 TP53 protein affects the reaction [7 more ... CTD PMID:21983885 benzo[a]pyrene diol epoxide I increases cleavage ISO RGD:69147 6480464 7 more ... CTD PMID:21983885 benzo[e]pyrene multiple interactions ISO RGD:69147 6480464 Genistein inhibits the reaction [benzo(e)pyrene results in increased activity of CASP9 protein], resveratrol inhibits the reaction [benzo(e)pyrene results in increased activity of CASP9 protein] CTD PMID:19959636 benzo[e]pyrene increases activity ISO RGD:69147 6480464 benzo(e)pyrene results in increased activity of CASP9 protein CTD PMID:18586875 , PMID:19959636 berberine increases cleavage ISO RGD:69147 6480464 Berberine results in increased cleavage of CASP9 protein CTD PMID:16505103 berberine multiple interactions EXP 6480464 [Berberine co-treated with Thioacetamide] results in increased expression of CASP9 mRNA CTD PMID:30138605 berberine multiple interactions ISO RGD:69147 6480464 [Berberine co-treated with Niacinamide] results in increased cleavage of CASP9 protein CTD PMID:26712469 beta-carboline increases expression ISO RGD:69147 6480464 norharman results in increased expression of CASP9 mRNA CTD PMID:35985368 Beta-Solamarine increases cleavage ISO RGD:69147 6480464 beta-solamarine results in increased cleavage of CASP9 protein CTD PMID:20647040 Beta-Solamarine multiple interactions ISO RGD:69147 6480464 beta-solamarine promotes the reaction [Cisplatin results in increased activity of CASP9 protein] CTD PMID:17619073 Beta-Solamarine increases activity ISO RGD:69147 6480464 beta-solamarine results in increased activity of CASP9 protein CTD PMID:17619073 betulin increases cleavage ISO RGD:69147 6480464 betulin results in increased cleavage of CASP9 protein CTD PMID:32190974 betulinic acid increases activity ISO RGD:69147 6480464 Betulinic Acid analog results in increased activity of CASP9 protein, Betulinic Acid results in increased activity of CASP9 protein CTD PMID:26772157 , PMID:29454615 bifenthrin increases expression ISO RGD:62159 6480464 bifenthrin results in increased expression of CASP9 mRNA CTD PMID:32408700 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:69147 6480464 benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Mustard Gas results in increased activity of CASP9 protein] more ... CTD PMID:16935404 more ... bis(2-chloroethyl) sulfide increases cleavage ISO RGD:69147 6480464 Mustard Gas results in increased cleavage of CASP9 protein CTD PMID:20435105 , PMID:25448276 bis(2-chloroethyl) sulfide increases cleavage EXP 6480464 Mustard Gas results in increased cleavage of CASP9 protein CTD PMID:20659490 bis(2-chloroethyl) sulfide increases activity ISO RGD:69147 6480464 Mustard Gas results in increased activity of CASP9 protein CTD PMID:12482751 more ... bis(2-ethylhexyl) phthalate increases activity ISO RGD:69147 6480464 Diethylhexyl Phthalate results in increased activity of CASP9 protein CTD PMID:22155658 bisphenol A increases expression ISO RGD:69147 6480464 bisphenol A results in increased expression of CASP9 mRNA, bisphenol A results in increased expression of CASP9 protein CTD PMID:21277958 more ... bisphenol A multiple interactions ISO RGD:69147 6480464 [naringenin co-treated with bisphenol A] results in increased expression of CASP9 mRNA, [naringenin metabolite co-treated with bisphenol A] results in increased expression of CASP9 mRNA CTD PMID:36235125 bisphenol A multiple interactions ISO RGD:62159 6480464 Drugs more ... CTD PMID:32488702 , PMID:36858637 bisphenol A increases cleavage ISO RGD:62159 6480464 bisphenol A results in increased cleavage of CASP9 protein CTD PMID:36858637 bisphenol A increases activity ISO RGD:69147 6480464 bisphenol A results in increased activity of CASP9 protein CTD PMID:30036487 more ... bisphenol A increases expression ISO RGD:62159 6480464 bisphenol A results in increased expression of CASP9 mRNA, bisphenol A results in increased expression of CASP9 protein CTD PMID:31201698 more ... bisphenol A increases activity ISO RGD:62159 6480464 bisphenol A results in increased activity of CASP9 protein CTD PMID:31387175 bisphenol A decreases expression ISO RGD:62159 6480464 bisphenol A results in decreased expression of CASP9 mRNA CTD PMID:29161229 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CASP9 mRNA, bisphenol A results in decreased expression of CASP9 protein CTD PMID:25181051 , PMID:27189055 bisphenol A affects expression ISO RGD:62159 6480464 bisphenol A affects the expression of CASP9 protein CTD PMID:23900028 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with naringin] results in decreased expression of CASP9 protein more ... CTD PMID:24884420 more ... bisphenol A increases activity EXP 6480464 bisphenol A results in increased activity of CASP9 protein CTD PMID:25461564 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CASP9 mRNA, bisphenol A results in increased expression of CASP9 protein CTD PMID:17322771 more ... bisphenol F increases expression ISO RGD:62159 6480464 bisphenol F results in increased expression of CASP9 mRNA CTD PMID:31453682 bleomycin A2 multiple interactions EXP 6480464 Bleomycin results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:15371238 bleomycin A2 multiple interactions ISO RGD:69147 6480464 [Polyphenols co-treated with Bleomycin] results in increased expression of CASP9 mRNA, [Tea co-treated with Bleomycin] results in increased expression of CASP9 mRNA CTD PMID:26800624 bleomycin A2 increases activity ISO RGD:62159 6480464 Bleomycin results in increased activity of CASP9 protein CTD PMID:22687607 bortezomib multiple interactions ISO RGD:69147 6480464 1 more ... CTD PMID:12893773 more ... bortezomib increases expression ISO RGD:69147 6480464 Bortezomib results in increased expression of CASP9 protein CTD PMID:17156654 bortezomib increases response to substance ISO RGD:69147 6480464 CASP9 gene SNP results in increased susceptibility to Bortezomib, CASP9 results in increased susceptibility to Bortezomib CTD PMID:18723477 , PMID:20864405 bortezomib increases cleavage ISO RGD:69147 6480464 Bortezomib results in increased cleavage of CASP9 protein CTD PMID:15509775 more ... brucine multiple interactions ISO RGD:69147 6480464 brucine results in increased activity of and results in increased cleavage of CASP9 protein more ... CTD PMID:16443926 brucine increases activity ISO RGD:69147 6480464 [brucine results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein, brucine results in increased activity of CASP9 protein CTD PMID:16443926 , PMID:21684292 Brusatol multiple interactions ISO RGD:62159 6480464 brusatol promotes the reaction [T-2 Toxin results in increased activity of CASP9 protein] CTD PMID:29432840 budesonide increases activity ISO RGD:69147 6480464 Budesonide results in increased activity of CASP9 protein CTD PMID:11734450 bufalin increases activity ISO RGD:69147 6480464 bufalin results in increased activity of CASP9 protein CTD PMID:27444971 bupivacaine decreases expression ISO RGD:69147 6480464 Bupivacaine results in decreased expression of CASP9 protein CTD PMID:20194319 buprofezin increases activity ISO RGD:69147 6480464 buprofezin results in increased activity of CASP9 protein CTD PMID:36287832 bupropion increases activity ISO RGD:69147 6480464 Bupropion results in increased activity of CASP9 protein CTD PMID:21354251 buserelin increases expression ISO RGD:69147 6480464 Buserelin results in increased expression of CASP9 protein CTD PMID:15965100 busulfan multiple interactions ISO RGD:69147 6480464 [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP9 protein, pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP9 protein] CTD PMID:19732952 , PMID:20933509 butachlor decreases expression ISO RGD:62159 6480464 butachlor results in decreased expression of CASP9 mRNA CTD PMID:34351278 butan-1-ol multiple interactions EXP 6480464 1-Butanol results in increased cleavage of and results in increased activity of CASP9 protein, Y 27632 inhibits the reaction [1-Butanol results in increased activity of and results in increased cleavage of CASP9 protein] CTD PMID:22564901 butein increases activity ISO RGD:69147 6480464 butein results in increased activity of CASP9 protein CTD PMID:35130734 butyric acid multiple interactions ISO RGD:62159 6480464 [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9 more ... CTD PMID:25478867 C.I. Natural Red 20 multiple interactions ISO RGD:62159 6480464 shikonin inhibits the reaction [Benzene results in increased cleavage of CASP9 protein], shikonin inhibits the reaction [Benzene results in increased expression of CASP9 mRNA] CTD PMID:36306860 cadmium atom multiple interactions ISO RGD:69147 6480464 Cadmium results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:19442655 cadmium atom increases cleavage EXP 6480464 Cadmium results in increased cleavage of CASP9 protein CTD PMID:23741317 , PMID:25643798 cadmium atom increases activity EXP 6480464 Cadmium results in increased activity of CASP9 protein CTD PMID:14977363 more ... cadmium atom increases activity ISO RGD:62159 6480464 Cadmium results in increased activity of CASP9 protein CTD PMID:19182378 cadmium atom multiple interactions ISO RGD:62159 6480464 hwanggunchungyitang inhibits the reaction [Cadmium results in increased activity of CASP9 protein] CTD PMID:19182378 cadmium atom multiple interactions EXP 6480464 2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP9 protein]] more ... CTD PMID:16263807 more ... cadmium dichloride multiple interactions ISO RGD:62159 6480464 1 more ... CTD PMID:18850067 more ... cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CASP9 mRNA, Cadmium Chloride results in increased expression of CASP9 protein modified form CTD PMID:28390674 more ... cadmium dichloride increases cleavage EXP 6480464 Cadmium Chloride results in increased cleavage of CASP9 protein CTD PMID:23405080 , PMID:35525383 cadmium dichloride increases expression ISO RGD:62159 6480464 Cadmium Chloride results in increased expression of CASP9 mRNA, Cadmium Chloride results in increased expression of CASP9 protein CTD PMID:25409916 , PMID:28342888 cadmium dichloride increases activity ISO RGD:62159 6480464 Cadmium Chloride results in increased activity of CASP9 protein CTD PMID:18850067 more ... cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of CASP9 mRNA CTD PMID:15842833 cadmium dichloride increases cleavage ISO RGD:69147 6480464 Cadmium Chloride results in increased cleavage of CASP9 protein CTD PMID:24419708 cadmium dichloride increases activity EXP 6480464 Cadmium Chloride results in increased activity of CASP9 protein CTD PMID:16478757 more ... cadmium dichloride increases activity ISO RGD:69147 6480464 Cadmium Chloride results in increased activity of CASP9 protein CTD PMID:16264267 cadmium dichloride multiple interactions EXP 6480464 2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP9 protein]] more ... CTD PMID:16263807 more ... cadmium dichloride increases expression ISO RGD:69147 6480464 Cadmium Chloride results in increased expression of CASP9 mRNA more ... CTD PMID:23941782 more ... cadmium dichloride multiple interactions ISO RGD:69147 6480464 Cadmium Chloride promotes the reaction [Fluorouracil results in decreased expression of CASP9 mRNA] more ... CTD PMID:23941782 , PMID:28342888 caffeine multiple interactions ISO RGD:69147 6480464 Caffeine inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP9 protein], Caffeine results in increased cleavage of and results in increased expression of CASP9 protein CTD PMID:16522534 , PMID:16777994 caffeine multiple interactions ISO RGD:62159 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 cajanol multiple interactions ISO RGD:69147 6480464 [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP9 protein CTD PMID:20638373 cajanol increases activity ISO RGD:69147 6480464 cajanol results in increased activity of CASP9 protein CTD PMID:20638373 Calcimycin increases activity ISO RGD:69147 6480464 Calcimycin results in increased activity of CASP9 protein CTD PMID:25410152 Calcimycin increases activity ISO RGD:62159 6480464 Calcimycin results in increased activity of CASP9 protein CTD PMID:25410152 calciol decreases expression ISO RGD:69147 6480464 Cholecalciferol results in decreased expression of CASP9 protein CTD PMID:18628207 calcitriol multiple interactions ISO RGD:69147 6480464 [Calcitriol co-treated with Gemcitabine] results in increased expression of CASP9 protein more ... CTD PMID:20699664 more ... calcitriol increases expression ISO RGD:69147 6480464 Calcitriol results in increased expression of CASP9 protein CTD PMID:31628941 calcium atom multiple interactions EXP 6480464 [Calcium co-treated with Zinc] affects the reaction [monoisoamyl-2 more ... CTD PMID:24184500 calcium dichloride multiple interactions EXP 6480464 cordycepin inhibits the reaction [Calcium Chloride results in increased cleavage of CASP9 protein] CTD PMID:36731150 calcium dichloride increases cleavage EXP 6480464 Calcium Chloride results in increased cleavage of CASP9 protein CTD PMID:36731150 calcium(0) multiple interactions EXP 6480464 [Calcium co-treated with Zinc] affects the reaction [monoisoamyl-2 more ... CTD PMID:24184500 camphene multiple interactions EXP 6480464 [camphene co-treated with geraniol] inhibits the reaction [nimesulide results in increased cleavage of CASP9 protein] CTD PMID:22509279 camptothecin multiple interactions ISO RGD:69147 6480464 [Camptothecin co-treated with FAS protein] results in increased activity of CASP9 protein more ... CTD PMID:15958570 more ... camptothecin increases activity ISO RGD:69147 6480464 Camptothecin results in increased activity of CASP9 protein CTD PMID:34635930 camptothecin decreases expression ISO RGD:69147 6480464 Camptothecin results in decreased expression of CASP9 mRNA CTD PMID:30581319 camptothecin increases expression ISO RGD:69147 6480464 Camptothecin results in increased expression of CASP9 protein CTD PMID:30885713 camptothecin increases cleavage ISO RGD:69147 6480464 Camptothecin results in increased cleavage of CASP9 protein CTD PMID:10896673 , PMID:24823293 camptothecin increases activity EXP 6480464 Camptothecin results in increased activity of CASP9 protein CTD PMID:16263807 camptothecin multiple interactions EXP 6480464 benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Camptothecin results in increased cleavage of CASP9 protein] more ... CTD PMID:16263807 , PMID:19497415 cannabidiol increases expression ISO RGD:69147 6480464 Cannabidiol results in increased expression of CASP9 mRNA CTD PMID:33244087 cannabidiol increases activity ISO RGD:69147 6480464 Cannabidiol results in increased activity of CASP9 protein CTD PMID:34302491 cannabidiol increases cleavage ISO RGD:69147 6480464 Cannabidiol results in increased cleavage of CASP9 protein CTD PMID:31349651 more ... cannabidiol multiple interactions ISO RGD:69147 6480464 3-methyladenine inhibits the reaction [Cannabidiol results in increased activity of CASP9 protein] more ... CTD PMID:30096889 more ... cantharidic acid increases cleavage ISO RGD:69147 6480464 cantharidic acid results in increased cleavage of CASP9 protein CTD PMID:29159945 more ... cantharidic acid multiple interactions ISO RGD:69147 6480464 SB 203580 inhibits the reaction [cantharidic acid results in increased cleavage of CASP9 protein] CTD PMID:29159945 , PMID:31916385 cantharidin increases expression ISO RGD:69147 6480464 Cantharidin results in increased expression of CASP9 mRNA, Cantharidin results in increased expression of CASP9 protein CTD PMID:27113412 cantharidin multiple interactions ISO RGD:69147 6480464 Cantharidin results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:27113412 capsaicin multiple interactions ISO RGD:69147 6480464 [Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein more ... CTD PMID:19939880 more ... capsaicin increases activity ISO RGD:69147 6480464 Capsaicin results in increased activity of CASP9 protein CTD PMID:19502594 more ... capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of CASP9 protein CTD PMID:16125681 capsaicin affects expression EXP 6480464 Capsaicin affects the expression of CASP9 protein CTD PMID:16477149 capsaicin increases expression ISO RGD:69147 6480464 Capsaicin results in increased expression of CASP9 mRNA CTD PMID:19502594 capsaicin increases cleavage ISO RGD:69147 6480464 Capsaicin results in increased cleavage of CASP9 protein CTD PMID:21647434 CARBENOXOLONE multiple interactions EXP 6480464 Carbenoxolone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP9 protein] CTD PMID:33242459 carbidopa multiple interactions ISO RGD:62159 6480464 [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] more ... CTD PMID:34560070 , PMID:35202708 carbidopa multiple interactions ISO RGD:69147 6480464 [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein], Carbidopa inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] CTD PMID:34560070 carbon atom multiple interactions ISO RGD:69147 6480464 [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of CASP9 mRNA more ... CTD PMID:31268311 carbon monoxide increases activity EXP 6480464 Carbon Monoxide results in increased activity of CASP9 protein CTD PMID:25562542 carbon monoxide multiple interactions ISO RGD:69147 6480464 [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of CASP9 mRNA CTD PMID:31268311 carbon nanotube multiple interactions ISO RGD:62159 6480464 [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] which results in decreased susceptibility to Nanotubes more ... CTD PMID:22664788 , PMID:32068018 carbon nanotube increases expression ISO RGD:69147 6480464 Nanotubes, Carbon results in increased expression of CASP9 mRNA CTD PMID:32493873 carbon nanotube increases activity ISO RGD:69147 6480464 Nanotubes, Carbon results in increased activity of CASP9 protein CTD PMID:28673683 carbon nanotube decreases expression ISO RGD:62159 6480464 Nanotubes, Carbon results in decreased expression of CASP9 mRNA CTD PMID:25620056 carboplatin increases activity ISO RGD:69147 6480464 Carboplatin results in increased activity of CASP9 protein CTD PMID:15996812 carboplatin decreases expression ISO RGD:69147 6480464 Carboplatin results in decreased expression of CASP9 mRNA CTD PMID:15576332 , PMID:17404015 carboplatin multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CASP9 protein], Pravastatin inhibits the reaction [Carboplatin results in increased expression of CASP9 protein] CTD PMID:18483861 carboplatin increases expression ISO RGD:62159 6480464 Carboplatin results in increased expression of CASP9 protein CTD PMID:18483861 carnosic acid multiple interactions ISO RGD:69147 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin inhibits the reaction [Pyruvaldehyde results in increased expression of CASP9 protein]] more ... CTD PMID:23239002 more ... carnosic acid multiple interactions ISO RGD:62159 6480464 salvin inhibits the reaction [sodium arsenite results in increased cleavage of CASP9 protein] CTD PMID:29854073 carnosic acid increases cleavage ISO RGD:69147 6480464 salvin results in increased cleavage of CASP9 protein CTD PMID:28918123 carnosic acid increases activity ISO RGD:69147 6480464 salvin results in increased activity of CASP9 protein CTD PMID:23239002 casticin multiple interactions ISO RGD:69147 6480464 casticin results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:27862857 casticin multiple interactions ISO RGD:62159 6480464 casticin promotes the reaction [Fluorouracil results in increased activity of CASP9 protein] CTD PMID:32270916 casticin increases activity ISO RGD:69147 6480464 casticin results in increased activity of CASP9 protein CTD PMID:29098808 catechol increases activity ISO RGD:69147 6480464 catechol results in increased activity of CASP9 protein CTD PMID:23776099 CCCP increases expression ISO RGD:69147 6480464 Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of CASP9 protein modified form CTD PMID:29241732 CCCP multiple interactions ISO RGD:69147 6480464 DNM1L protein promotes the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of CASP9 protein modified form] CTD PMID:29241732 celastrol multiple interactions ISO RGD:69147 6480464 Uridine inhibits the reaction [celastrol results in increased cleavage of CASP9 protein] CTD PMID:27374097 celastrol increases expression ISO RGD:69147 6480464 celastrol results in increased expression of CASP9 mRNA CTD PMID:27374097 celastrol increases cleavage ISO RGD:69147 6480464 celastrol results in increased cleavage of CASP9 protein CTD PMID:21466843 , PMID:27374097 celecoxib multiple interactions ISO RGD:69147 6480464 3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP9 protein]] more ... CTD PMID:15197583 more ... celecoxib increases activity ISO RGD:62159 6480464 Celecoxib results in increased activity of CASP9 protein CTD PMID:17201140 , PMID:17761345 celecoxib increases cleavage ISO RGD:69147 6480464 Celecoxib results in increased cleavage of CASP9 protein CTD PMID:17612393 more ... celecoxib increases activity ISO RGD:69147 6480464 Celecoxib results in increased activity of CASP9 protein CTD PMID:12824303 ceric oxide increases expression ISO RGD:69147 6480464 ceric oxide results in increased expression of CASP9 protein CTD PMID:24987704 ceritinib increases cleavage ISO RGD:69147 6480464 ceritinib analog results in increased cleavage of CASP9 protein CTD PMID:35803438 cerivastatin increases activity ISO RGD:69147 6480464 cerivastatin results in increased activity of CASP9 protein CTD PMID:15705602 , PMID:16470222 cerulenin increases activity ISO RGD:62159 6480464 Cerulenin results in increased activity of CASP9 protein CTD PMID:20805790 ceruletide multiple interactions EXP 6480464 Ceruletide results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:16339139 cetrorelix increases activity ISO RGD:62159 6480464 cetrorelix results in increased activity of CASP9 protein CTD PMID:17268770 cetrorelix increases activity EXP 6480464 cetrorelix results in increased activity of CASP9 protein CTD PMID:17268770 CGP 52608 multiple interactions ISO RGD:69147 6480464 CGP 52608 promotes the reaction [RORA protein binds to CASP9 gene] CTD PMID:28238834 chalcone increases cleavage ISO RGD:69147 6480464 Chalcone results in increased cleavage of CASP9 protein CTD PMID:20620131 chalcone multiple interactions ISO RGD:69147 6480464 MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP9 protein] CTD PMID:20620131 chalcones multiple interactions ISO RGD:69147 6480464 BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of and results in increased activity of CASP9 protein], Chalcones analog results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:30576621 chalcones increases expression ISO RGD:69147 6480464 Chalcones analog results in increased expression of CASP9 mRNA CTD PMID:32856275 chelerythrine multiple interactions EXP 6480464 malonic acid inhibits the reaction [chelerythrine results in increased activity of CASP9 protein], Rotenone inhibits the reaction [chelerythrine results in increased activity of CASP9 protein] CTD PMID:21664962 chelerythrine increases cleavage ISO RGD:69147 6480464 chelerythrine results in increased cleavage of CASP9 protein CTD PMID:26124276 chelerythrine increases activity EXP 6480464 chelerythrine results in increased activity of CASP9 protein CTD PMID:21664962 chenodeoxycholic acid multiple interactions ISO RGD:69147 6480464 [Chenodeoxycholic Acid co-treated with ursodoxicoltaurine] results in increased activity of CASP9 protein, Chenodeoxycholic Acid results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:14976352 , PMID:19054763 chenodeoxycholic acid increases activity ISO RGD:69147 6480464 Chenodeoxycholic Acid results in increased activity of CASP9 protein CTD PMID:14976352 chitosan multiple interactions EXP 6480464 Chitosan analog inhibits the reaction [Doxorubicin results in increased expression of CASP9 protein] CTD PMID:30928397 chloroacetic acid increases cleavage ISO RGD:62159 6480464 chloroacetic acid results in increased cleavage of CASP9 protein CTD PMID:23103613 chlorogenic acid multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Methotrexate results in increased activity of CASP9 protein] CTD PMID:28479099 chloroquine multiple interactions ISO RGD:69147 6480464 [Chloroquine co-treated with vandetanib] results in increased activity of CASP9 protein more ... CTD PMID:23151917 more ... chloroquine increases cleavage ISO RGD:69147 6480464 Chloroquine results in increased cleavage of CASP9 protein CTD PMID:23151917 , PMID:28906492 chlorpyrifos multiple interactions ISO RGD:69147 6480464 [Chlorpyrifos affects the localization of CASP9 protein] which results in increased activity of CYCS protein, MitoTEMPO inhibits the reaction [Chlorpyrifos results in increased expression of CASP9 protein] CTD PMID:23416140 , PMID:26435000 chlorpyrifos increases expression ISO RGD:62159 6480464 Chlorpyrifos results in increased expression of CASP9 mRNA CTD PMID:30378422 , PMID:32149475 chlorpyrifos affects expression ISO RGD:62159 6480464 Chlorpyrifos affects the expression of CASP9 mRNA, Chlorpyrifos affects the expression of CASP9 protein CTD PMID:29156651 , PMID:33349080 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of CASP9 protein CTD PMID:30990955 chlorpyrifos increases cleavage ISO RGD:69147 6480464 Chlorpyrifos results in increased cleavage of CASP9 protein CTD PMID:24793810 chlorpyrifos increases expression ISO RGD:69147 6480464 Chlorpyrifos results in increased expression of CASP9 protein, Chlorpyrifos results in increased expression of CASP9 protein modified form CTD PMID:23416140 , PMID:26435000 chlorpyrifos multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased activity of CASP9 protein], Quercetin inhibits the reaction [Chlorpyrifos results in increased expression of CASP9 protein] CTD PMID:22714038 , PMID:30990955 chlorpyrifos increases activity EXP 6480464 Chlorpyrifos results in increased activity of CASP9 protein CTD PMID:22714038 , PMID:27941166 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of CASP9 mRNA CTD PMID:17452286 cholesterol multiple interactions EXP 6480464 6-hydroxy-2 more ... CTD PMID:19477266 cholesterol multiple interactions ISO RGD:69147 6480464 [[[EGF protein binds to 1 more ... CTD PMID:35385781 cholesterol increases expression EXP 6480464 Cholesterol analog results in increased expression of CASP9 mRNA CTD PMID:19477266 cholesterol increases activity EXP 6480464 Cholesterol analog results in increased activity of CASP9 protein CTD PMID:19477266 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in increased activity of CASP9 protein, geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased activity of CASP9 protein] CTD PMID:26695085 chromium(6+) multiple interactions ISO RGD:62159 6480464 [Arsenates co-treated with chromium hexavalent ion] results in increased activity of CASP9 protein CTD PMID:19895865 chromium(6+) multiple interactions ISO RGD:69147 6480464 dipropylenetriamine-NONOate inhibits the reaction [chromium hexavalent ion results in increased activity of CASP9 protein], pimagedine promotes the reaction [chromium hexavalent ion results in increased activity of CASP9 protein] CTD PMID:19556603 chromium(6+) increases activity ISO RGD:69147 6480464 chromium hexavalent ion results in increased activity of CASP9 protein CTD PMID:19556603 chromone multiple interactions ISO RGD:69147 6480464 benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [4-chromone analog results in increased expression of CASP9 protein modified form] CTD PMID:30256521 chromone increases expression ISO RGD:69147 6480464 4-chromone analog results in increased expression of CASP9 protein modified form CTD PMID:30256521 chrysazin multiple interactions ISO RGD:69147 6480464 benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [danthron results in increased activity of CASP9 protein], danthron results in increased activity of and results in increased expression of CASP9 protein CTD PMID:21126053 chrysazin increases expression ISO RGD:69147 6480464 danthron results in increased expression of CASP9 mRNA CTD PMID:21126053 chrysin multiple interactions ISO RGD:69147 6480464 [Cisplatin co-treated with chrysin] results in increased cleavage of CASP9 protein CTD PMID:25770930 chrysin increases cleavage ISO RGD:69147 6480464 chrysin results in increased cleavage of CASP9 protein CTD PMID:18331776 , PMID:25770930 ciglitazone multiple interactions ISO RGD:69147 6480464 [Niflumic Acid co-treated with ciglitazone] results in increased cleavage of CASP9 protein more ... CTD PMID:21067863 cilostazol multiple interactions ISO RGD:69147 6480464 [Meloxicam co-treated with Cilostazol] results in increased activity of CASP9 protein CTD PMID:35920412 cilostazol increases activity ISO RGD:69147 6480464 Cilostazol results in increased activity of CASP9 protein CTD PMID:35920412 cimetidine increases activity ISO RGD:69147 6480464 Cimetidine results in increased activity of CASP9 protein CTD PMID:17273750 , PMID:20127008 Cinobufotalin increases cleavage ISO RGD:69147 6480464 cinobufotalin results in increased cleavage of CASP9 protein CTD PMID:22898211 ciprofloxacin increases activity ISO RGD:69147 6480464 Ciprofloxacin results in increased activity of CASP9 protein CTD PMID:11875713 ciprofloxacin increases activity EXP 6480464 Ciprofloxacin results in increased activity of CASP9 protein CTD PMID:30273099 Cirsimarin decreases expression ISO RGD:69147 6480464 cirsimarin results in decreased expression of CASP9 mRNA CTD PMID:35710092 cisplatin multiple interactions ISO RGD:69147 6480464 4-amylcinnamoylanthranilic acid inhibits the reaction [Eicosapentaenoic Acid promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] more ... CTD PMID:12565868 more ... cisplatin increases expression ISO RGD:62159 6480464 Cisplatin results in increased expression of CASP9 protein modified form CTD PMID:35367536 cisplatin increases activity ISO RGD:69147 6480464 Cisplatin results in increased activity of CASP9 protein CTD PMID:12565868 more ... cisplatin increases cleavage ISO RGD:69147 127284886 cisplatin increases cleavage of CASP9 protein in stomach RGD cisplatin increases cleavage ISO RGD:69147 6480464 Cisplatin results in increased cleavage of CASP9 protein CTD PMID:15496615 more ... cisplatin increases activity ISO RGD:62159 6480464 Cisplatin results in increased activity of CASP9 protein CTD PMID:21526214 , PMID:22269388 cisplatin multiple interactions EXP 6480464 fisetin inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein], Melatonin inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] CTD PMID:25184746 , PMID:36006825 cisplatin increases cleavage EXP 6480464 Cisplatin results in increased cleavage of CASP9 protein CTD PMID:25184746 , PMID:36006825 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of CASP9 protein CTD PMID:21525749 cisplatin increases cleavage ISO RGD:62159 6480464 Cisplatin results in increased cleavage of CASP9 protein CTD PMID:21616140 more ... cisplatin multiple interactions ISO RGD:62159 6480464 [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] more ... CTD PMID:21526214 more ... cisplatin increases expression ISO RGD:69147 6480464 Cisplatin results in increased expression of CASP9 mRNA more ... CTD PMID:16803524 more ... cisplatin decreases expression ISO RGD:69147 6480464 Cisplatin results in decreased expression of CASP9 mRNA, Cisplatin results in decreased expression of CASP9 protein CTD PMID:17404015 more ... cladribine multiple interactions ISO RGD:69147 6480464 BCL2 affects the reaction [Cladribine results in increased cleavage of and results in increased activity of CASP9 protein] more ... CTD PMID:12948851 , PMID:15516989 cladribine increases activity ISO RGD:69147 6480464 Cladribine results in increased activity of CASP9 protein CTD PMID:11672427 , PMID:12948851 clavulone II multiple interactions ISO RGD:69147 6480464 clavulone II results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:15920677 Clivoline increases activity ISO RGD:69147 6480464 clivorine results in increased activity of CASP9 protein CTD PMID:19437449 Clivoline multiple interactions ISO RGD:69147 6480464 EGF protein inhibits the reaction [clivorine results in increased activity of CASP9 protein] CTD PMID:19437449 clofarabine multiple interactions ISO RGD:69147 6480464 [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP9 protein CTD PMID:20933509 clofibrate decreases expression ISO RGD:62159 6480464 Clofibrate results in decreased expression of CASP9 mRNA CTD PMID:17585979 clomipramine increases activity ISO RGD:62159 6480464 Clomipramine results in increased activity of CASP9 protein CTD PMID:28482088 clonidine increases activity ISO RGD:69147 6480464 Clonidine results in increased activity of CASP9 protein CTD PMID:28115640 clonidine (amino form) increases activity ISO RGD:69147 6480464 Clonidine results in increased activity of CASP9 protein CTD PMID:28115640 clonidine (imino form) increases activity ISO RGD:69147 6480464 Clonidine results in increased activity of CASP9 protein CTD PMID:28115640 clorgyline multiple interactions ISO RGD:69147 6480464 Clorgyline inhibits the reaction [Carbon Tetrachloride results in increased cleavage of CASP9 protein] more ... CTD PMID:35202708 cobalt dichloride increases activity ISO RGD:69147 6480464 cobaltous chloride results in increased activity of CASP9 protein CTD PMID:21687937 , PMID:23380477 cobalt dichloride multiple interactions ISO RGD:69147 6480464 cobaltous chloride inhibits the reaction [Gentamicins results in increased cleavage of CASP9 protein] more ... CTD PMID:23145036 , PMID:23380477 cocaine affects expression ISO RGD:62159 6480464 Cocaine affects the expression of CASP9 mRNA CTD PMID:15681117 cocaine increases activity EXP 6480464 Cocaine results in increased activity of CASP9 protein CTD PMID:10604926 more ... cocaine multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Cocaine results in increased activity of CASP9 protein] CTD PMID:15365088 cocaine affects expression EXP 6480464 Cocaine affects the expression of CASP9 protein CTD PMID:16179556 cocaine increases expression ISO RGD:69147 6480464 Cocaine results in increased expression of CASP9 protein CTD PMID:16686379 codeinone increases activity ISO RGD:69147 6480464 6-codeinone results in increased activity of CASP9 protein CTD PMID:12894543 coenzyme Q10 multiple interactions EXP 6480464 coenzyme Q10 inhibits the reaction [Doxorubicin results in increased expression of CASP9 protein] CTD PMID:27087047 colistin increases cleavage ISO RGD:62159 6480464 Colistin results in increased cleavage of CASP9 protein CTD PMID:34560125 colistin increases activity ISO RGD:69147 6480464 Colistin results in increased activity of CASP9 protein CTD PMID:35378205 colistin multiple interactions ISO RGD:69147 6480464 4-(5-benzo(1 more ... CTD PMID:35378205 colistin increases activity ISO RGD:62159 6480464 Colistin results in increased activity of CASP9 protein CTD PMID:35378205 colistin increases expression ISO RGD:62159 6480464 Colistin results in increased expression of CASP9 mRNA CTD PMID:34560125 concanamycin A multiple interactions ISO RGD:62159 6480464 concanamycin A inhibits the reaction [enterotoxin C more ... CTD PMID:27742270 copper atom multiple interactions ISO RGD:69147 6480464 [[Ditiocarb binds to Copper] which affects the localization of CYCS protein] promotes the reaction [[[CYCS protein binds to APAF1 protein binds to CASP9 protein] which results in increased metabolism of and results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein] more ... CTD PMID:17327230 more ... copper atom increases expression EXP 6480464 Copper results in increased expression of CASP9 protein CTD PMID:30556269 copper atom increases cleavage ISO RGD:62159 6480464 Copper analog results in increased cleavage of CASP9 protein CTD PMID:21319953 copper atom multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein, Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein] CTD PMID:22085843 copper atom increases activity ISO RGD:62159 6480464 Copper analog results in increased activity of CASP9 protein CTD PMID:22000994 copper(0) multiple interactions ISO RGD:69147 6480464 [[Ditiocarb binds to Copper] which affects the localization of CYCS protein] promotes the reaction [[[CYCS protein binds to APAF1 protein binds to CASP9 protein] which results in increased metabolism of and results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein] more ... CTD PMID:17327230 more ... copper(0) increases expression EXP 6480464 Copper results in increased expression of CASP9 protein CTD PMID:30556269 copper(0) increases cleavage ISO RGD:62159 6480464 Copper analog results in increased cleavage of CASP9 protein CTD PMID:21319953 copper(0) multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein, Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein] CTD PMID:22085843 copper(0) increases activity ISO RGD:62159 6480464 Copper analog results in increased activity of CASP9 protein CTD PMID:22000994 copper(II) chloride multiple interactions EXP 6480464 [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP9 protein more ... CTD PMID:20920558 copper(II) chloride increases expression ISO RGD:62159 6480464 cupric chloride results in increased expression of CASP9 protein CTD PMID:23313662 , PMID:24170445 copper(II) sulfate multiple interactions EXP 6480464 andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein] more ... CTD PMID:20946909 more ... copper(II) sulfate increases activity EXP 6480464 Copper Sulfate results in increased activity of CASP9 protein CTD PMID:20946909 coptisine increases cleavage ISO RGD:69147 6480464 coptisine analog results in increased cleavage of CASP9 protein CTD PMID:30472432 cordycepin multiple interactions ISO RGD:69147 6480464 Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP9 protein] CTD PMID:21310227 cordycepin increases cleavage ISO RGD:69147 6480464 cordycepin results in increased cleavage of CASP9 protein CTD PMID:35732609 cordycepin multiple interactions EXP 6480464 cordycepin inhibits the reaction [Calcium Chloride results in increased cleavage of CASP9 protein] CTD PMID:36731150 cordycepin increases expression ISO RGD:69147 6480464 cordycepin results in increased expression of CASP9 mRNA CTD PMID:28987792 cordycepin increases activity ISO RGD:69147 6480464 cordycepin results in increased activity of CASP9 protein CTD PMID:21310227 , PMID:21933677 corilagin multiple interactions EXP 6480464 corilagin inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] CTD PMID:35103375 coumarin increases expression ISO RGD:69147 6480464 coumarin analog results in increased expression of CASP9 mRNA CTD PMID:32578917 coumestrol increases expression ISO RGD:69147 6480464 Coumestrol results in increased expression of CASP9 protein CTD PMID:28986287 crocidolite asbestos increases cleavage ISO RGD:69147 6480464 Asbestos, Crocidolite results in increased cleavage of CASP9 protein CTD PMID:17191120 crocidolite asbestos increases expression ISO RGD:62159 6480464 Asbestos, Crocidolite results in increased expression of CASP9 protein modified form CTD PMID:24918270 crocidolite asbestos increases cleavage ISO RGD:62159 6480464 Asbestos, Crocidolite results in increased cleavage of CASP9 protein CTD PMID:12626342 crocidolite asbestos multiple interactions ISO RGD:62159 6480464 rottlerin inhibits the reaction [Asbestos, Crocidolite results in increased cleavage of CASP9 protein] CTD PMID:12626342 crocidolite asbestos increases activity ISO RGD:69147 6480464 Asbestos, Crocidolite results in increased activity of CASP9 protein CTD PMID:22608188 crocidolite asbestos multiple interactions ISO RGD:69147 6480464 Asbestos more ... CTD PMID:22608188 crocin-1 multiple interactions EXP 6480464 crocin inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein], crocin inhibits the reaction [Malathion results in increased cleavage of CASP9 protein] CTD PMID:27353299 , PMID:35274200 crocin-1 increases activity ISO RGD:69147 6480464 crocin results in increased activity of CASP9 protein CTD PMID:32886819 crotonaldehyde increases activity EXP 6480464 2-butenal results in increased activity of CASP9 protein CTD PMID:23535401 crotonaldehyde increases expression EXP 6480464 2-butenal results in increased expression of CASP9 protein CTD PMID:33749501 crotonaldehyde affects expression EXP 6480464 2-butenal affects the expression of CASP9 protein CTD PMID:31345100 Cryptotanshinone increases activity ISO RGD:69147 6480464 cryptotanshinone results in increased activity of CASP9 protein CTD PMID:26564229 cucurbitacin E increases cleavage ISO RGD:69147 6480464 cucurbitacin E results in increased cleavage of CASP9 protein CTD PMID:27106530 cucurbitacin I increases cleavage ISO RGD:69147 6480464 cucurbitacin I results in increased cleavage of CASP9 protein CTD PMID:24858077 curcumin decreases expression ISO RGD:69147 6480464 Curcumin results in decreased expression of CASP9 mRNA, Curcumin results in decreased expression of CASP9 protein CTD PMID:16101141 more ... curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [aristolochic acid I results in increased expression of and results in increased cleavage of CASP9 protein] more ... CTD PMID:20869986 , PMID:36037877 curcumin increases activity EXP 6480464 Curcumin results in increased activity of CASP9 protein CTD PMID:19095035 curcumin increases expression ISO RGD:69147 6480464 Curcumin results in increased expression of CASP9 mRNA, Curcumin results in increased expression of CASP9 protein CTD PMID:18555241 more ... curcumin multiple interactions ISO RGD:62159 6480464 [Curcumin co-treated with Gemcitabine] results in decreased expression of CASP9 protein more ... CTD PMID:17277231 more ... curcumin increases cleavage ISO RGD:69147 6480464 Curcumin results in increased cleavage of CASP9 protein CTD PMID:14555224 , PMID:21594647 curcumin increases activity ISO RGD:69147 6480464 Curcumin results in increased activity of CASP9 protein CTD PMID:17671742 , PMID:34994998 curcumin multiple interactions ISO RGD:69147 6480464 [Curcumin co-treated with Arsenic Trioxide] results in increased cleavage of CASP9 protein more ... CTD PMID:16023083 more ... cycloheximide multiple interactions ISO RGD:69147 6480464 [Cycloheximide co-treated with TNF] results in increased activity of CASP9 protein more ... CTD PMID:12925536 , PMID:18222423 cycloheximide increases activity ISO RGD:62159 6480464 Cycloheximide results in increased activity of CASP9 protein CTD PMID:14502240 cyclophosphamide multiple interactions ISO RGD:69147 6480464 BCL2 protein inhibits the reaction [Cyclophosphamide results in increased activity of CASP9 protein], Cyclophosphamide results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:11723234 , PMID:17898787 cyclophosphamide multiple interactions ISO RGD:62159 6480464 ganoderic acid A inhibits the reaction [Cyclophosphamide results in increased expression of CASP9 protein] CTD PMID:30506662 cyclophosphamide increases expression ISO RGD:62159 6480464 Cyclophosphamide results in increased expression of CASP9 protein CTD PMID:30506662 cyclophosphamide increases activity EXP 6480464 Cyclophosphamide results in increased activity of CASP9 protein CTD PMID:11723234 cyclosporin A multiple interactions ISO RGD:69147 6480464 [Cyclosporine co-treated with NGF protein] results in increased activity of CASP9 protein more ... CTD PMID:15548389 more ... cyclosporin A multiple interactions ISO RGD:62159 6480464 Cyclosporine results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:22155090 cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP9 mRNA more ... CTD PMID:33396045 more ... cylindrospermopsin increases expression ISO RGD:69147 6480464 cylindrospermopsin results in increased expression of CASP9 mRNA CTD PMID:23726867 cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP9 mRNA more ... CTD PMID:22048644 more ... cypermethrin multiple interactions ISO RGD:69147 6480464 Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of CASP9 mRNA] CTD PMID:29945211 cypermethrin increases expression ISO RGD:69147 6480464 cypermethrin results in increased expression of CASP9 mRNA CTD PMID:27704156 , PMID:29945211 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of CASP9 mRNA CTD PMID:22528246 cytochalasin B increases cleavage ISO RGD:69147 6480464 Cytochalasin B results in increased cleavage of CASP9 protein CTD PMID:27640744 D-glucitol increases activity EXP 6480464 Sorbitol results in increased activity of CASP9 protein CTD PMID:20609311 D-glucitol multiple interactions EXP 6480464 Spironolactone inhibits the reaction [Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP9 protein]], Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP9 protein] CTD PMID:20609311 D-glucose multiple interactions ISO RGD:69147 6480464 [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein more ... CTD PMID:17309078 , PMID:30431688 D-glucose increases cleavage ISO RGD:69147 6480464 Glucose results in increased cleavage of CASP9 protein CTD PMID:30431688 D-glucose increases expression EXP 6480464 Glucose results in increased expression of CASP9 mRNA CTD PMID:23192364 D-glucose increases activity EXP 6480464 Glucose results in increased activity of CASP9 CTD PMID:18791325 D-glucose multiple interactions EXP 6480464 [Glucose co-treated with IGF2R protein modified form] results in increased expression of CASP9 protein more ... CTD PMID:18791325 more ... D-mannitol increases activity ISO RGD:69147 6480464 Mannitol results in increased activity of CASP9 protein CTD PMID:12011046 D-penicillamine multiple interactions EXP 6480464 andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]] more ... CTD PMID:20946909 dactolisib multiple interactions ISO RGD:69147 6480464 Chloroquine promotes the reaction [dactolisib results in increased cleavage of CASP9 protein], dactolisib promotes the reaction [Chloroquine results in increased cleavage of CASP9 protein] CTD PMID:23151917 dactolisib increases cleavage ISO RGD:69147 6480464 dactolisib results in increased cleavage of CASP9 protein CTD PMID:23151917 dantrolene multiple interactions ISO RGD:69147 6480464 Dantrolene inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] CTD PMID:23022152 DAPT multiple interactions EXP 6480464 N-(N-(3, 5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]] CTD PMID:34897970 daunorubicin affects expression ISO RGD:69147 6480464 Daunorubicin affects the expression of CASP9 mRNA CTD PMID:27780733 daunorubicin increases cleavage ISO RGD:69147 6480464 Daunorubicin results in increased cleavage of CASP9 protein CTD PMID:34963561 DDE increases activity ISO RGD:69147 6480464 Dichlorodiphenyl Dichloroethylene results in increased activity of CASP9 protein CTD PMID:19545618 DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CASP9 mRNA CTD PMID:21384494 , PMID:24576310 DDE increases activity EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased activity of CASP9 protein CTD PMID:24576310 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of CASP9 mRNA CTD PMID:23914054 decabromodiphenyl ether multiple interactions EXP 6480464 [Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in increased cleavage of CASP9 protein CTD PMID:33252648 delphinidin multiple interactions ISO RGD:69147 6480464 [delphinidin results in increased susceptibility to sodium arsenite] which results in increased cleavage of CASP9 protein, delphinidin results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:25954945 , PMID:30125548 delphinidin increases expression ISO RGD:69147 6480464 delphinidin results in increased expression of CASP9 protein CTD PMID:33955636 demethoxycurcumin decreases expression ISO RGD:69147 6480464 demethoxycurcumin results in decreased expression of CASP9 mRNA CTD PMID:33582110 demethoxycurcumin increases cleavage ISO RGD:69147 6480464 demethoxycurcumin results in increased cleavage of CASP9 protein CTD PMID:34291863 demethoxycurcumin increases activity ISO RGD:69147 6480464 demethoxycurcumin results in increased activity of CASP9 protein CTD PMID:33582110 demethoxyfumitremorgin C increases activity ISO RGD:69147 6480464 demethoxyfumitremorgin C results in increased activity of CASP9 protein CTD PMID:28359723 Dendrobine multiple interactions ISO RGD:69147 6480464 dendrobine inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP9 protein] CTD PMID:36058301 deoxycholic acid multiple interactions ISO RGD:69147 6480464 Aspirin inhibits the reaction [Deoxycholic Acid results in increased activity of CASP9 protein] more ... CTD PMID:17644113 more ... deoxycholic acid increases cleavage ISO RGD:69147 6480464 Deoxycholic Acid results in increased cleavage of CASP9 protein CTD PMID:21362092 deoxycholic acid increases activity ISO RGD:69147 6480464 Deoxycholic Acid results in increased activity of CASP9 protein CTD PMID:17644113 deoxynivalenol decreases expression ISO RGD:69147 6480464 deoxynivalenol results in decreased expression of CASP9 protein CTD PMID:22269384 deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of CASP9 mRNA CTD PMID:34673182 deoxynivalenol multiple interactions EXP 6480464 benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of CASP9 mRNA] CTD PMID:34673182 deoxynivalenol multiple interactions ISO RGD:69147 6480464 Zearalenone promotes the reaction [[Aflatoxin B1 co-treated with deoxynivalenol] results in increased expression of CASP9 mRNA] CTD PMID:30668976 deoxynivalenol multiple interactions ISO RGD:62159 6480464 deoxynivalenol results in increased activity of and results in increased cleavage of CASP9 protein CTD PMID:22491426 deoxynivalenol increases expression ISO RGD:69147 6480464 deoxynivalenol results in increased expression of CASP9 mRNA, deoxynivalenol results in increased expression of CASP9 protein CTD PMID:22269384 more ... deoxynivalenol increases activity ISO RGD:69147 6480464 deoxynivalenol results in increased activity of CASP9 protein CTD PMID:22269384 desferrioxamine B multiple interactions ISO RGD:69147 6480464 Deferoxamine inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein] CTD PMID:12540492 , PMID:14766669 desipramine increases activity EXP 6480464 Desipramine results in increased activity of CASP9 protein CTD PMID:20549303 Destruxin B increases cleavage ISO RGD:69147 6480464 destruxin B results in increased cleavage of CASP9 protein CTD PMID:24434019 Destruxin B multiple interactions ISO RGD:69147 6480464 destruxin B results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:23751424 dexamethasone increases cleavage ISO RGD:69147 6480464 Dexamethasone results in increased cleavage of CASP9 protein CTD PMID:16445836 dexamethasone increases cleavage EXP 6480464 Dexamethasone results in increased cleavage of CASP9 protein CTD PMID:30506661 dexamethasone increases activity ISO RGD:69147 6480464 Dexamethasone results in increased activity of CASP9 protein CTD PMID:11734450 more ... dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [TGFB1 protein results in increased activity of CASP9 protein], fludarabine inhibits the reaction [Dexamethasone results in increased cleavage of CASP9 protein] CTD PMID:15388240 , PMID:30506661 dexamethasone multiple interactions ISO RGD:62159 6480464 Spermine inhibits the reaction [Dexamethasone results in increased activity of CASP9 protein] CTD PMID:11399061 dexamethasone increases activity ISO RGD:62159 6480464 Dexamethasone results in increased activity of CASP9 protein CTD PMID:11399061 dexamethasone multiple interactions ISO RGD:69147 6480464 isocoumarin NM-3 promotes the reaction [Dexamethasone results in increased activity of CASP9 protein] CTD PMID:15574755 dexamethasone decreases expression ISO RGD:62159 6480464 Dexamethasone results in decreased expression of CASP9 mRNA CTD PMID:15944155 dexmedetomidine increases activity ISO RGD:69147 6480464 Dexmedetomidine results in increased activity of CASP9 protein CTD PMID:18724006 Diacetoxyscirpenol decreases expression ISO RGD:62159 6480464 diacetoxyscirpenol results in decreased expression of CASP9 mRNA CTD PMID:31836554 diallyl disulfide increases activity ISO RGD:69147 6480464 diallyl disulfide results in increased activity of CASP9 protein CTD PMID:14522920 , PMID:17647244 diallyl disulfide increases cleavage ISO RGD:69147 6480464 diallyl disulfide results in increased cleavage of CASP9 protein CTD PMID:30677442 diallyl disulfide multiple interactions ISO RGD:69147 6480464 diallyl disulfide promotes the reaction [TNFSF10 protein results in increased cleavage of CASP9 protein] CTD PMID:30677442 Diallyl sulfide increases activity ISO RGD:69147 6480464 allyl sulfide results in increased activity of CASP9 protein CTD PMID:17647244 diallyl trisulfide multiple interactions ISO RGD:69147 6480464 [diallyl trisulfide results in increased susceptibility to TNFSF10 protein] which results in increased cleavage of CASP9 protein, Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of CASP9 protein] CTD PMID:22578287 , PMID:28571773 diallyl trisulfide increases activity ISO RGD:69147 6480464 diallyl trisulfide results in increased activity of CASP9 protein CTD PMID:22595511 diallyl trisulfide increases cleavage ISO RGD:69147 6480464 diallyl trisulfide results in increased cleavage of CASP9 protein CTD PMID:20055834 , PMID:22578287 diarsenic trioxide increases cleavage EXP 6480464 Arsenic Trioxide results in increased cleavage of CASP9 protein CTD PMID:24634002 diarsenic trioxide multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [CASP9 protein binds to CYCS protein]] more ... CTD PMID:21145380 , PMID:24634002 diarsenic trioxide increases activity ISO RGD:62159 6480464 Arsenic Trioxide results in increased activity of CASP9 protein CTD PMID:21565247 , PMID:24157283 diarsenic trioxide increases cleavage ISO RGD:62159 6480464 Arsenic Trioxide results in increased cleavage of CASP9 protein CTD PMID:24801902 diarsenic trioxide decreases expression ISO RGD:69147 6480464 Arsenic Trioxide results in decreased expression of CASP9 protein CTD PMID:22963400 , PMID:29164574 diarsenic trioxide increases expression ISO RGD:69147 6480464 Arsenic Trioxide results in increased expression of CASP9 protein CTD PMID:23980369 diarsenic trioxide increases expression ISO RGD:62159 6480464 Arsenic Trioxide results in increased expression of CASP9 protein modified form CTD PMID:28587418 diarsenic trioxide increases cleavage ISO RGD:69147 6480464 Arsenic Trioxide results in increased cleavage of CASP9 protein CTD PMID:12480548 more ... diarsenic trioxide multiple interactions ISO RGD:62159 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CASP9 protein] more ... CTD PMID:15688020 more ... diarsenic trioxide multiple interactions ISO RGD:69147 6480464 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein] more ... CTD PMID:17237268 more ... diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CASP9 mRNA CTD PMID:19730151 diarsenic trioxide decreases expression ISO RGD:62159 6480464 Arsenic Trioxide results in decreased expression of CASP9 protein CTD PMID:18336854 diarsenic trioxide increases activity ISO RGD:69147 6480464 Arsenic Trioxide results in increased activity of CASP9 protein CTD PMID:12148893 more ... diarsenic trioxide increases activity EXP 6480464 Arsenic Trioxide results in increased activity of CASP9 protein CTD PMID:21145380 diazinon affects expression EXP 6480464 Diazinon affects the expression of CASP9 mRNA CTD PMID:17452286 diazinon multiple interactions ISO RGD:69147 6480464 Magnesium Oxide analog inhibits the reaction [Diazinon results in increased activity of CASP9 protein] more ... CTD PMID:27920530 diazinon increases activity ISO RGD:69147 6480464 Diazinon results in increased activity of CASP9 protein CTD PMID:27920530 diazinon increases expression ISO RGD:69147 6480464 Diazinon results in increased expression of CASP9 mRNA CTD PMID:27920530 diazinon multiple interactions EXP 6480464 crocin inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein], Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein] CTD PMID:27353299 diazinon increases cleavage EXP 6480464 Diazinon results in increased cleavage of CASP9 protein CTD PMID:27353299 dibenziodolium multiple interactions ISO RGD:69147 6480464 diphenyleneiodonium inhibits the reaction [ganoderic acid analog results in increased activity of CASP9 protein] more ... CTD PMID:26282491 , PMID:33577942 dibenzoylmethane multiple interactions ISO RGD:69147 6480464 ODC1 protein inhibits the reaction [dibenzoylmethane results in increased activity of CASP9 protein] CTD PMID:21523861 dibutyl phthalate increases activity EXP 6480464 Dibutyl Phthalate results in increased activity of CASP9 protein CTD PMID:30910607 dibutyl phthalate increases expression ISO RGD:62159 6480464 Dibutyl Phthalate results in increased expression of CASP9 protein CTD PMID:31712109 dibutyl phthalate multiple interactions ISO RGD:62159 6480464 alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP9 protein] more ... CTD PMID:30910607 , PMID:31712109 dibutyl phthalate increases activity ISO RGD:62159 6480464 Dibutyl Phthalate results in increased activity of CASP9 protein CTD PMID:30910607 dibutyl phthalate multiple interactions EXP 6480464 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2 more ... CTD PMID:30910607 dichlorvos multiple interactions EXP 6480464 [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein] CTD PMID:16973328 dichlorvos increases activity EXP 6480464 Dichlorvos results in increased activity of CASP9 protein CTD PMID:16973328 diclofenac multiple interactions ISO RGD:69147 6480464 [TNF protein co-treated with Diclofenac] results in increased activity of CASP9 protein more ... CTD PMID:16388830 , PMID:27313093 diclofenac increases expression ISO RGD:69147 6480464 Diclofenac results in increased expression of CASP9 mRNA CTD PMID:29027214 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of CASP9 mRNA CTD PMID:29027214 diclofenac increases activity ISO RGD:69147 6480464 Diclofenac results in increased activity of CASP9 protein CTD PMID:27313093 diclofenac increases activity EXP 6480464 Diclofenac results in increased activity of CASP9 protein CTD PMID:14609740 , PMID:25014874 Didymin increases activity ISO RGD:69147 6480464 didymin results in increased activity of CASP9 protein CTD PMID:27899290 Didymin multiple interactions ISO RGD:69147 6480464 locostatin inhibits the reaction [didymin results in increased activity of CASP9 protein] CTD PMID:27899290 dieckol increases activity ISO RGD:69147 6480464 dieckol results in increased activity of CASP9 protein CTD PMID:31291034 dieckol multiple interactions ISO RGD:62159 6480464 dieckol inhibits the reaction [9 more ... CTD PMID:33347706 dieldrin increases activity EXP 6480464 Dieldrin results in increased activity of CASP9 protein CTD PMID:12831855 diepoxybutane multiple interactions ISO RGD:69147 6480464 benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [diepoxybutane results in increased activity of CASP9 protein] CTD PMID:14998682 diepoxybutane increases expression ISO RGD:69147 6480464 diepoxybutane results in increased expression of CASP9 mRNA CTD PMID:29792945 diepoxybutane increases activity ISO RGD:69147 6480464 diepoxybutane results in increased activity of CASP9 protein CTD PMID:14998682 diethyl maleate increases expression ISO RGD:69147 6480464 diethyl maleate results in increased expression of CASP9 mRNA CTD PMID:11875189 diethyldithiocarbamic acid multiple interactions ISO RGD:69147 6480464 [[Ditiocarb binds to Copper] which affects the localization of CYCS protein] promotes the reaction [[[CYCS protein binds to APAF1 protein binds to CASP9 protein] which results in increased metabolism of and results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein] CTD PMID:22951949 digitoxin increases cleavage ISO RGD:69147 6480464 Digitoxin analog results in increased cleavage of CASP9 protein, Digitoxin results in increased cleavage of CASP9 protein CTD PMID:22037315 dihydrolipoic acid increases activity ISO RGD:62159 6480464 dihydrolipoic acid results in increased activity of CASP9 protein CTD PMID:21462292 dihydrolipoic acid multiple interactions ISO RGD:62159 6480464 2-phenyl-4 more ... CTD PMID:21462292 dihydrosanguinarine increases activity ISO RGD:69147 6480464 dihydrosanguinarine results in increased activity of CASP9 protein CTD PMID:19346183 dimethylarsinic acid multiple interactions EXP 6480464 benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [CASP9 protein results in increased susceptibility to Cacodylic Acid] CTD PMID:15276415 dimethylarsinic acid increases response to substance EXP 6480464 CASP9 protein results in increased susceptibility to Cacodylic Acid CTD PMID:15276415 dimethylarsinous acid increases activity ISO RGD:69147 6480464 dimethylarsinous acid results in increased activity of CASP9 protein CTD PMID:30262279 dioscin multiple interactions EXP 6480464 dioscin inhibits the reaction [Ethanol results in increased expression of CASP9 protein] CTD PMID:24146112 dioscin decreases expression ISO RGD:69147 6480464 dioscin results in decreased expression of CASP9 mRNA, dioscin results in decreased expression of CASP9 protein CTD PMID:33359023 dioscin increases expression ISO RGD:69147 6480464 dioscin results in increased expression of CASP9 mRNA, dioscin results in increased expression of CASP9 protein CTD PMID:29990575 dioscin multiple interactions ISO RGD:62159 6480464 dioscin inhibits the reaction [Ethanol results in increased expression of CASP9 protein] CTD PMID:24146112 diosgenin multiple interactions ISO RGD:69147 6480464 3-methyladenine inhibits the reaction [Diosgenin inhibits the reaction [alpha-Chlorohydrin results in increased activity of CASP9 protein]] more ... CTD PMID:35149085 diosmin multiple interactions EXP 6480464 Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP9 protein] CTD PMID:23665045 dioxygen multiple interactions ISO RGD:69147 6480464 iroxanadine inhibits the reaction [Oxygen deficiency results in increased activity of CASP9 protein] more ... CTD PMID:15583868 , PMID:24860939 dioxygen multiple interactions EXP 6480464 (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide inhibits the reaction [[Apigenin co-treated with Oxygen deficiency] results in increased expression of CASP9 protein modified form] more ... CTD PMID:24058562 more ... dioxygen increases cleavage EXP 6480464 Oxygen deficiency results in increased cleavage of CASP9 protein CTD PMID:15786717 more ... dioxygen affects response to substance EXP 6480464 CASP9 protein affects the susceptibility to Oxygen deficiency CTD PMID:11042672 dioxygen increases activity ISO RGD:69147 6480464 Oxygen deficiency results in increased activity of CASP9 protein CTD PMID:15583868 diquat multiple interactions ISO RGD:62159 6480464 Diquat results in increased cleavage of and results in increased activity of CASP9 protein more ... CTD PMID:18164269 , PMID:20826540 diquat multiple interactions EXP 6480464 Meloxicam inhibits the reaction [Diquat results in increased expression of CASP9 protein modified form] CTD PMID:29484840 diquat increases expression EXP 6480464 Diquat results in increased expression of CASP9 protein modified form CTD PMID:29484840 diquat increases cleavage ISO RGD:62159 6480464 Diquat results in increased cleavage of CASP9 protein CTD PMID:20826540 disodium selenite increases expression ISO RGD:69147 6480464 Sodium Selenite results in increased expression of CASP9 mRNA CTD PMID:16705456 disodium selenite increases cleavage ISO RGD:69147 6480464 Sodium Selenite results in increased cleavage of CASP9 protein CTD PMID:28161410 disodium selenite decreases activity EXP 6480464 Sodium Selenite results in decreased activity of CASP9 protein CTD PMID:18209489 disulfiram multiple interactions ISO RGD:69147 6480464 [Disulfiram binds to Copper] which results in increased activity of CASP9 protein CTD PMID:24690739 divanadium pentaoxide increases activity EXP 6480464 vanadium pentoxide results in increased activity of CASP9 protein CTD PMID:19646462 dizocilpine maleate increases activity ISO RGD:62159 6480464 Dizocilpine Maleate results in increased activity of CASP9 protein CTD PMID:19759125 donepezil hydrochloride increases activity ISO RGD:69147 6480464 Donepezil results in increased activity of CASP9 protein CTD PMID:20522977 dorsomorphin increases cleavage ISO RGD:69147 6480464 dorsomorphin results in increased cleavage of CASP9 protein CTD PMID:31900833 doxorubicin multiple interactions ISO RGD:69147 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein] more ... CTD PMID:15812552 more ... doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of CASP9 mRNA more ... CTD PMID:27087047 more ... doxorubicin increases activity EXP 6480464 Doxorubicin results in increased activity of CASP9 protein CTD PMID:15799720 more ... doxorubicin increases cleavage ISO RGD:69147 6480464 Doxorubicin results in increased cleavage of CASP9 protein CTD PMID:15555623 more ... doxorubicin increases activity ISO RGD:69147 6480464 Doxorubicin analog results in increased activity of CASP9 protein, Doxorubicin results in increased activity of CASP9 protein CTD PMID:11779855 more ... doxorubicin increases expression ISO RGD:69147 6480464 Doxorubicin results in increased expression of CASP9 mRNA more ... CTD PMID:15576332 more ... doxorubicin increases activity ISO RGD:62159 6480464 Doxorubicin results in increased activity of CASP9 protein CTD PMID:16018998 more ... doxorubicin increases cleavage EXP 6480464 Doxorubicin results in increased cleavage of CASP9 protein CTD PMID:18775851 more ... doxorubicin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]] more ... CTD PMID:16357363 more ... doxorubicin increases expression ISO RGD:62159 6480464 Doxorubicin results in increased expression of CASP9 mRNA more ... CTD PMID:19286953 more ... doxorubicin multiple interactions ISO RGD:62159 6480464 5 more ... CTD PMID:17481927 more ... doxorubicin decreases expression ISO RGD:69147 6480464 Doxorubicin results in decreased expression of CASP9 mRNA CTD PMID:17404015 , PMID:30581319 doxorubicin affects expression ISO RGD:69147 6480464 Doxorubicin affects the expression of CASP9 mRNA CTD PMID:16705698 , PMID:27780733 doxorubicin affects activity ISO RGD:69147 6480464 Doxorubicin affects the activity of CASP9 protein CTD PMID:15870702 drimenol increases cleavage ISO RGD:69147 6480464 drimenol results in increased cleavage of CASP9 protein CTD PMID:30935903 ebselen multiple interactions EXP 6480464 ebselen inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] CTD PMID:18629305 ebselen multiple interactions ISO RGD:69147 6480464 ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP9 protein] CTD PMID:23649643 Echimidine increases activity ISO RGD:69147 6480464 echimidine results in increased activity of CASP9 protein CTD PMID:29458164 Echinocystic acid increases activity ISO RGD:69147 6480464 echinocystic acid analog results in increased activity of CASP9 protein CTD PMID:15863893 edaravone increases activity ISO RGD:69147 6480464 Edaravone analog results in increased activity of CASP9 protein CTD PMID:25684395 elemental carbon multiple interactions ISO RGD:69147 6480464 [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of CASP9 mRNA more ... CTD PMID:31268311 elemental selenium multiple interactions ISO RGD:69147 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein]] more ... CTD PMID:17339365 more ... elemental selenium multiple interactions EXP 6480464 [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA] more ... CTD PMID:21628957 more ... elemental selenium decreases activity ISO RGD:62159 6480464 Selenium results in decreased activity of CASP9 protein CTD PMID:17997286 ellagic acid multiple interactions ISO RGD:69147 6480464 Ellagic Acid results in increased expression of and results in increased activity of CASP9 protein CTD PMID:23554011 ellipticine multiple interactions ISO RGD:69147 6480464 ellipticine results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:21843585 ellipticine increases activity ISO RGD:69147 6480464 ellipticine results in increased activity of CASP9 protein CTD PMID:16027529 embelin increases degradation ISO RGD:69147 6480464 embelin results in increased degradation of CASP9 protein CTD PMID:28722333 embelin multiple interactions ISO RGD:69147 6480464 3-methyladenine promotes the reaction [embelin results in increased degradation of CASP9 protein] CTD PMID:28722333 emetine increases activity ISO RGD:62159 6480464 Emetine results in increased activity of CASP9 protein CTD PMID:14502240 emodin increases expression ISO RGD:62159 6480464 Emodin results in increased expression of CASP9 mRNA CTD PMID:21319176 emodin multiple interactions EXP 6480464 [2 more ... CTD PMID:35753641 enalapril decreases activity EXP 6480464 Enalapril results in decreased activity of CASP9 protein CTD PMID:21153712 endosulfan multiple interactions EXP 6480464 Endosulfan results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:30796443 entinostat increases cleavage ISO RGD:62159 6480464 entinostat results in increased cleavage of CASP9 protein CTD PMID:29845424 epichlorohydrin increases expression ISO RGD:69147 6480464 Epichlorohydrin results in increased expression of CASP9 mRNA CTD PMID:29792945 equol increases cleavage ISO RGD:69147 6480464 Equol results in increased cleavage of CASP9 protein CTD PMID:18973749 eriocitrin increases expression ISO RGD:69147 6480464 eriocitrin results in increased expression of CASP9 protein CTD PMID:34724282 erythrosin B multiple interactions EXP 6480464 [Tartrazine co-treated with Erythrosine] affects the expression of CASP9 mRNA CTD PMID:32981412 esculetin increases activity ISO RGD:69147 6480464 esculetin results in increased activity of CASP9 protein CTD PMID:24995577 , PMID:26388407 esculetin increases cleavage ISO RGD:69147 6480464 esculetin results in increased cleavage of CASP9 protein CTD PMID:31313495 etacrynic acid increases cleavage ISO RGD:69147 6480464 Ethacrynic Acid results in increased cleavage of CASP9 protein CTD PMID:23082001 etacrynic acid multiple interactions ISO RGD:69147 6480464 arsenic trioxide promotes the reaction [Ethacrynic Acid results in increased cleavage of CASP9 protein] more ... CTD PMID:23082001 ethanol multiple interactions EXP 6480464 [2 more ... CTD PMID:24146112 more ... ethanol increases cleavage ISO RGD:69147 6480464 Ethanol results in increased cleavage of CASP9 protein CTD PMID:35149083 ethanol affects splicing ISO RGD:62159 6480464 Ethanol affects the splicing of CASP9 mRNA CTD PMID:30319688 ethanol increases activity EXP 6480464 Ethanol results in increased activity of CASP9 protein CTD PMID:25289771 ethanol multiple interactions ISO RGD:62159 6480464 dioscin inhibits the reaction [Ethanol results in increased expression of CASP9 protein] CTD PMID:24146112 ethanol increases expression ISO RGD:62159 6480464 Ethanol results in increased expression of CASP9 protein CTD PMID:24146112 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CASP9 mRNA, Ethanol results in increased expression of CASP9 protein CTD PMID:23273579 more ... ethanol increases cleavage EXP 6480464 Ethanol results in increased cleavage of CASP9 protein CTD PMID:25859307 , PMID:29085585 ethylbenzene increases expression EXP 6480464 ethylbenzene results in increased expression of CASP9 mRNA, ethylbenzene results in increased expression of CASP9 protein CTD PMID:20137408 more ... ethylene glycol multiple interactions EXP 6480464 caryophyllene inhibits the reaction [Ethylene Glycol results in decreased expression of CASP9 protein] CTD PMID:34468068 ethylene glycol decreases expression EXP 6480464 Ethylene Glycol results in decreased expression of CASP9 protein CTD PMID:34468068 etodolac increases activity ISO RGD:69147 6480464 Etodolac results in increased activity of CASP9 protein CTD PMID:16046235 , PMID:16104877 etoposide multiple interactions ISO RGD:69147 6480464 [CASP8 co-treated with TP53] affects the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP9 protein] more ... CTD PMID:16364925 more ... etoposide increases cleavage ISO RGD:69147 6480464 Etoposide results in increased cleavage of CASP9 protein CTD PMID:12925536 more ... etoposide increases activity ISO RGD:69147 6480464 Etoposide results in increased activity of CASP9 protein CTD PMID:18056177 etoposide affects expression ISO RGD:69147 6480464 Etoposide affects the expression of CASP9 protein CTD PMID:15215046 eugenol multiple interactions ISO RGD:62159 6480464 Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] CTD PMID:20434464 eugenol increases expression ISO RGD:69147 6480464 Eugenol results in increased expression of CASP9 mRNA CTD PMID:30518369 eugenol increases activity ISO RGD:69147 6480464 Eugenol results in increased activity of CASP9 protein CTD PMID:25455450 EUK-134 multiple interactions ISO RGD:69147 6480464 EUK-134 inhibits the reaction [Capsaicin results in increased cleavage of CASP9 protein] more ... CTD PMID:21647434 , PMID:25005833 farrerol increases cleavage ISO RGD:69147 6480464 farrerol results in increased cleavage of CASP9 protein CTD PMID:35833306 fenbendazole increases expression ISO RGD:69147 6480464 Fenbendazole analog results in increased expression of CASP9 mRNA, Fenbendazole results in increased expression of CASP9 mRNA CTD PMID:35569513 fenbendazole increases cleavage ISO RGD:69147 6480464 Fenbendazole analog results in increased cleavage of CASP9 protein, Fenbendazole results in increased cleavage of CASP9 protein CTD PMID:35569513 fenhexamid multiple interactions ISO RGD:69147 6480464 [N-(2 more ... CTD PMID:33484789 fenitrothion multiple interactions EXP 6480464 [Vehicle Emissions results in increased abundance of Particulate Matter] promotes the reaction [Fenitrothion results in increased expression of CASP9 mRNA] more ... CTD PMID:33393722 more ... fenitrothion increases expression EXP 6480464 Fenitrothion results in increased expression of CASP9 mRNA CTD PMID:33393722 more ... fenpyroximate increases activity ISO RGD:69147 6480464 fenpyroximate results in increased activity of CASP9 protein CTD PMID:36933581 fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP9 mRNA more ... CTD PMID:33396045 more ... fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of CASP9 mRNA CTD PMID:30307764 ferric oxide increases activity ISO RGD:69147 6480464 ferric oxide results in increased activity of CASP9 protein CTD PMID:33554279 ferrosoferric oxide multiple interactions ISO RGD:69147 6480464 [Ferrosoferric Oxide binds to titanium dioxide] which results in increased cleavage of CASP9 protein CTD PMID:30098274 fipronil increases activity ISO RGD:69147 6480464 fipronil results in increased activity of CASP9 protein CTD PMID:22421270 fisetin multiple interactions ISO RGD:69147 6480464 [Cisplatin co-treated with fisetin] promotes the reaction [CASP9 protein results in increased cleavage of CASP7 protein] more ... CTD PMID:21216935 fisetin increases activity ISO RGD:69147 6480464 fisetin results in increased activity of CASP9 protein CTD PMID:28181380 fisetin multiple interactions EXP 6480464 fisetin inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] CTD PMID:25184746 flavanone multiple interactions ISO RGD:69147 6480464 flavanone results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:22056764 flavones increases activity ISO RGD:69147 6480464 Flavones analog results in increased activity of CASP9 protein CTD PMID:20674374 flavonoids increases activity ISO RGD:69147 6480464 Flavonoids results in increased activity of CASP9 protein CTD PMID:24036141 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of CASP9 mRNA CTD PMID:18035473 flavonoids increases activity ISO RGD:62159 6480464 Flavonoids results in increased activity of CASP9 protein CTD PMID:24036141 flavonols multiple interactions ISO RGD:69147 6480464 Flavonols results in increased activity of and results in increased cleavage of CASP9 protein CTD PMID:28235426 fluoxetine increases activity ISO RGD:62159 6480464 Fluoxetine results in increased activity of CASP9 protein CTD PMID:28482088 flutamide multiple interactions ISO RGD:62159 6480464 CBL protein affects the reaction [Flutamide results in increased activity of CASP9 protein] CTD PMID:16301331 flutamide increases activity ISO RGD:62159 6480464 Flutamide results in increased activity of CASP9 protein CTD PMID:16301331 folic acid multiple interactions ISO RGD:62159 6480464 Folic Acid inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form co-treated with MAPT protein mutant form] results in increased expression of CASP9 protein modified form] CTD PMID:29068127 folic acid multiple interactions ISO RGD:69147 6480464 Folic Acid inhibits the reaction [aluminum maltolate results in increased cleavage of CASP9 protein] more ... CTD PMID:27113042 , PMID:30581319 folic acid multiple interactions EXP 6480464 Folic Acid inhibits the reaction [Nicotine results in increased expression of CASP9 protein] CTD PMID:29972271 folic acid increases expression ISO RGD:62159 6480464 Folic Acid results in increased expression of CASP9 protein modified form CTD PMID:29068127 formaldehyde increases activity ISO RGD:69147 6480464 Formaldehyde results in increased activity of CASP9 protein CTD PMID:20347000 formaldehyde multiple interactions ISO RGD:69147 6480464 PRDX2 protein inhibits the reaction [Formaldehyde results in increased activity of CASP9 protein] CTD PMID:20347000 formononetin increases activity ISO RGD:69147 6480464 formononetin results in increased activity of CASP9 protein CTD PMID:23867903 formononetin multiple interactions ISO RGD:69147 6480464 Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP9 mRNA] more ... CTD PMID:23867903 formononetin increases expression ISO RGD:69147 6480464 formononetin results in increased expression of CASP9 mRNA CTD PMID:23867903 fraxetin decreases activity ISO RGD:69147 6480464 fraxetin results in decreased activity of CASP9 protein CTD PMID:15996779 fructose multiple interactions ISO RGD:62159 6480464 [Fructose co-treated with Dietary Fats] results in increased expression of CASP9 mRNA more ... CTD PMID:28916335 fructose decreases cleavage EXP 6480464 Fructose results in decreased cleavage of CASP9 protein CTD PMID:33475235 fructose multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Fructose results in decreased cleavage of CASP9 protein] CTD PMID:33475235 fulvestrant multiple interactions ISO RGD:69147 6480464 [Estradiol co-treated with Fulvestrant co-treated with 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3 more ... CTD PMID:31945389 , PMID:33484789 fumonisin B1 multiple interactions ISO RGD:62159 6480464 [fumonisin B1 co-treated with ochratoxin A] results in increased cleavage of CASP9 protein, fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 mRNA] CTD PMID:36397609 furan increases expression EXP 6480464 furan results in increased expression of CASP9 mRNA CTD PMID:20562052 furan increases activity EXP 6480464 furan results in increased activity of CASP9 protein CTD PMID:32758512 furan multiple interactions EXP 6480464 protocatechuic acid inhibits the reaction [furan results in increased activity of CASP9 protein] CTD PMID:32758512 furosemide affects expression EXP 6480464 Furosemide affects the expression of CASP9 mRNA CTD PMID:17497460 Fusarenone X increases expression ISO RGD:62159 6480464 fusarenon-X results in increased expression of CASP9 mRNA CTD PMID:24983900 galactose multiple interactions EXP 6480464 [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] CTD PMID:25997894 galactose increases expression ISO RGD:62159 6480464 Galactose results in increased expression of CASP9 mRNA CTD PMID:33761044 galactose multiple interactions ISO RGD:62159 6480464 albicanol inhibits the reaction [Galactose results in increased expression of CASP9 mRNA] CTD PMID:33761044 galactose increases expression EXP 6480464 Galactose results in increased expression of CASP9 protein CTD PMID:32295448 gallic acid multiple interactions ISO RGD:69147 6480464 1 more ... CTD PMID:27060209 gallic acid increases cleavage ISO RGD:69147 6480464 Gallic Acid results in increased cleavage of CASP9 protein CTD PMID:27060209 gamma-aminobutyric acid decreases cleavage EXP 6480464 gamma-Aminobutyric Acid results in decreased cleavage of CASP9 protein CTD PMID:29708300 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of CASP9 protein CTD PMID:19038305 gamma-hexachlorocyclohexane multiple interactions EXP 6480464 Ro 31-8220 inhibits the reaction [Hexachlorocyclohexane results in increased activity of CASP9 protein], TEMPO inhibits the reaction [Hexachlorocyclohexane results in increased activity of CASP9 protein] CTD PMID:22001173 gamma-hexachlorocyclohexane increases activity EXP 6480464 Hexachlorocyclohexane results in increased activity of CASP9 protein CTD PMID:22001173 gamma-hexachlorocyclohexane decreases activity EXP 6480464 Hexachlorocyclohexane results in decreased activity of CASP9 protein CTD PMID:19041923 gamma-tocopherol increases activity ISO RGD:69147 6480464 gamma-Tocopherol results in increased activity of CASP9 protein CTD PMID:15596715 Ganoderic acid A multiple interactions ISO RGD:62159 6480464 ganoderic acid A inhibits the reaction [Cyclophosphamide results in increased expression of CASP9 protein] CTD PMID:30506662 Garcinol increases cleavage ISO RGD:69147 6480464 garcinol results in increased cleavage of CASP9 protein CTD PMID:16052481 gardenin B multiple interactions ISO RGD:69147 6480464 gardenin B results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:27423764 Gastrodin affects activity ISO RGD:62159 6480464 gastrodin affects the activity of CASP9 protein CTD PMID:23578476 gedunin increases activity ISO RGD:69147 6480464 gedunin results in increased activity of CASP9 protein CTD PMID:21381696 geldanamycin multiple interactions ISO RGD:69147 6480464 geldanamycin inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein] CTD PMID:16311509 gemcitabine multiple interactions ISO RGD:69147 6480464 [Calcitriol co-treated with Gemcitabine] results in increased expression of CASP9 protein more ... CTD PMID:20699664 more ... gemcitabine increases activity ISO RGD:69147 6480464 Gemcitabine results in increased activity of CASP9 protein CTD PMID:12479703 more ... gemcitabine multiple interactions ISO RGD:62159 6480464 [Curcumin co-treated with Gemcitabine] results in decreased expression of CASP9 protein CTD PMID:17440100 gemcitabine increases cleavage ISO RGD:69147 6480464 Gemcitabine results in increased cleavage of CASP9 protein CTD PMID:15726400 geneticin increases activity ISO RGD:69147 6480464 antibiotic G 418 results in increased activity of CASP9 protein CTD PMID:15241557 geneticin multiple interactions ISO RGD:69147 6480464 benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [antibiotic G 418 results in increased activity of CASP9 protein] CTD PMID:15241557 genistein multiple interactions ISO RGD:69147 6480464 [Genistein co-treated with TNFSF10 protein] results in increased activity of CASP9 protein more ... CTD PMID:19497411 more ... genistein increases cleavage EXP 6480464 Genistein results in increased cleavage of CASP9 protein CTD PMID:24884420 genistein multiple interactions EXP 6480464 bisphenol A promotes the reaction [Genistein results in increased cleavage of CASP9 protein] CTD PMID:24884420 genistein increases cleavage ISO RGD:69147 6480464 Genistein results in increased cleavage of CASP9 protein CTD PMID:24299158 genistein increases activity ISO RGD:69147 6480464 Genistein results in increased activity of CASP9 protein CTD PMID:20219070 gentamycin increases cleavage ISO RGD:69147 6480464 Gentamicins results in increased cleavage of CASP9 protein CTD PMID:23145036 gentamycin increases expression ISO RGD:69147 6480464 Gentamicins results in increased expression of CASP9 mRNA CTD PMID:29992668 gentamycin multiple interactions EXP 6480464 Gentamicins results in increased cleavage of and results in increased activity of CASP9 protein, tetramethylpyrazine inhibits the reaction [Gentamicins results in increased activity of CASP9 protein] CTD PMID:17132701 , PMID:18842672 gentamycin increases activity EXP 6480464 Gentamicins results in increased activity of CASP9 protein CTD PMID:17132701 gentamycin multiple interactions ISO RGD:69147 6480464 cobaltous chloride inhibits the reaction [Gentamicins results in increased cleavage of CASP9 protein] CTD PMID:23145036 Gentiopicrin multiple interactions ISO RGD:62159 6480464 gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP9 protein], gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CASP9 protein modified form] CTD PMID:20558151 geraniol multiple interactions EXP 6480464 [camphene co-treated with geraniol] inhibits the reaction [nimesulide results in increased cleavage of CASP9 protein] more ... CTD PMID:21907755 more ... geraniol increases expression ISO RGD:69147 6480464 geraniol results in increased expression of CASP9 mRNA, geraniol results in increased expression of CASP9 protein CTD PMID:30506710 geraniol multiple interactions ISO RGD:62159 6480464 geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:24768735 gibberellin A3 increases expression EXP 6480464 gibberellic acid results in increased expression of CASP9 mRNA, gibberellic acid results in increased expression of CASP9 protein CTD PMID:31733319 gingerol multiple interactions ISO RGD:62159 6480464 gingerol inhibits the reaction [Testosterone results in decreased expression of CASP9 protein] CTD PMID:18030663 gingerol increases cleavage ISO RGD:69147 6480464 gingerol results in increased cleavage of CASP9 protein CTD PMID:28249781 gingerol affects activity ISO RGD:62159 6480464 gingerol affects the activity of CASP9 protein CTD PMID:17454143 gingerol increases expression ISO RGD:69147 6480464 gingerol results in increased expression of CASP9 mRNA, gingerol results in increased expression of CASP9 protein CTD PMID:18030663 , PMID:19481070 gingerol multiple interactions ISO RGD:69147 6480464 gingerol inhibits the reaction [Testosterone results in decreased expression of CASP9 protein] CTD PMID:18030663 Ginkgoic acid increases cleavage ISO RGD:69147 127284886 Ginkgoic acid increases cleavage of CASP9 protein in stomach RGD ginsenoside Rg1 increases activity ISO RGD:62159 6480464 ginsenoside Rg1 results in increased activity of CASP9 protein CTD PMID:28371286 ginsenoside Rg1 multiple interactions ISO RGD:69147 6480464 ginsenoside Rg1 promotes the reaction [Doxorubicin results in increased expression of CASP9 mRNA] CTD PMID:34783124 ginsenoside Rg1 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in increased cleavage of CASP9 protein]], ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in increased cleavage of CASP9 protein] CTD PMID:34859534 glabridin increases cleavage ISO RGD:69147 6480464 glabridin results in increased cleavage of CASP9 protein CTD PMID:29663662 glucaric acid multiple interactions ISO RGD:62159 6480464 [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9 more ... CTD PMID:25478867 glucose multiple interactions ISO RGD:69147 6480464 [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein more ... CTD PMID:17309078 , PMID:30431688 glucose increases cleavage ISO RGD:69147 6480464 Glucose results in increased cleavage of CASP9 protein CTD PMID:30431688 glucose increases expression EXP 6480464 Glucose results in increased expression of CASP9 mRNA CTD PMID:23192364 glucose increases activity EXP 6480464 Glucose results in increased activity of CASP9 CTD PMID:18791325 glucose multiple interactions EXP 6480464 [Glucose co-treated with IGF2R protein modified form] results in increased expression of CASP9 protein more ... CTD PMID:18791325 more ... glutathione multiple interactions ISO RGD:69147 6480464 Glutathione affects the reaction [SOD2 protein affects the activity of CASP9 protein], Glutathione inhibits the reaction [Thimerosal results in increased activity of CASP9 protein] CTD PMID:12140745 , PMID:18594523 glutathione multiple interactions ISO RGD:62159 6480464 Glutathione inhibits the reaction [Buthionine Sulfoximine results in increased activity of CASP9 protein] CTD PMID:33309544 glycochenodeoxycholic acid increases activity EXP 6480464 Glycochenodeoxycholic Acid results in increased activity of CASP9 protein CTD PMID:15767249 glycochenodeoxycholic acid multiple interactions ISO RGD:69147 6480464 Sulfasalazine inhibits the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP9 protein] CTD PMID:16322111 glycochenodeoxycholic acid increases activity ISO RGD:69147 6480464 Glycochenodeoxycholic Acid results in increased activity of CASP9 protein CTD PMID:16322111 glycyrrhizinic acid multiple interactions EXP 6480464 Glycyrrhizic Acid inhibits the reaction [Benzo(a)pyrene results in increased activity of CASP9 protein] CTD PMID:22051199 glycyrrhizinic acid increases activity ISO RGD:69147 6480464 Glycyrrhizic Acid results in increased activity of CASP9 protein CTD PMID:35844403 glyphosate decreases expression ISO RGD:69147 6480464 glyphosate results in decreased expression of CASP9 protein CTD PMID:24073338 glyphosate increases expression ISO RGD:69147 6480464 glyphosate results in increased expression of CASP9 mRNA CTD PMID:31874349 glyphosate multiple interactions EXP 6480464 [Surface-Active Agents co-treated with glyphosate] results in increased activity of CASP9 protein CTD PMID:23099315 gold atom multiple interactions ISO RGD:69147 6480464 [Gold analog co-treated with Platinum] results in increased activity of CASP9 protein, [Gold analog co-treated with Platinum] results in increased expression of CASP9 mRNA CTD PMID:25846798 gold atom increases cleavage ISO RGD:69147 6480464 Gold analog results in increased cleavage of CASP9 protein CTD PMID:26551149 gold atom multiple interactions EXP 6480464 [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP9 protein CTD PMID:27836789 gold(0) multiple interactions ISO RGD:69147 6480464 [Gold analog co-treated with Platinum] results in increased activity of CASP9 protein, [Gold analog co-treated with Platinum] results in increased expression of CASP9 mRNA CTD PMID:25846798 gold(0) increases cleavage ISO RGD:69147 6480464 Gold analog results in increased cleavage of CASP9 protein CTD PMID:26551149 gold(0) multiple interactions EXP 6480464 [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP9 protein CTD PMID:27836789 gossypol increases cleavage ISO RGD:69147 6480464 Gossypol results in increased cleavage of CASP9 protein CTD PMID:18840529 gossypol multiple interactions ISO RGD:62159 6480464 [gossypol acetic acid results in increased abundance of Gossypol] promotes the reaction [ponatinib results in increased expression of CASP9 protein] more ... CTD PMID:34699866 gossypol multiple interactions EXP 6480464 [Gossypol co-treated with Methyltestosterone co-treated with Ethinyl Estradiol] results in increased expression of CASP9 mRNA CTD PMID:15451339 graphite multiple interactions ISO RGD:69147 6480464 [Graphite analog co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of and results in increased cleavage of CASP9 protein CTD PMID:25446327 Grifolin increases activity ISO RGD:69147 6480464 grifolin results in increased activity of CASP9 protein CTD PMID:15949805 griseofulvin increases activity ISO RGD:69147 6480464 Griseofulvin results in increased activity of CASP9 protein CTD PMID:23329179 guggulsterone increases activity ISO RGD:69147 6480464 pregna-4 more ... CTD PMID:17475222 harman increases expression ISO RGD:69147 6480464 harman results in increased expression of CASP9 mRNA CTD PMID:35985368 Heliotrine increases activity ISO RGD:69147 6480464 heliotrine results in increased activity of CASP9 protein CTD PMID:29458164 hesperidin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [Acetaminophen results in increased expression of CASP9 mRNA], Hesperidin inhibits the reaction [Acetaminophen results in increased expression of CASP9 protein] CTD PMID:22093918 hexachlorobenzene multiple interactions EXP 6480464 Hexachlorobenzene results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:19182106 hexachlorobenzene increases activity EXP 6480464 Hexachlorobenzene results in increased activity of CASP9 protein CTD PMID:21787832 hexadecanoic acid multiple interactions ISO RGD:69147 6480464 3-N-1(spermine)-7 more ... CTD PMID:32369900 hexadecanoic acid multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]] more ... CTD PMID:34897970 hexadecanoic acid increases expression EXP 6480464 Palmitic Acid results in increased expression of CASP9 protein modified form CTD PMID:34897970 hispidin multiple interactions EXP 6480464 hispidin inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] CTD PMID:26318906 hispidin increases activity EXP 6480464 hispidin results in increased activity of CASP9 protein CTD PMID:26318906 homoeriodictyol multiple interactions ISO RGD:69147 6480464 homoeriodictyol inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] CTD PMID:29902531 Honokiol increases activity ISO RGD:69147 6480464 honokiol results in increased activity of CASP9 protein CTD PMID:15802533 , PMID:25106108 hydrogen chloride decreases expression ISO RGD:69147 6480464 Hydrochloric Acid results in decreased expression of CASP9 mRNA CTD PMID:15046208 hydrogen peroxide increases expression ISO RGD:69147 6480464 Hydrogen Peroxide results in increased expression of CASP9 mRNA, Hydrogen Peroxide results in increased expression of CASP9 protein CTD PMID:20361964 more ... hydrogen peroxide increases activity ISO RGD:69147 6480464 Hydrogen Peroxide results in increased activity of CASP9 protein CTD PMID:14753751 more ... hydrogen peroxide increases cleavage ISO RGD:69147 6480464 Hydrogen Peroxide results in increased cleavage of CASP9 protein CTD PMID:25005833 more ... hydrogen peroxide increases cleavage ISO RGD:62159 6480464 Hydrogen Peroxide results in increased cleavage of CASP9 protein CTD PMID:12626342 more ... hydrogen peroxide affects expression ISO RGD:69147 6480464 Hydrogen Peroxide affects the expression of CASP9 protein CTD PMID:21179406 hydrogen peroxide multiple interactions ISO RGD:62159 6480464 PARP1 protein promotes the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein], Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] CTD PMID:15876423 , PMID:20878536 hydrogen peroxide multiple interactions ISO RGD:69147 6480464 [sodium cyanate co-treated with Hydrogen Peroxide] results in increased activity of CASP9 protein more ... CTD PMID:14753751 more ... hydrogen peroxide increases activity EXP 6480464 Hydrogen Peroxide results in increased activity of CASP9 protein CTD PMID:14505808 , PMID:16647178 hydrogen peroxide multiple interactions EXP 6480464 3 more ... CTD PMID:14505808 more ... hydroquinone decreases expression ISO RGD:69147 6480464 hydroquinone results in decreased expression of CASP9 mRNA CTD PMID:15452088 hydroquinone increases expression ISO RGD:62159 6480464 hydroquinone results in increased expression of CASP9 protein CTD PMID:27606422 hydroquinone multiple interactions ISO RGD:69147 6480464 Lithium Chloride inhibits the reaction [hydroquinone results in increased expression of CASP9 protein modified form], Okadaic Acid inhibits the reaction [hydroquinone results in increased cleavage of CASP9 protein] CTD PMID:23288922 , PMID:28886972 hydroquinone increases expression ISO RGD:69147 6480464 hydroquinone results in increased expression of CASP9 protein modified form CTD PMID:28886972 hydroquinone increases activity ISO RGD:69147 6480464 hydroquinone results in increased activity of CASP9 protein CTD PMID:15816534 more ... hydroquinone increases cleavage ISO RGD:69147 6480464 hydroquinone results in increased cleavage of CASP9 protein CTD PMID:15777082 more ... hydroxamic acid multiple interactions EXP 6480464 Hydroxamic Acids analog promotes the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP9 protein modified form] CTD PMID:30503585 icariside II increases cleavage ISO RGD:69147 6480464 baohuoside I results in increased cleavage of CASP9 protein CTD PMID:22687635 icariside II increases activity ISO RGD:69147 6480464 baohuoside I results in increased activity of CASP9 protein CTD PMID:19289254 ifosfamide multiple interactions ISO RGD:69147 6480464 BCL2 protein inhibits the reaction [Ifosfamide results in increased activity of CASP9 protein] CTD PMID:11723234 ifosfamide multiple interactions EXP 6480464 Carnitine inhibits the reaction [Ifosfamide results in increased expression of CASP9 mRNA] CTD PMID:23213347 ifosfamide increases expression EXP 6480464 Ifosfamide results in increased expression of CASP9 mRNA CTD PMID:23213347 indocyanine green increases expression ISO RGD:69147 6480464 Indocyanine Green results in increased expression of CASP9 mRNA, Indocyanine Green results in increased expression of CASP9 protein CTD PMID:23675521 indole-3-methanol increases activity ISO RGD:69147 6480464 indole-3-carbinol results in increased activity of CASP9 protein CTD PMID:16082211 indole-3-methanol increases cleavage ISO RGD:62159 6480464 indole-3-carbinol results in increased cleavage of CASP9 protein CTD PMID:29775573 indole-3-methanol multiple interactions ISO RGD:69147 6480464 indole-3-carbinol results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:20335513 indometacin multiple interactions ISO RGD:69147 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Indomethacin results in increased activity of CASP9 protein] more ... CTD PMID:15804060 more ... indometacin increases expression ISO RGD:69147 6480464 Indomethacin results in increased expression of CASP9 mRNA CTD PMID:29027214 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of CASP9 mRNA CTD PMID:29027214 indometacin increases activity ISO RGD:69147 6480464 Indomethacin results in increased activity of CASP9 protein CTD PMID:11005569 more ... indometacin increases activity EXP 6480464 Indomethacin results in increased activity of CASP9 protein CTD PMID:16184425 , PMID:19220725 indometacin multiple interactions EXP 6480464 Indomethacin inhibits the reaction [COL2A1 results in decreased expression of CASP9 protein] more ... CTD PMID:16184425 more ... insulin multiple interactions EXP 6480464 Insulin promotes the reaction [Ozone inhibits the reaction [Streptozocin results in increased expression of CASP9 mRNA]] CTD PMID:26614261 inulin multiple interactions ISO RGD:62159 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CASP9 mRNA CTD PMID:36331819 iohexol increases expression ISO RGD:69147 6480464 Iohexol results in increased expression of CASP9 mRNA, Iohexol results in increased expression of CASP9 protein CTD PMID:29705293 iopamidol multiple interactions ISO RGD:69147 6480464 Iopamidol results in increased expression of and results in increased cleavage of CASP9 protein CTD PMID:29705293 iopamidol increases expression ISO RGD:69147 6480464 Iopamidol results in increased expression of CASP9 mRNA CTD PMID:29705293 irinotecan increases activity ISO RGD:69147 6480464 Irinotecan results in increased activity of CASP9 protein CTD PMID:22898888 irinotecan multiple interactions ISO RGD:69147 6480464 benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Irinotecan results in increased activity of CASP9 protein] more ... CTD PMID:18182997 , PMID:22898888 iron(III) nitrilotriacetate multiple interactions EXP 6480464 [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP9 protein more ... CTD PMID:21907755 isatin multiple interactions ISO RGD:69147 6480464 [Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased cleavage of CASP9 protein, [Copper binds to Isatin binds to trimethylenediamine] which results in increased cleavage of CASP9 protein CTD PMID:17327230 Isoangustone A increases cleavage ISO RGD:69147 6480464 isoangustone A results in increased cleavage of CASP9 protein CTD PMID:20229524 isoflavones increases expression EXP 6480464 Isoflavones results in increased expression of CASP9 mRNA CTD PMID:25035168 isoflurane decreases expression EXP 6480464 Isoflurane results in decreased expression of CASP9 mRNA CTD PMID:16978161 isoflurane increases activity ISO RGD:62159 6480464 Isoflurane results in increased activity of CASP9 protein CTD PMID:23922164 isoflurane multiple interactions ISO RGD:62159 6480464 resveratrol inhibits the reaction [Isoflurane results in increased activity of CASP9 protein] CTD PMID:23922164 isoliquiritigenin multiple interactions ISO RGD:69147 6480464 20-hydroxyeicosa-5(Z) more ... CTD PMID:23747687 , PMID:25094029 isoliquiritigenin increases activity ISO RGD:69147 6480464 isoliquiritigenin results in increased activity of CASP9 protein CTD PMID:16158945 isoliquiritigenin increases cleavage ISO RGD:69147 6480464 isoliquiritigenin results in increased cleavage of CASP9 protein CTD PMID:25094029 isoniazide multiple interactions ISO RGD:69147 6480464 Quercetin inhibits the reaction [Isoniazid results in increased cleavage of CASP9 protein] CTD PMID:31332904 isoniazide increases cleavage ISO RGD:69147 6480464 Isoniazid results in increased cleavage of CASP9 protein CTD PMID:31332904 isoprenaline multiple interactions EXP 6480464 anethole inhibits the reaction [Isoproterenol results in increased cleavage of CASP9 protein] more ... CTD PMID:25794854 more ... isoprenaline increases cleavage EXP 6480464 Isoproterenol results in increased cleavage of CASP9 protein CTD PMID:35430261 isoprenaline increases activity EXP 6480464 Isoproterenol results in increased activity of CASP9 protein CTD PMID:32865837 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of CASP9 mRNA, Isoproterenol results in increased expression of CASP9 protein CTD PMID:24286936 more ... isorhamnetin decreases expression ISO RGD:69147 6480464 3-methylquercetin results in decreased expression of CASP9 protein CTD PMID:22992727 isotretinoin increases expression ISO RGD:62159 6480464 Isotretinoin results in increased expression of CASP9 protein CTD PMID:27606422 kaempferol increases cleavage ISO RGD:69147 6480464 kaempferol results in increased cleavage of CASP9 protein CTD PMID:18331776 kaempferol multiple interactions EXP 6480464 [kaempferol inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in increased expression of CASP9 protein CTD PMID:36049518 kaempferol multiple interactions ISO RGD:69147 6480464 kaempferol inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] CTD PMID:20594614 kahweol multiple interactions ISO RGD:69147 6480464 kahweol inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP9 protein] CTD PMID:31306736 ketamine increases activity ISO RGD:69147 6480464 Ketamine results in increased activity of CASP9 protein CTD PMID:19001360 ketamine increases expression EXP 6480464 Ketamine results in increased expression of CASP9 mRNA CTD PMID:20080153 ketoconazole increases expression ISO RGD:62159 6480464 Ketoconazole results in increased expression of CASP9 mRNA CTD PMID:25808816 Kukoamine B multiple interactions ISO RGD:69147 6480464 kukoamine B inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP9 protein] CTD PMID:26164594 L-1,4-dithiothreitol multiple interactions ISO RGD:62159 6480464 Dithiothreitol inhibits the reaction [2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP9 protein] CTD PMID:11226294 L-ascorbic acid multiple interactions EXP 6480464 [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein], Ascorbic Acid inhibits the reaction [Norepinephrine results in increased activity of CASP9 protein] CTD PMID:15158148 , PMID:16973328 L-ascorbic acid multiple interactions ISO RGD:69147 6480464 Ascorbic Acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein] CTD PMID:23711929 L-gamma-glutamyl-L-cysteine multiple interactions EXP 6480464 2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [gamma-glutamylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP9 protein]] more ... CTD PMID:34767868 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in increased activity of CASP9 protein, geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased activity of CASP9 protein] CTD PMID:26695085 L-mimosine multiple interactions ISO RGD:69147 6480464 Mimosine results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:18058236 lapatinib multiple interactions ISO RGD:69147 6480464 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [Lapatinib results in increased cleavage of CASP9 protein] CTD PMID:29387217 lapatinib increases cleavage ISO RGD:69147 6480464 Lapatinib results in increased cleavage of CASP9 protein CTD PMID:29387217 lead diacetate multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP9 protein more ... CTD PMID:23906897 more ... lead diacetate increases expression ISO RGD:62159 6480464 lead acetate results in increased expression of CASP9 protein CTD PMID:27604105 lead diacetate multiple interactions ISO RGD:62159 6480464 [lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP9 protein more ... CTD PMID:27236077 more ... lead diacetate increases activity ISO RGD:62159 6480464 lead acetate results in increased activity of CASP9 protein CTD PMID:27236077 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of CASP9 mRNA CTD PMID:23906897 lead nitrate multiple interactions ISO RGD:62159 6480464 mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP9 protein] CTD PMID:23451106 lead nitrate multiple interactions ISO RGD:69147 6480464 [lead nitrate results in increased abundance of Lead] which results in increased activity of CASP9 protein more ... CTD PMID:30738203 lead nitrate increases expression ISO RGD:62159 6480464 lead nitrate results in increased expression of CASP9 protein CTD PMID:23451106 lead(0) multiple interactions ISO RGD:69147 6480464 [lead nitrate results in increased abundance of Lead] which results in increased activity of CASP9 protein more ... CTD PMID:30738203 lead(0) multiple interactions ISO RGD:62159 6480464 [lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP9 protein, [lead acetate results in increased abundance of Lead] which results in increased expression of CASP9 mRNA CTD PMID:37397918 lead(0) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP9 protein, Carbenoxolone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP9 protein] CTD PMID:33242459 lead(II) chloride increases cleavage ISO RGD:69147 6480464 lead chloride results in increased cleavage of CASP9 protein CTD PMID:24419708 leflunomide decreases expression ISO RGD:69147 6480464 leflunomide results in decreased expression of CASP9 mRNA CTD PMID:28988120 Leonurine multiple interactions EXP 6480464 leonurine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CASP9 protein] CTD PMID:31005592 Leonurine multiple interactions ISO RGD:62159 6480464 leonurine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CASP9 protein] CTD PMID:31005592 leuprolide increases expression ISO RGD:69147 6480464 Leuprolide results in increased expression of CASP9 protein CTD PMID:15965100 Licochalcone A increases cleavage ISO RGD:69147 6480464 licochalcone A results in increased cleavage of CASP9 protein CTD PMID:30983163 Licochalcone A multiple interactions ISO RGD:69147 6480464 SB 203580 inhibits the reaction [licochalcone A results in increased cleavage of CASP9 protein] CTD PMID:30983163 licoricidin increases activity ISO RGD:69147 6480464 licoricidin results in increased activity of CASP9 protein CTD PMID:37013980 lidocaine decreases expression ISO RGD:69147 6480464 Lidocaine results in decreased expression of CASP9 protein CTD PMID:20194319 limonin increases activity ISO RGD:69147 6480464 limonin results in increased activity of CASP9 protein CTD PMID:31702096 linalool increases expression ISO RGD:69147 6480464 linalool results in increased expression of CASP9 mRNA CTD PMID:26703569 linalool increases activity ISO RGD:69147 6480464 linalool results in increased activity of CASP9 protein CTD PMID:28567457 lipoic acid increases activity ISO RGD:69147 6480464 Thioctic Acid results in increased activity of CASP9 protein CTD PMID:16990509 lipoic acid multiple interactions ISO RGD:69147 6480464 Thioctic Acid inhibits the reaction [Zinc Oxide analog results in increased activity of CASP9 protein] CTD PMID:27544635 lipoic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of CASP9 mRNA more ... CTD PMID:19951573 more ... lipopolysaccharide increases activity ISO RGD:69147 6480464 Lipopolysaccharides results in increased activity of CASP9 protein CTD PMID:20848084 lipopolysaccharide increases cleavage ISO RGD:69147 6480464 Lipopolysaccharides results in increased cleavage of CASP9 protein CTD PMID:32048402 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CASP9 protein CTD PMID:30084861 lipopolysaccharide increases activity ISO RGD:62159 6480464 Lipopolysaccharides results in increased activity of CASP9 protein CTD PMID:23170834 , PMID:30261164 lipopolysaccharide increases cleavage EXP 6480464 Lipopolysaccharides results in increased cleavage of CASP9 protein CTD PMID:25557508 more ... lipopolysaccharide multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in increased cleavage of CASP9 protein]] more ... CTD PMID:25557508 more ... lipopolysaccharide multiple interactions ISO RGD:62159 6480464 [Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP9 protein more ... CTD PMID:20558151 more ... lipopolysaccharide increases expression ISO RGD:69147 6480464 Lipopolysaccharides results in increased expression of CASP9 protein CTD PMID:21844306 lipopolysaccharide multiple interactions ISO RGD:69147 6480464 Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased activity of CASP9 protein] more ... CTD PMID:20848084 , PMID:32048402 lithium carbonate increases expression ISO RGD:62159 6480464 Lithium Carbonate results in increased expression of CASP9 protein CTD PMID:34984798 lithium chloride multiple interactions ISO RGD:69147 6480464 Lithium Chloride inhibits the reaction [hydroquinone results in increased expression of CASP9 protein modified form], Lithium Chloride inhibits the reaction [quinocetone results in increased cleavage of CASP9 protein] CTD PMID:28343033 , PMID:28886972 lithocholic acid multiple interactions ISO RGD:69147 6480464 [[[[[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein] which results in increased cleavage of BID protein] which results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein more ... CTD PMID:19054763 loganin decreases expression ISO RGD:62159 6480464 loganin results in decreased expression of CASP9 mRNA CTD PMID:20966881 lonafarnib multiple interactions ISO RGD:69147 6480464 [lonafarnib co-treated with Bortezomib] results in increased cleavage of CASP9 protein CTD PMID:16118318 lonafarnib increases cleavage ISO RGD:69147 6480464 lonafarnib results in increased cleavage of CASP9 protein CTD PMID:16118318 Longikaurin A increases expression ISO RGD:69147 6480464 longikaurin A results in increased expression of CASP9 protein modified form CTD PMID:28801140 lonidamine multiple interactions ISO RGD:69147 6480464 [Curcumin co-treated with lonidamine] results in increased cleavage of CASP9 protein more ... CTD PMID:20605902 , PMID:21889928 loratadine increases cleavage ISO RGD:69147 6480464 Loratadine results in increased cleavage of CASP9 protein CTD PMID:20570632 losartan increases cleavage EXP 6480464 Losartan results in increased cleavage of CASP9 protein CTD PMID:12623880 lovastatin increases activity ISO RGD:62159 6480464 Lovastatin results in increased activity of CASP9 protein CTD PMID:15180944 lovastatin multiple interactions EXP 6480464 Lovastatin inhibits the reaction [Cholesterol, Dietary results in decreased expression of CASP9 protein] CTD PMID:35734936 lovastatin increases activity ISO RGD:69147 6480464 Lovastatin results in increased activity of CASP9 protein CTD PMID:12933658 , PMID:15705602 lupeol increases expression ISO RGD:69147 6480464 lupeol results in increased expression of CASP9 mRNA, lupeol results in increased expression of CASP9 protein CTD PMID:30506710 lupeol multiple interactions EXP 6480464 lupeol inhibits the reaction [COL2A1 results in decreased expression of CASP9 protein] CTD PMID:35446470 Lupiwighteone increases cleavage ISO RGD:69147 6480464 lupiwighteone results in increased cleavage of CASP9 protein CTD PMID:31604113 luteolin increases cleavage ISO RGD:69147 6480464 Luteolin results in increased cleavage of CASP9 protein CTD PMID:18331776 more ... luteolin increases activity ISO RGD:69147 6480464 Luteolin results in increased activity of CASP9 protein CTD PMID:21601631 , PMID:27489195 luteolin 7-O-beta-D-glucoside increases cleavage ISO RGD:69147 6480464 luteolin-7-glucoside results in increased cleavage of CASP9 protein CTD PMID:34165247 LY294002 multiple interactions ISO RGD:69147 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Indomethacin results in increased activity of CASP9 protein] more ... CTD PMID:12438947 more ... LY294002 increases cleavage ISO RGD:69147 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased cleavage of CASP9 protein CTD PMID:16412023 , PMID:35123989 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]] more ... CTD PMID:19801490 more ... lycopene multiple interactions EXP 6480464 lycopene inhibits the reaction [Sodium Fluoride results in increased expression of CASP9 mRNA] CTD PMID:27871895 lycopene multiple interactions ISO RGD:62159 6480464 lycopene inhibits the reaction [Sodium Fluoride results in increased activity of CASP9 protein], lycopene inhibits the reaction [Sodium Fluoride results in increased expression of CASP9 mRNA] CTD PMID:27871895 magnesium oxide multiple interactions ISO RGD:69147 6480464 Magnesium Oxide analog inhibits the reaction [Diazinon results in increased activity of CASP9 protein] more ... CTD PMID:27920530 Magnolol increases activity ISO RGD:69147 6480464 magnolol results in increased activity of CASP9 protein CTD PMID:31714653 malathion increases activity ISO RGD:62159 6480464 Malathion results in increased activity of CASP9 protein CTD PMID:12505448 malathion increases cleavage EXP 6480464 Malathion results in increased cleavage of CASP9 protein CTD PMID:35274200 malathion increases activity EXP 6480464 Malathion results in increased activity of CASP9 protein CTD PMID:27941166 malathion increases cleavage ISO RGD:69147 6480464 Malathion results in increased cleavage of CASP9 protein CTD PMID:30769050 malathion multiple interactions ISO RGD:69147 6480464 Acetylcysteine inhibits the reaction [Malathion results in increased cleavage of CASP9 protein] CTD PMID:30769050 malathion multiple interactions EXP 6480464 [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA] more ... CTD PMID:21628957 , PMID:35274200 malathion increases expression EXP 6480464 Malathion results in increased expression of CASP9 mRNA CTD PMID:21628957 malonic acid multiple interactions EXP 6480464 malonic acid inhibits the reaction [chelerythrine results in increased activity of CASP9 protein] CTD PMID:21664962 mancozeb increases activity ISO RGD:69147 6480464 mancozeb results in increased activity of CASP9 protein CTD PMID:22824503 maneb multiple interactions ISO RGD:62159 6480464 [Maneb co-treated with Paraquat] results in increased expression of CASP9 mRNA more ... CTD PMID:20964710 , PMID:23963992 maneb increases activity ISO RGD:69147 6480464 Maneb results in increased activity of CASP9 protein CTD PMID:22824503 manganese atom increases cleavage EXP 6480464 Manganese results in increased cleavage of CASP9 protein CTD PMID:16787641 manganese atom multiple interactions ISO RGD:69147 6480464 SNCA protein inhibits the reaction [Manganese results in increased activity of CASP9 protein] CTD PMID:25416158 manganese atom increases activity EXP 6480464 Manganese results in increased activity of CASP9 protein CTD PMID:25416158 manganese(0) increases cleavage EXP 6480464 Manganese results in increased cleavage of CASP9 protein CTD PMID:16787641 manganese(0) increases activity EXP 6480464 Manganese results in increased activity of CASP9 protein CTD PMID:25416158 manganese(0) multiple interactions ISO RGD:69147 6480464 SNCA protein inhibits the reaction [Manganese results in increased activity of CASP9 protein] CTD PMID:25416158 manganese(II) chloride increases activity ISO RGD:62159 6480464 manganese chloride results in increased activity of CASP9 protein CTD PMID:17483122 manganese(II) chloride multiple interactions EXP 6480464 bafilomycin A1 inhibits the reaction [manganese chloride results in increased cleavage of CASP9 protein] more ... CTD PMID:28378122 manganese(II) chloride increases activity EXP 6480464 manganese chloride results in increased activity of CASP9 protein CTD PMID:25416158 manganese(II) chloride multiple interactions ISO RGD:69147 6480464 SNCA protein inhibits the reaction [manganese chloride results in increased activity of CASP9 protein] CTD PMID:25416158 manganese(II) chloride increases cleavage EXP 6480464 manganese chloride results in increased cleavage of CASP9 protein CTD PMID:16787641 more ... manganese(II) chloride multiple interactions ISO RGD:62159 6480464 PRNP protein inhibits the reaction [manganese chloride results in increased activity of CASP9 protein] CTD PMID:17483122 mangiferin multiple interactions ISO RGD:62159 6480464 mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP9 protein] CTD PMID:23451106 mangiferin multiple interactions EXP 6480464 mangiferin inhibits the reaction [Galactosamine results in increased expression of CASP9 protein] CTD PMID:22118634 masoprocol increases activity ISO RGD:69147 6480464 Masoprocol results in increased activity of CASP9 protein CTD PMID:15034932 mechlorethamine increases activity ISO RGD:69147 6480464 Mechlorethamine results in increased activity of CASP9 protein CTD PMID:16738803 , PMID:23649643 mechlorethamine multiple interactions ISO RGD:69147 6480464 ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP9 protein], Mechlorethamine results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:22285227 , PMID:23649643 melamine multiple interactions ISO RGD:69147 6480464 1 more ... CTD PMID:22915474 melamine increases cleavage ISO RGD:69147 6480464 melamine results in increased cleavage of CASP9 protein CTD PMID:22915474 melatonin multiple interactions ISO RGD:69147 6480464 Melatonin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] more ... CTD PMID:20130848 more ... melatonin multiple interactions ISO RGD:62159 6480464 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of CASP9 mRNA] more ... CTD PMID:20964710 more ... melatonin increases activity ISO RGD:69147 6480464 Melatonin results in increased activity of CASP9 protein CTD PMID:19012662 , PMID:19552762 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] more ... CTD PMID:19220725 more ... melittin multiple interactions ISO RGD:62159 6480464 Melitten inhibits the reaction [TGFB1 protein results in increased cleavage of CASP9 protein] CTD PMID:21871910 melittin increases expression ISO RGD:69147 6480464 Melitten analog results in increased expression of CASP9 mRNA, Melitten analog results in increased expression of CASP9 protein CTD PMID:29387245 melittin multiple interactions EXP 6480464 Melitten promotes the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of CASP9 mRNA], Melitten promotes the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of CASP9 protein] CTD PMID:21354845 melittin multiple interactions ISO RGD:69147 6480464 Melitten results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:21456063 meloxicam multiple interactions EXP 6480464 Meloxicam inhibits the reaction [Diquat results in increased expression of CASP9 protein modified form] CTD PMID:29484840 meloxicam multiple interactions ISO RGD:69147 6480464 [Meloxicam co-treated with Cilostazol] results in increased activity of CASP9 protein CTD PMID:35920412 meloxicam increases activity ISO RGD:69147 6480464 Meloxicam results in increased activity of CASP9 protein CTD PMID:35920412 melphalan multiple interactions ISO RGD:69147 6480464 Melphalan results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:22285227 memantine increases expression ISO RGD:69147 6480464 Memantine results in increased expression of CASP9 protein CTD PMID:29226720 menadione multiple interactions ISO RGD:69147 6480464 [sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein more ... CTD PMID:19082730 more ... menadione increases cleavage ISO RGD:69147 6480464 Vitamin K 3 results in increased cleavage of CASP9 protein CTD PMID:25005833 menadione increases cleavage EXP 6480464 Vitamin K 3 results in increased cleavage of CASP9 protein CTD PMID:16310883 menadione multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP9 protein] CTD PMID:16310883 mercury atom increases expression EXP 6480464 Mercury results in increased expression of CASP9 protein CTD PMID:21186712 mercury dichloride increases expression ISO RGD:62159 6480464 Mercuric Chloride results in increased expression of CASP9 protein CTD PMID:21373768 mercury(0) increases expression EXP 6480464 Mercury results in increased expression of CASP9 protein CTD PMID:21186712 methamphetamine multiple interactions ISO RGD:69147 6480464 ATF4 protein affects the reaction [Methamphetamine results in increased cleavage of CASP9 protein] more ... CTD PMID:27323860 methamphetamine increases cleavage EXP 6480464 Methamphetamine results in increased cleavage of CASP9 protein CTD PMID:32676729 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of CASP9 mRNA CTD PMID:17450226 methimazole multiple interactions EXP 6480464 Methimazole results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:17171702 methotrexate increases expression ISO RGD:69147 6480464 Methotrexate results in increased expression of CASP9 mRNA CTD PMID:21678067 , PMID:29027214 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of CASP9 mRNA CTD PMID:29027214 methotrexate increases activity EXP 6480464 Methotrexate results in increased activity of CASP9 protein CTD PMID:28479099 methotrexate multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [Methotrexate results in increased activity of CASP9 protein] CTD PMID:28479099 methotrexate decreases expression ISO RGD:69147 6480464 Methotrexate results in decreased expression of CASP9 mRNA CTD PMID:24449571 methoxsalen decreases expression ISO RGD:69147 6480464 Methoxsalen results in decreased expression of CASP9 protein CTD PMID:22796345 methoxyacetic acid multiple interactions ISO RGD:69147 6480464 [1-aminomethylphosphonic acid co-treated with methoxyacetic acid] results in increased expression of CASP9 protein CTD PMID:26006246 methoxyacetic acid increases activity EXP 6480464 methoxyacetic acid results in increased activity of CASP9 protein CTD PMID:12220648 methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of CASP9 protein CTD PMID:20227399 methoxychlor increases activity ISO RGD:62159 6480464 Methoxychlor results in increased activity of CASP9 protein CTD PMID:20568958 methyl methanesulfonate increases activity ISO RGD:62159 6480464 Methyl Methanesulfonate results in increased activity of CASP9 protein CTD PMID:16019050 methylglyoxal increases expression ISO RGD:69147 6480464 Pyruvaldehyde results in increased expression of CASP9 protein CTD PMID:26577515 methylglyoxal increases cleavage ISO RGD:69147 6480464 Pyruvaldehyde results in increased cleavage of CASP9 protein CTD PMID:33930484 methylglyoxal multiple interactions EXP 6480464 Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased expression of CASP9 protein] CTD PMID:34455488 methylglyoxal decreases expression EXP 6480464 Pyruvaldehyde results in decreased expression of CASP9 protein CTD PMID:34455488 methylglyoxal increases activity ISO RGD:69147 6480464 Pyruvaldehyde results in increased activity of CASP9 protein CTD PMID:31254498 methylglyoxal multiple interactions ISO RGD:69147 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin inhibits the reaction [Pyruvaldehyde results in increased expression of CASP9 protein]] more ... CTD PMID:26577515 more ... methylisothiazolinone increases expression ISO RGD:69147 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of CASP9 protein modified form CTD PMID:29110394 methylmercury chloride increases activity ISO RGD:62159 6480464 methylmercuric chloride results in increased activity of CASP9 protein CTD PMID:27178136 methylmercury chloride multiple interactions EXP 6480464 1 more ... CTD PMID:35678294 methylmercury chloride increases cleavage EXP 6480464 methylmercuric chloride results in increased cleavage of CASP9 protein CTD PMID:35678294 methylmercury chloride multiple interactions ISO RGD:62159 6480464 Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of CASP9 protein modified form] CTD PMID:31330229 methylmercury chloride increases expression ISO RGD:62159 6480464 methylmercuric chloride results in increased expression of CASP9 protein modified form CTD PMID:31330229 Methylone increases activity EXP 6480464 methylone results in increased activity of CASP9 protein CTD PMID:27255387 methylseleninic acid multiple interactions ISO RGD:69147 6480464 [2 more ... CTD PMID:17339365 more ... methylseleninic acid increases cleavage ISO RGD:69147 6480464 [methylselenic acid results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein, methylselenic acid results in increased cleavage of CASP9 protein CTD PMID:18444175 , PMID:18790785 methylseleninic acid increases expression ISO RGD:69147 6480464 methylselenic acid results in increased expression of CASP9 mRNA CTD PMID:12517777 methyltestosterone multiple interactions EXP 6480464 [Gossypol co-treated with Methyltestosterone co-treated with Ethinyl Estradiol] results in increased expression of CASP9 mRNA CTD PMID:15451339 metoprolol increases cleavage ISO RGD:69147 6480464 Metoprolol results in increased cleavage of CASP9 protein CTD PMID:19106745 mevalonic acid multiple interactions ISO RGD:69147 6480464 Mevalonic Acid inhibits the reaction [Simvastatin results in increased cleavage of CASP9 protein] CTD PMID:20045437 mevalonic acid multiple interactions EXP 6480464 Mevalonic Acid inhibits the reaction [Atorvastatin results in increased activity of CASP9 protein] CTD PMID:18339080 microcystin-LR increases expression ISO RGD:62159 6480464 cyanoginosin LR results in increased expression of CASP9 protein CTD PMID:23454832 microcystin-LR increases activity ISO RGD:69147 6480464 cyanoginosin LR results in increased activity of CASP9 protein CTD PMID:35905885 microcystin-LR multiple interactions EXP 6480464 [cyanoginosin LR co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of CASP9 protein CTD PMID:34740672 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of CASP9 protein CTD PMID:34740672 mifepristone multiple interactions ISO RGD:69147 6480464 [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CASP9 mRNA] CTD PMID:22736252 minocycline decreases activity ISO RGD:62159 6480464 Minocycline results in decreased activity of CASP9 protein CTD PMID:12930891 minocycline decreases expression EXP 6480464 Minocycline results in decreased expression of CASP9 mRNA CTD PMID:14998631 minocycline multiple interactions EXP 6480464 Minocycline inhibits the reaction [HTT protein mutant form results in increased activity of CASP9 protein], Minocycline results in decreased expression of and results in decreased activity of CASP9 protein CTD PMID:12930891 , PMID:14998631 mitomycin C multiple interactions ISO RGD:69147 6480464 Mitomycin promotes the reaction [CASP9 protein results in increased secretion of CYCS protein], Mitomycin results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:10960761 , PMID:12181741 mitomycin C increases activity ISO RGD:69147 6480464 Mitomycin results in increased activity of CASP9 protein CTD PMID:16186332 more ... mitoxantrone increases activity ISO RGD:69147 6480464 Mitoxantrone results in increased activity of CASP9 protein CTD PMID:12948851 MK-2206 multiple interactions ISO RGD:69147 6480464 MK 2206 inhibits the reaction [Soot analog results in increased expression of CASP9 protein] CTD PMID:30240709 MK-2206 multiple interactions EXP 6480464 [MK 2206 inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in increased expression of CASP9 protein CTD PMID:36049518 molybdenum atom increases activity ISO RGD:69147 6480464 Molybdenum analog results in increased activity of CASP9 protein CTD PMID:26391003 mono(2-ethylhexyl) phthalate increases activity ISO RGD:69147 6480464 mono-(2-ethylhexyl)phthalate results in increased activity of CASP9 protein CTD PMID:24706461 monocrotophos increases expression EXP 6480464 Monocrotophos results in increased expression of CASP9 mRNA more ... CTD PMID:20957986 , PMID:21445290 monosodium L-glutamate multiple interactions ISO RGD:62159 6480464 [Fats more ... CTD PMID:23783067 morin multiple interactions EXP 6480464 morin inhibits the reaction [Acetaminophen results in increased activity of CASP9 protein], morin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein] CTD PMID:19931519 , PMID:26767949 morphine increases activity ISO RGD:69147 6480464 Morphine results in increased activity of CASP9 protein CTD PMID:19292871 morphine increases expression EXP 6480464 Morphine results in increased expression of CASP9 mRNA CTD PMID:15183518 Morroniside decreases expression ISO RGD:62159 6480464 morroniside results in decreased expression of CASP9 mRNA CTD PMID:20966881 morusin increases cleavage ISO RGD:69147 6480464 morusin results in increased cleavage of CASP9 protein CTD PMID:33035517 morusin multiple interactions ISO RGD:69147 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [morusin results in increased cleavage of CASP9 protein] more ... CTD PMID:33035517 Muconic dialdehyde increases cleavage ISO RGD:69147 6480464 muconaldehyde results in increased cleavage of CASP9 protein CTD PMID:34624356 myo-inositol hexakisphosphate multiple interactions ISO RGD:69147 6480464 Phytic Acid inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein] CTD PMID:12540492 , PMID:14766669 myricetin increases activity ISO RGD:69147 6480464 myricetin results in increased activity of CASP9 protein CTD PMID:15748703 myricetin increases cleavage ISO RGD:69147 6480464 myricetin results in increased cleavage of CASP9 protein CTD PMID:29698783 myristicin increases activity ISO RGD:69147 6480464 myristicin results in increased activity of CASP9 protein CTD PMID:29174417 Myrtucommulone A decreases expression ISO RGD:62159 6480464 myrtucommulone A results in decreased expression of CASP9 mRNA CTD PMID:26032814 N(gamma)-nitro-L-arginine methyl ester multiple interactions EXP 6480464 [NG-Nitroarginine Methyl Ester co-treated with bisphenol A co-treated with naringin] results in decreased expression of CASP9 protein more ... CTD PMID:32172062 more ... N(gamma)-nitro-L-arginine methyl ester increases expression EXP 6480464 NG-Nitroarginine Methyl Ester results in increased expression of CASP9 protein CTD PMID:32172062 more ... N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases activity ISO RGD:69147 6480464 N more ... CTD PMID:17169355 N,N-dimethylformamide multiple interactions ISO RGD:69147 6480464 CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form], Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form] CTD PMID:29984871 N,N-dimethylformamide increases expression ISO RGD:69147 6480464 Dimethylformamide results in increased expression of CASP9 protein modified form CTD PMID:29984871 N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide multiple interactions ISO RGD:69147 6480464 N-(1 more ... CTD PMID:25263579 N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide multiple interactions EXP 6480464 N-(1 more ... CTD PMID:25263579 N-(p-amylcinnamoyl)anthranilic acid multiple interactions ISO RGD:62159 6480464 4-amylcinnamoylanthranilic acid inhibits the reaction [Buthionine Sulfoximine results in increased activity of CASP9 protein] CTD PMID:33309544 N-(p-amylcinnamoyl)anthranilic acid multiple interactions ISO RGD:69147 6480464 4-amylcinnamoylanthranilic acid inhibits the reaction [Eicosapentaenoic Acid promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] CTD PMID:35395232 N-acetyl-L-cysteine multiple interactions ISO RGD:69147 6480464 [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein more ... CTD PMID:15496615 more ... N-acetyl-L-cysteine increases expression ISO RGD:69147 6480464 Acetylcysteine results in increased expression of CASP9 protein modified form CTD PMID:31433961 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP9 protein] more ... CTD PMID:15158148 more ... N-acetyl-L-cysteine multiple interactions ISO RGD:69147 127284886 N-acetyl-L-cysteine inhibits the reaction [Ginkgoic acid increases cleavage of CASP9 protein in stomach] RGD N-acetyl-L-cysteine multiple interactions ISO RGD:69147 127284846 N-acetyl-L-cysteine inhibits the reaction [apigenin-7-O-gentiobioside increases cleavage of CASP9 protein in the stomach) RGD N-acetyl-L-cysteine multiple interactions ISO RGD:62159 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CASP9 protein] more ... CTD PMID:18336854 more ... N-acylsphinganine increases cleavage ISO RGD:69147 6480464 dihydroceramide metabolite results in increased cleavage of CASP9 protein CTD PMID:17586710 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:69147 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:15498850 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases activity ISO RGD:62159 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of CASP9 protein CTD PMID:16880202 N-formyl-L-methionyl-L-leucyl-L-phenylalanine multiple interactions ISO RGD:69147 6480464 Melatonin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CASP9 protein] CTD PMID:20130848 N-formyl-L-methionyl-L-leucyl-L-phenylalanine increases activity ISO RGD:69147 6480464 N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CASP9 protein CTD PMID:20130848 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 Copper Sulfate inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein] more ... CTD PMID:18037221 more ... N-methyl-4-phenylpyridinium increases activity ISO RGD:69147 6480464 1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein CTD PMID:31342299 , PMID:33414358 N-methyl-4-phenylpyridinium increases expression ISO RGD:69147 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CASP9 protein modified form CTD PMID:31342299 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:69147 6480464 2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein] more ... CTD PMID:31342299 , PMID:33414358 N-methyl-4-phenylpyridinium increases activity EXP 6480464 1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein CTD PMID:18037221 more ... N-methyl-N'-nitro-N-nitrosoguanidine increases activity ISO RGD:69147 6480464 Methylnitronitrosoguanidine results in increased activity of CASP9 protein CTD PMID:15589979 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions EXP 6480464 corilagin inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] CTD PMID:35103375 N-methyl-N'-nitro-N-nitrosoguanidine decreases expression EXP 6480464 Methylnitronitrosoguanidine results in decreased expression of CASP9 protein CTD PMID:35103375 N-methyl-N'-nitro-N-nitrosoguanidine decreases expression ISO RGD:62159 6480464 Methylnitronitrosoguanidine results in decreased expression of CASP9 protein CTD PMID:20434464 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:62159 6480464 Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] CTD PMID:20434464 N-methyl-N'-nitro-N-nitrosoguanidine increases activity ISO RGD:62159 6480464 Methylnitronitrosoguanidine results in increased activity of CASP9 protein CTD PMID:16019050 N-methyl-N-nitrosourea multiple interactions EXP 6480464 [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP9 mRNA CTD PMID:20732338 N-nitrosodiethylamine increases expression ISO RGD:62159 6480464 Diethylnitrosamine results in increased expression of CASP9 mRNA CTD PMID:18691550 N-nitrosodiethylamine multiple interactions EXP 6480464 [3 more ... CTD PMID:19931519 more ... N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of CASP9 mRNA, Diethylnitrosamine results in decreased expression of CASP9 protein CTD PMID:19931519 more ... N-nitrosodiethylamine multiple interactions ISO RGD:62159 6480464 MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CASP9 mRNA] CTD PMID:18691550 N-phenylthiourea increases expression ISO RGD:69147 6480464 Phenylthiourea results in increased expression of CASP9 protein CTD PMID:16447258 N-phosphocreatine multiple interactions EXP 6480464 Phosphocreatine inhibits the reaction [Pyruvaldehyde results in decreased expression of CASP9 protein], Phosphocreatine inhibits the reaction [Streptozocin results in decreased expression of CASP9 protein] CTD PMID:34455488 N-tosyl-L-phenylalanyl chloromethyl ketone multiple interactions ISO RGD:69147 6480464 Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:19679660 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions ISO RGD:69147 6480464 Ranitidine inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] CTD PMID:19723537 naphthalene multiple interactions ISO RGD:69147 6480464 [naphthalene binds to pyrrolo(2 more ... CTD PMID:21732540 naringin increases expression ISO RGD:69147 6480464 naringin results in increased expression of CASP9 mRNA CTD PMID:22847135 naringin multiple interactions EXP 6480464 [bisphenol A co-treated with naringin] results in decreased expression of CASP9 protein more ... CTD PMID:25773745 more ... navitoclax increases cleavage ISO RGD:69147 6480464 navitoclax results in increased cleavage of CASP9 protein CTD PMID:21562047 , PMID:28947240 nefazodone increases activity ISO RGD:69147 6480464 nefazodone results in increased activity of CASP9 protein CTD PMID:27288927 Neferine increases cleavage ISO RGD:69147 6480464 neferine results in increased cleavage of CASP9 protein CTD PMID:31207222 Neferine multiple interactions ISO RGD:69147 6480464 FGFR2 protein inhibits the reaction [neferine results in increased cleavage of CASP9 protein], MIR374A mRNA inhibits the reaction [neferine results in increased cleavage of CASP9 protein] CTD PMID:31207222 Neferine multiple interactions EXP 6480464 neferine inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 mRNA], neferine inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein] CTD PMID:30423403 nelfinavir decreases activity ISO RGD:62159 6480464 Nelfinavir results in decreased activity of CASP9 protein CTD PMID:18497877 neoastilbin multiple interactions ISO RGD:69147 6480464 astilbin inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] CTD PMID:29471006 neomycin multiple interactions ISO RGD:62159 6480464 peoniflorin inhibits the reaction [Neomycin results in increased expression of CASP9 mRNA], peoniflorin inhibits the reaction [Neomycin results in increased expression of CASP9 protein modified form] CTD PMID:29292089 neomycin increases expression ISO RGD:62159 6480464 Neomycin results in increased expression of CASP9 mRNA, Neomycin results in increased expression of CASP9 protein modified form CTD PMID:29292089 nevadensin increases activity ISO RGD:69147 6480464 nevadensin results in increased activity of CASP9 protein CTD PMID:34635930 nickel atom multiple interactions ISO RGD:69147 6480464 [cobalt ferrite binds to Nickel] which results in increased expression of CASP9 protein modified form more ... CTD PMID:20577783 more ... nickel atom increases expression EXP 6480464 Nickel analog results in increased expression of CASP9 mRNA CTD PMID:27257140 nickel dichloride increases activity EXP 6480464 nickel chloride results in increased activity of CASP9 protein CTD PMID:21843586 nickel dichloride increases expression ISO RGD:62159 6480464 nickel chloride results in increased expression of CASP9 mRNA, nickel chloride results in increased expression of CASP9 protein CTD PMID:36421005 nickel dichloride multiple interactions ISO RGD:62159 6480464 Melatonin inhibits the reaction [nickel chloride results in increased expression of CASP9 mRNA] more ... CTD PMID:36421005 nickel dichloride decreases expression ISO RGD:69147 6480464 nickel chloride results in decreased expression of CASP9 protein CTD PMID:28552779 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CASP9 mRNA CTD PMID:22546817 nickel dichloride increases activity ISO RGD:69147 6480464 nickel chloride results in increased activity of CASP9 protein CTD PMID:23566959 nickel dichloride multiple interactions ISO RGD:69147 6480464 [TP53 mutant form inhibits the reaction [nickel chloride results in increased activity of CASP9 protein]] which results in decreased cleavage of CASP3 protein more ... CTD PMID:23566959 nickel dichloride multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [nickel chloride results in increased activity of CASP9 protein] CTD PMID:21843586 nickel ferrite increases activity ISO RGD:69147 6480464 nickel ferrite analog results in increased activity of CASP9 protein, nickel ferrite results in increased activity of CASP9 protein CTD PMID:21382431 , PMID:25966046 nickel ferrite increases expression ISO RGD:69147 6480464 nickel ferrite analog results in increased expression of CASP9 mRNA, nickel ferrite results in increased expression of CASP9 mRNA CTD PMID:21382431 , PMID:25966046 nickel sulfate multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of CASP9 mRNA] more ... CTD PMID:28296042 , PMID:34612572 nickel sulfate multiple interactions ISO RGD:69147 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein]], Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein] CTD PMID:34612572 nickel sulfate increases expression ISO RGD:69147 6480464 nickel sulfate results in increased expression of CASP9 protein CTD PMID:34612572 nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of CASP9 mRNA, nickel sulfate results in increased expression of CASP9 protein CTD PMID:28296042 , PMID:34612572 niclosamide increases expression ISO RGD:69147 6480464 Niclosamide results in increased expression of CASP9 mRNA, Niclosamide results in increased expression of CASP9 protein modified form CTD PMID:26116531 , PMID:36318118 niclosamide multiple interactions ISO RGD:69147 6480464 TP53 gene mutant form promotes the reaction [Niclosamide results in increased cleavage of CASP9 protein] CTD PMID:30258081 niclosamide increases cleavage ISO RGD:69147 6480464 Niclosamide results in increased cleavage of CASP9 protein CTD PMID:26703449 , PMID:30258081 nicotinamide multiple interactions EXP 6480464 Niacinamide inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] CTD PMID:16505238 nicotinamide multiple interactions ISO RGD:69147 6480464 [Berberine co-treated with Niacinamide] results in increased cleavage of CASP9 protein CTD PMID:26712469 nicotinamide multiple interactions ISO RGD:62159 6480464 [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9 more ... CTD PMID:25478867 nicotine multiple interactions ISO RGD:62159 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 nicotine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [Nicotine results in increased expression of CASP9 protein] CTD PMID:29972271 nicotine increases expression EXP 6480464 Nicotine results in increased expression of CASP9 protein CTD PMID:29972271 nicotine decreases expression ISO RGD:69147 6480464 Nicotine results in decreased expression of CASP9 mRNA CTD PMID:16949557 nicotine multiple interactions ISO RGD:69147 6480464 Nicotine inhibits the reaction [[Cisplatin co-treated with Etoposide] results in increased activity of CASP9 protein] CTD PMID:18676776 Niflumic acid multiple interactions ISO RGD:69147 6480464 [Niflumic Acid co-treated with ciglitazone] results in increased cleavage of CASP9 protein more ... CTD PMID:21067863 nifuroxazide multiple interactions EXP 6480464 nifuroxazide inhibits the reaction [Streptozocin results in increased activity of CASP9 protein] CTD PMID:29606028 nilotinib increases cleavage ISO RGD:69147 6480464 nilotinib results in increased cleavage of CASP9 protein CTD PMID:26549707 nimesulide increases cleavage EXP 6480464 nimesulide results in increased cleavage of CASP9 protein CTD PMID:22509279 nimesulide multiple interactions EXP 6480464 [camphene co-treated with geraniol] inhibits the reaction [nimesulide results in increased cleavage of CASP9 protein], Silymarin inhibits the reaction [nimesulide results in increased cleavage of CASP9 protein] CTD PMID:22509279 nimesulide increases activity EXP 6480464 nimesulide results in increased activity of CASP9 protein CTD PMID:19772912 nimesulide multiple interactions ISO RGD:69147 6480464 benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [nimesulide results in increased cleavage of and results in increased activity of CASP9 protein] more ... CTD PMID:19360361 , PMID:21745461 nimodipine multiple interactions EXP 6480464 Nimodipine inhibits the reaction [Sevoflurane results in increased expression of CASP9 protein modified form] CTD PMID:33171207 nimustine increases cleavage ISO RGD:69147 6480464 Nimustine results in increased cleavage of CASP9 protein CTD PMID:26418950 nimustine multiple interactions ISO RGD:69147 6480464 BCL2L11 mutant form inhibits the reaction [Nimustine results in increased cleavage of CASP9 protein] CTD PMID:26418950 nitric oxide decreases activity ISO RGD:62159 6480464 Nitric Oxide results in decreased activity of CASP9 protein CTD PMID:14634119 nitric oxide multiple interactions ISO RGD:62159 6480464 [Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP9 protein CTD PMID:22878015 nitric oxide increases activity ISO RGD:69147 6480464 Nitric Oxide results in increased activity of CASP9 protein CTD PMID:15126337 nitroprusside decreases activity ISO RGD:69147 6480464 Nitroprusside results in decreased activity of CASP9 protein CTD PMID:22543296 nitroprusside multiple interactions ISO RGD:62159 6480464 [Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP9 protein CTD PMID:22878015 nitroprusside multiple interactions ISO RGD:69147 6480464 epigallocatechin gallate inhibits the reaction [Nitroprusside binds to and results in increased activity of CASP9 protein] more ... CTD PMID:22178905 , PMID:23665936 nitroprusside increases activity ISO RGD:69147 6480464 Nitroprusside results in increased activity of CASP9 protein CTD PMID:22178905 nobiletin multiple interactions ISO RGD:69147 6480464 AGN 193109 inhibits the reaction [nobiletin results in decreased expression of and results in increased cleavage of CASP9 protein], nobiletin results in decreased expression of and results in increased cleavage of CASP9 protein CTD PMID:33058988 nocodazole increases cleavage ISO RGD:69147 6480464 Nocodazole analog results in increased cleavage of CASP9 protein CTD PMID:28412508 Nodularin increases activity EXP 6480464 nodularin results in increased activity of CASP9 protein CTD PMID:25192816 notoginsenoside R1 multiple interactions ISO RGD:62159 6480464 notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased activity of CASP9 protein] CTD PMID:23170834 NS-398 increases activity ISO RGD:69147 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased activity of CASP9 protein CTD PMID:12414664 NS-398 multiple interactions ISO RGD:69147 6480464 PTGS2 protein inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased activity of CASP9 protein] CTD PMID:12414664 Nutlin-3 multiple interactions ISO RGD:69147 6480464 [nutlin 3 co-treated with Bortezomib] results in increased activity of CASP9 protein, nutlin 3 results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:16014563 , PMID:20850924 O-acetyl-L-carnitine multiple interactions EXP 6480464 Acetylcarnitine inhibits the reaction [sodium arsenite results in increased activity of CASP9 protein] CTD PMID:29278859 Obacunone increases cleavage ISO RGD:69147 6480464 obacunone results in increased cleavage of CASP9 protein CTD PMID:25592883 Obacunone increases activity ISO RGD:69147 6480464 obacunone results in increased activity of CASP9 protein CTD PMID:21333732 ochratoxin A multiple interactions ISO RGD:69147 6480464 BNIP3L protein promotes the reaction [ochratoxin A results in decreased expression of CASP9 mRNA] more ... CTD PMID:19367635 more ... ochratoxin A increases expression ISO RGD:62159 6480464 ochratoxin A results in increased expression of CASP9 mRNA CTD PMID:36397609 ochratoxin A multiple interactions ISO RGD:62159 6480464 [fumonisin B1 co-treated with ochratoxin A] results in increased cleavage of CASP9 protein, fumonisin B1 promotes the reaction [ochratoxin A results in increased expression of CASP9 mRNA] CTD PMID:36397609 ochratoxin A decreases expression ISO RGD:69147 6480464 ochratoxin A results in decreased expression of CASP9 mRNA CTD PMID:17316727 , PMID:24755393 ochratoxin A increases cleavage ISO RGD:69147 6480464 ochratoxin A results in increased cleavage of CASP9 protein CTD PMID:20549612 , PMID:33465424 ochratoxin A increases activity ISO RGD:69147 6480464 ochratoxin A results in increased activity of CASP9 protein CTD PMID:15056805 ochratoxin A increases activity EXP 6480464 ochratoxin A results in increased activity of CASP9 protein CTD PMID:19562491 okadaic acid multiple interactions ISO RGD:69147 6480464 Okadaic Acid inhibits the reaction [hydroquinone results in increased cleavage of CASP9 protein], Okadaic Acid results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:19084044 , PMID:23288922 okadaic acid increases expression ISO RGD:69147 6480464 Okadaic Acid results in increased expression of CASP9 mRNA, Okadaic Acid results in increased expression of CASP9 protein modified form CTD PMID:31926150 okadaic acid increases activity ISO RGD:69147 6480464 Okadaic Acid results in increased activity of CASP9 protein CTD PMID:31926150 okadaic acid increases activity EXP 6480464 Okadaic Acid results in increased activity of CASP9 protein CTD PMID:26732598 olaparib multiple interactions ISO RGD:69147 6480464 [olaparib co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein, olaparib inhibits the reaction [Methylmercury Compounds results in increased expression of CASP9 protein] CTD PMID:25531448 , PMID:35396826 oleamide multiple interactions ISO RGD:69147 6480464 oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] CTD PMID:23747833 oleanolic acid multiple interactions ISO RGD:69147 6480464 Oleanolic Acid inhibits the reaction [ochratoxin A results in increased cleavage of CASP9 protein] CTD PMID:33465424 oleanolic acid multiple interactions ISO RGD:62159 6480464 Oleanolic Acid inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] CTD PMID:31306688 oleanolic acid increases cleavage ISO RGD:69147 6480464 Oleanolic Acid results in increased cleavage of CASP9 protein CTD PMID:22678527 oleanolic acid decreases expression ISO RGD:69147 6480464 Oleanolic Acid analog results in decreased expression of CASP9 protein CTD PMID:26612655 oleic acid multiple interactions EXP 6480464 IRS2 inhibits the reaction [Oleic Acid results in increased cleavage of CASP9 protein] CTD PMID:14604813 oleic acid multiple interactions ISO RGD:69147 6480464 3-N-1(spermine)-7 more ... CTD PMID:32369900 oleic acid increases cleavage EXP 6480464 Oleic Acid results in increased cleavage of CASP9 protein CTD PMID:14604813 oligopeptide multiple interactions EXP 6480464 Oligopeptides inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP9 protein] CTD PMID:25868679 omacetaxine mepesuccinate increases expression ISO RGD:69147 6480464 Homoharringtonine results in increased expression of CASP9 protein CTD PMID:23980369 omacetaxine mepesuccinate increases cleavage ISO RGD:69147 6480464 Homoharringtonine results in increased cleavage of CASP9 protein CTD PMID:31726078 orlistat increases activity ISO RGD:62159 6480464 orlistat results in increased activity of CASP9 protein CTD PMID:20805790 orlistat multiple interactions EXP 6480464 Orlistat inhibits the reaction [Dietary Fats results in increased expression of CASP9 mRNA] CTD PMID:32450208 oroxylin A decreases expression ISO RGD:69147 6480464 5, 7-dihydroxy-6-methoxy-2-phenylchromen-4-one results in decreased expression of CASP9 protein CTD PMID:19135124 osthole increases cleavage ISO RGD:69147 6480464 osthol results in increased cleavage of CASP9 protein CTD PMID:29319219 , PMID:31870840 ouabain multiple interactions ISO RGD:69147 6480464 Ouabain results in increased expression of and results in increased activity of CASP9 protein CTD PMID:31436044 oxidopamine increases activity ISO RGD:69147 6480464 Oxidopamine results in increased activity of CASP9 protein CTD PMID:19780897 , PMID:19781563 oxidopamine increases cleavage ISO RGD:69147 6480464 Oxidopamine results in increased cleavage of CASP9 protein CTD PMID:32167238 oxidopamine multiple interactions ISO RGD:69147 6480464 sulforaphane inhibits the reaction [Oxidopamine results in increased activity of CASP9 protein], Valproic Acid inhibits the reaction [Oxidopamine results in increased cleavage of CASP9 protein] CTD PMID:19780897 , PMID:32167238 oxidopamine increases activity EXP 6480464 Oxidopamine results in increased activity of CASP9 protein CTD PMID:21846476 oxybenzone increases activity EXP 6480464 oxybenzone results in increased activity of CASP9 protein CTD PMID:30099065 oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of CASP9 mRNA CTD PMID:30316929 ozone increases cleavage EXP 6480464 Ozone results in increased cleavage of CASP9 protein CTD PMID:22727909 ozone decreases expression EXP 6480464 Ozone results in decreased expression of CASP9 mRNA CTD PMID:26614261 ozone multiple interactions EXP 6480464 Insulin promotes the reaction [Ozone inhibits the reaction [Streptozocin results in increased expression of CASP9 mRNA]], Ozone inhibits the reaction [Streptozocin results in increased expression of CASP9 mRNA] CTD PMID:26614261 p-menthan-3-ol increases expression ISO RGD:69147 6480464 Menthol results in increased expression of CASP9 mRNA CTD PMID:26760959 paclitaxel multiple interactions ISO RGD:69147 6480464 [4-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-N more ... CTD PMID:14749477 more ... paclitaxel affects response to substance ISO RGD:69147 6480464 CASP9 protein affects the susceptibility to Paclitaxel CTD PMID:17652622 paclitaxel multiple interactions ISO RGD:62159 6480464 CASP9 protein affects the reaction [Paclitaxel results in increased activity of and results in increased cleavage of CASP3 protein] CTD PMID:17652622 paclitaxel increases activity ISO RGD:69147 6480464 Paclitaxel results in increased activity of CASP9 protein CTD PMID:18098270 paclitaxel increases expression ISO RGD:69147 6480464 Paclitaxel results in increased expression of CASP9 mRNA more ... CTD PMID:15907983 more ... paeoniflorin multiple interactions ISO RGD:62159 6480464 peoniflorin inhibits the reaction [Neomycin results in increased expression of CASP9 mRNA], peoniflorin inhibits the reaction [Neomycin results in increased expression of CASP9 protein modified form] CTD PMID:29292089 pamidronate increases cleavage ISO RGD:69147 6480464 pamidronate results in increased cleavage of CASP9 protein CTD PMID:16298452 Panduratin A increases cleavage ISO RGD:69147 6480464 panduratin A results in increased cleavage of CASP9 protein CTD PMID:16497706 panobinostat multiple interactions ISO RGD:69147 6480464 [resveratrol co-treated with panobinostat] results in increased cleavage of CASP9 protein CTD PMID:22923501 paracetamol increases cleavage EXP 6480464 Acetaminophen results in increased cleavage of CASP9 protein CTD PMID:19922764 paracetamol increases activity EXP 6480464 Acetaminophen results in increased activity of CASP9 protein CTD PMID:26767949 paracetamol multiple interactions EXP 6480464 Hesperidin inhibits the reaction [Acetaminophen results in increased expression of CASP9 mRNA] more ... CTD PMID:22093918 , PMID:26767949 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CASP9 mRNA, Acetaminophen results in increased expression of CASP9 protein CTD PMID:21807079 , PMID:22093918 paracetamol decreases activity EXP 6480464 Acetaminophen results in decreased activity of CASP9 CTD PMID:20079345 paracetamol increases cleavage ISO RGD:62159 6480464 Acetaminophen results in increased cleavage of CASP9 protein CTD PMID:14747384 paracetamol multiple interactions ISO RGD:62159 6480464 manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Acetaminophen results in increased activity of CASP9 protein] CTD PMID:11343246 paracetamol increases activity ISO RGD:62159 6480464 Acetaminophen results in increased activity of CASP9 protein CTD PMID:11343246 , PMID:30375433 paracetamol affects expression ISO RGD:62159 6480464 Acetaminophen affects the expression of CASP9 mRNA CTD PMID:17562736 paracetamol increases activity ISO RGD:69147 6480464 Acetaminophen results in increased activity of CASP9 CTD PMID:12005112 paraoxon multiple interactions ISO RGD:62159 6480464 benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Paraoxon results in increased cleavage of and results in increased activity of CASP9 protein] more ... CTD PMID:12831782 paraquat increases activity ISO RGD:69147 6480464 Paraquat results in increased activity of CASP9 protein CTD PMID:18253895 more ... paraquat increases expression EXP 6480464 Paraquat results in increased expression of CASP9 protein CTD PMID:32680482 paraquat increases expression ISO RGD:62159 6480464 Paraquat results in increased expression of CASP9 protein modified form CTD PMID:27442881 paraquat increases activity EXP 6480464 Paraquat results in increased activity of CASP9 protein CTD PMID:24912633 paraquat decreases expression ISO RGD:69147 6480464 Paraquat results in decreased expression of CASP9 mRNA CTD PMID:18836921 paraquat multiple interactions ISO RGD:62159 6480464 [Maneb co-treated with Paraquat] results in increased expression of CASP9 mRNA more ... CTD PMID:20964710 , PMID:23963992 paraquat increases cleavage ISO RGD:69147 6480464 Paraquat results in increased cleavage of CASP9 protein CTD PMID:22043816 paraquat increases expression ISO RGD:69147 6480464 Paraquat results in increased expression of CASP9 mRNA more ... CTD PMID:17064354 more ... paraquat multiple interactions ISO RGD:69147 6480464 [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in increased expression of CASP9 mRNA] more ... CTD PMID:22043816 more ... parathion-methyl increases activity EXP 6480464 Methyl Parathion results in increased activity of CASP9 protein CTD PMID:27941166 paroxetine increases activity ISO RGD:62159 6480464 Paroxetine results in increased activity of CASP9 protein CTD PMID:28482088 Parthenin increases activity ISO RGD:69147 6480464 parthenin analog results in increased activity of CASP9 protein CTD PMID:25196075 patulin increases activity ISO RGD:69147 6480464 Patulin results in increased activity of CASP9 protein CTD PMID:33577942 patulin multiple interactions ISO RGD:69147 6480464 diphenyleneiodonium inhibits the reaction [Patulin results in increased activity of CASP9 protein] CTD PMID:33577942 Pendulone increases activity ISO RGD:69147 6480464 pendulone results in increased activity of CASP9 protein CTD PMID:35288263 pentachlorophenol multiple interactions ISO RGD:69147 6480464 [Pentachlorophenol co-treated with copper-1 more ... CTD PMID:30590774 pentetic acid increases activity ISO RGD:69147 6480464 Pentetic Acid results in increased activity of CASP9 protein CTD PMID:17169355 Pentoxifylline multiple interactions ISO RGD:69147 6480464 [Pentoxifylline co-treated with TNFSF10 protein] results in increased activity of CASP9 protein CTD PMID:20804743 pepstatin A multiple interactions EXP 6480464 pepstatin inhibits the reaction [manganese chloride results in increased cleavage of CASP9 protein] CTD PMID:28378122 pepstatin A multiple interactions ISO RGD:69147 6480464 pepstatin inhibits the reaction [Doxorubicin results in increased expression of CASP9 protein modified form], pepstatin inhibits the reaction [syringic acid analog results in increased secretion of CASP9 protein] CTD PMID:31226464 , PMID:34523043 perfluorooctane-1-sulfonic acid increases expression ISO RGD:69147 6480464 perfluorooctane sulfonic acid results in increased expression of CASP9 mRNA CTD PMID:19468714 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:62159 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CASP9 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CASP9 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid increases cleavage ISO RGD:62159 6480464 perfluorooctane sulfonic acid results in increased cleavage of CASP9 protein CTD PMID:34303733 perfluorooctane-1-sulfonic acid increases activity ISO RGD:69147 6480464 perfluorooctane sulfonic acid results in increased activity of CASP9 protein CTD PMID:22976841 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CASP9 mRNA, perfluorooctane sulfonic acid results in increased expression of CASP9 protein CTD PMID:24616003 perfluorooctane-1-sulfonic acid increases expression ISO RGD:62159 6480464 perfluorooctane sulfonic acid results in increased expression of CASP9 mRNA CTD PMID:21115943 perfluorooctanoic acid increases expression ISO RGD:69147 6480464 perfluorooctanoic acid results in increased expression of CASP9 mRNA, perfluorooctanoic acid results in increased expression of CASP9 protein CTD PMID:19468714 , PMID:34765786 perfluorooctanoic acid increases cleavage ISO RGD:69147 6480464 perfluorooctanoic acid results in increased cleavage of CASP9 protein CTD PMID:35123991 peroxynitrous acid increases expression EXP 6480464 Peroxynitrous Acid results in increased expression of CASP9 mRNA CTD PMID:20869986 peroxynitrous acid multiple interactions EXP 6480464 Curcumin inhibits the reaction [Peroxynitrous Acid results in increased cleavage of and results in increased activity of CASP9 protein] more ... CTD PMID:20869986 phenanthridone multiple interactions ISO RGD:69147 6480464 [eprenetapopt co-treated with phenanthridone] results in increased cleavage of CASP9 protein CTD PMID:29416738 phenethyl caffeate multiple interactions ISO RGD:62159 6480464 caffeic acid phenethyl ester inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased activity of CASP9 protein] CTD PMID:34743973 phenethyl isothiocyanate increases activity ISO RGD:69147 6480464 phenethyl isothiocyanate results in increased activity of CASP9 protein CTD PMID:16054126 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CASP9 mRNA CTD PMID:23273579 phenobarbital multiple interactions EXP 6480464 [3 more ... CTD PMID:27048571 phenol increases activity ISO RGD:69147 6480464 Phenol results in increased activity of CASP9 protein CTD PMID:23776099 phenylephrine increases activity ISO RGD:69147 6480464 Phenylephrine results in increased activity of CASP9 protein CTD PMID:31605733 phloretin multiple interactions ISO RGD:69147 6480464 [Ruthenium binds to Phloretin] which results in decreased expression of and results in increased cleavage of CASP9 protein CTD PMID:34896434 phloroglucinol increases cleavage ISO RGD:69147 6480464 Phloroglucinol metabolite results in increased cleavage of CASP9 protein CTD PMID:22796323 phorate increases expression EXP 6480464 Phorate results in increased expression of CASP9 mRNA, Phorate results in increased expression of CASP9 protein CTD PMID:22197610 phorbol 12,13-dibutanoate increases cleavage ISO RGD:62159 6480464 Phorbol 12, 13-Dibutyrate results in increased cleavage of CASP9 protein CTD PMID:12626342 phorbol 12,13-dibutanoate multiple interactions ISO RGD:62159 6480464 rottlerin inhibits the reaction [Phorbol 12, 13-Dibutyrate results in increased cleavage of CASP9 protein] CTD PMID:12626342 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:69147 6480464 [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP9 protein, [Graphite analog co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of and results in increased cleavage of CASP9 protein CTD PMID:17309078 , PMID:25446327 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:62159 6480464 [9 more ... CTD PMID:32662567 phorbol 13-acetate 12-myristate decreases expression ISO RGD:69147 6480464 Tetradecanoylphorbol Acetate results in decreased expression of CASP9 protein CTD PMID:24073338 phosphatidylcholine multiple interactions ISO RGD:69147 6480464 [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CASP9 protein CTD PMID:21695227 phytol multiple interactions ISO RGD:62159 6480464 [Phytol co-treated with Benzo(a)pyrene] results in decreased expression of CASP9 protein CTD PMID:30520250 phytosphingosine multiple interactions ISO RGD:69147 6480464 3 more ... CTD PMID:17237268 Pinacidil decreases expression EXP 6480464 Pinacidil results in decreased expression of CASP9 mRNA CTD PMID:17612592 piperine increases cleavage ISO RGD:69147 6480464 piperine results in increased cleavage of CASP9 protein CTD PMID:28341137 pirinixic acid multiple interactions ISO RGD:62159 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CASP9 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:62159 6480464 pirinixic acid results in increased expression of CASP9 mRNA CTD PMID:17426115 platinum multiple interactions ISO RGD:69147 6480464 [Gold analog co-treated with Platinum] results in increased activity of CASP9 protein, [Gold analog co-treated with Platinum] results in increased expression of CASP9 mRNA CTD PMID:25846798 platinum(0) multiple interactions ISO RGD:69147 6480464 [Gold analog co-treated with Platinum] results in increased activity of CASP9 protein, [Gold analog co-treated with Platinum] results in increased expression of CASP9 mRNA CTD PMID:25846798 platycodin D increases activity ISO RGD:69147 6480464 platycodin D results in increased activity of CASP9 protein CTD PMID:20412017 platycodin D increases cleavage ISO RGD:69147 6480464 platycodin D results in increased cleavage of CASP9 protein CTD PMID:23236765 , PMID:24048756 platycodin D multiple interactions ISO RGD:69147 6480464 [platycodin D co-treated with Imatinib Mesylate] results in increased cleavage of CASP9 protein CTD PMID:29552859 plumbagin multiple interactions ISO RGD:62159 6480464 Acetylcysteine inhibits the reaction [plumbagin results in increased activity of CASP9 protein] CTD PMID:20576514 plumbagin increases activity EXP 6480464 plumbagin results in increased activity of CASP9 protein CTD PMID:34302802 plumbagin increases expression ISO RGD:69147 6480464 plumbagin results in increased expression of CASP9 mRNA CTD PMID:36336213 plumbagin decreases expression ISO RGD:69147 6480464 plumbagin results in decreased expression of CASP9 protein CTD PMID:36336213 plumbagin increases activity ISO RGD:62159 6480464 plumbagin results in increased activity of CASP9 protein CTD PMID:20576514 podophyllotoxin increases activity ISO RGD:69147 6480464 Podophyllotoxin results in increased activity of CASP9 protein CTD PMID:21916509 , PMID:33722735 poly(I:C) increases activity ISO RGD:69147 6480464 Poly I-C results in increased activity of CASP9 protein CTD PMID:21418039 poly(I:C) multiple interactions ISO RGD:69147 6480464 Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [Poly I-C results in increased activity of CASP9 protein]] more ... CTD PMID:21418039 poly(methyl methacrylate) macromolecule increases expression ISO RGD:69147 6480464 Polymethyl Methacrylate results in increased expression of CASP9 mRNA CTD PMID:34245821 Polygodial increases cleavage ISO RGD:69147 6480464 polygodial results in increased cleavage of CASP9 protein CTD PMID:30935903 ponatinib multiple interactions ISO RGD:62159 6480464 [gossypol acetic acid results in increased abundance of Gossypol] promotes the reaction [ponatinib results in increased expression of CASP9 protein], ponatinib promotes the reaction [[gossypol acetic acid results in increased abundance of Gossypol] which results in increased expression of CASP9 protein] CTD PMID:34699866 ponatinib increases expression ISO RGD:62159 6480464 ponatinib results in increased expression of CASP9 protein CTD PMID:34699866 potassium dichromate increases expression ISO RGD:69147 6480464 Potassium Dichromate results in increased expression of CASP9 protein modified form CTD PMID:32569804 potassium dichromate increases activity ISO RGD:62159 6480464 Potassium Dichromate results in increased activity of CASP9 protein CTD PMID:25409916 potassium dichromate increases expression ISO RGD:62159 6480464 Potassium Dichromate results in increased expression of CASP9 mRNA CTD PMID:25409916 potassium dichromate multiple interactions ISO RGD:62159 6480464 [Cadmium Chloride co-treated with Potassium Dichromate] results in increased activity of CASP9 protein, [Cadmium Chloride co-treated with Potassium Dichromate] results in increased expression of CASP9 mRNA CTD PMID:25409916 potassium dichromate multiple interactions ISO RGD:69147 6480464 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of CASP9 protein modified form] more ... CTD PMID:32569804 potassium iodide increases expression EXP 6480464 Potassium Iodide results in increased expression of CASP9 protein CTD PMID:32593569 Pramanicin increases activity ISO RGD:69147 6480464 pramanicin analog results in increased activity of CASP9 protein CTD PMID:23441183 Pranoprofen increases activity ISO RGD:69147 6480464 pyranoprofen results in increased activity of CASP9 protein CTD PMID:31765691 pravastatin multiple interactions EXP 6480464 Pravastatin inhibits the reaction [Carboplatin results in increased expression of CASP9 protein] CTD PMID:18483861 prazosin increases activity ISO RGD:69147 6480464 Prazosin results in increased activity of CASP9 protein CTD PMID:26449523 probenecid multiple interactions ISO RGD:62159 6480464 [Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:24768735 procyanidin B2 decreases activity ISO RGD:69147 6480464 procyanidin B2 results in decreased activity of CASP9 protein CTD PMID:21505870 procyanidin B2 multiple interactions ISO RGD:69147 6480464 procyanidin B2 inhibits the reaction [MFGE8 protein results in increased activity of CASP9 protein] CTD PMID:21505870 procymidone increases expression ISO RGD:62159 6480464 procymidone results in increased expression of CASP9, procymidone results in increased expression of CASP9 mRNA CTD PMID:33413771 , PMID:35913088 prodigiosin increases cleavage ISO RGD:69147 6480464 Prodigiosin results in increased cleavage of CASP9 protein CTD PMID:15746575 , PMID:19133282 prodigiosin increases activity ISO RGD:69147 6480464 Prodigiosin results in increased activity of CASP9 protein CTD PMID:31077745 progesterone multiple interactions EXP 6480464 [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP9 mRNA CTD PMID:20732338 progesterone multiple interactions ISO RGD:69147 6480464 Progesterone inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] CTD PMID:23482746 propiconazole decreases expression ISO RGD:62159 6480464 propiconazole results in decreased expression of CASP9 mRNA CTD PMID:21278054 propofol decreases cleavage EXP 6480464 Propofol results in decreased cleavage of CASP9 protein CTD PMID:21468576 propofol multiple interactions ISO RGD:69147 6480464 Acetylcysteine inhibits the reaction [Propofol results in increased cleavage of CASP9 protein] CTD PMID:28804952 propofol increases cleavage ISO RGD:69147 6480464 Propofol results in increased cleavage of CASP9 protein CTD PMID:28804952 propofol increases activity ISO RGD:62159 6480464 Propofol results in increased activity of CASP9 protein CTD PMID:21786383 propranolol increases cleavage ISO RGD:69147 6480464 Propranolol results in increased cleavage of CASP9 protein CTD PMID:19106745 propranolol increases cleavage EXP 6480464 Propranolol results in increased cleavage of CASP9 protein CTD PMID:35738838 propranolol multiple interactions EXP 6480464 Fat Emulsions, Intravenous inhibits the reaction [Propranolol results in increased cleavage of CASP9 protein] CTD PMID:35738838 propylparaben increases expression ISO RGD:69147 6480464 propylparaben results in increased expression of CASP9 mRNA, propylparaben results in increased expression of CASP9 protein CTD PMID:24481588 prostaglandin E2 multiple interactions ISO RGD:69147 6480464 Dinoprostone inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP9 protein] CTD PMID:25094029 pterostilbene increases expression ISO RGD:69147 6480464 pterostilbene results in increased expression of CASP9 protein CTD PMID:20152895 pterostilbene multiple interactions ISO RGD:69147 6480464 pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP9 protein], Thapsigargin promotes the reaction [pterostilbene results in increased activity of CASP9 protein] CTD PMID:25341683 , PMID:33930484 pterostilbene increases activity ISO RGD:69147 6480464 pterostilbene results in increased activity of CASP9 protein CTD PMID:25341683 pterostilbene increases cleavage ISO RGD:62159 6480464 pterostilbene results in increased cleavage of CASP9 protein CTD PMID:20681671 Punicalagin increases expression ISO RGD:69147 6480464 punicalagin results in increased expression of CASP9 protein CTD PMID:33720461 puromycin increases activity ISO RGD:62159 6480464 Puromycin results in increased activity of CASP9 protein CTD PMID:14502240 purpurin increases expression ISO RGD:69147 6480464 purpurin results in increased expression of CASP9 mRNA CTD PMID:33368780 putrescine increases expression EXP 6480464 Putrescine results in increased expression of CASP9 protein CTD PMID:17606387 pyrethrins increases activity ISO RGD:69147 6480464 Pyrethrins results in increased activity of CASP9 protein CTD PMID:27939866 pyrethrins increases expression EXP 6480464 Pyrethrins results in increased expression of CASP9 mRNA CTD PMID:36053783 pyrimethamine increases activity ISO RGD:69147 6480464 Pyrimethamine results in increased activity of CASP9 protein CTD PMID:18593930 pyrogallol increases expression ISO RGD:62159 6480464 Pyrogallol results in increased expression of CASP9 mRNA CTD PMID:20362636 pyrovalerone increases activity ISO RGD:69147 6480464 pyrovalerone analog results in increased activity of CASP9 protein CTD PMID:28578026 pyrroles increases activity ISO RGD:69147 6480464 Pyrroles analog results in increased activity of CASP9 protein CTD PMID:30543781 pyrrolidine dithiocarbamate increases activity ISO RGD:69147 6480464 pyrrolidine dithiocarbamic acid results in increased activity of CASP9 protein CTD PMID:12198114 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein more ... CTD PMID:20920558 , PMID:22085843 pyrroloquinoline quinone multiple interactions ISO RGD:69147 6480464 PQQ Cofactor inhibits the reaction [Doxorubicin results in increased expression of CASP9 protein modified form] CTD PMID:31226464 pyruvic acid multiple interactions EXP 6480464 [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] CTD PMID:25997894 quercetin increases activity ISO RGD:62159 6480464 Quercetin results in increased activity of CASP9 protein CTD PMID:26076811 quercetin increases expression ISO RGD:62159 6480464 Quercetin results in increased expression of CASP9 protein CTD PMID:18586010 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of CASP9 mRNA] more ... CTD PMID:14505808 more ... quercetin increases expression ISO RGD:69147 6480464 Quercetin analog results in increased expression of CASP9 mRNA more ... CTD PMID:22983795 more ... quercetin multiple interactions ISO RGD:69147 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased cleavage of CASP9 protein] more ... CTD PMID:15583868 more ... quercetin increases cleavage ISO RGD:69147 6480464 Quercetin analog results in increased cleavage of CASP9 protein, Quercetin results in increased cleavage of CASP9 protein CTD PMID:18331776 more ... quercetin increases activity ISO RGD:69147 6480464 Quercetin results in increased activity of CASP9 protein CTD PMID:16158945 more ... quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of CASP9 mRNA CTD PMID:23281070 quercetin multiple interactions ISO RGD:62159 6480464 [Quercetin co-treated with Curcumin] inhibits the reaction [Benzo(a)pyrene results in decreased activity of CASP9 protein] more ... CTD PMID:15876423 , PMID:28681665 quercetin 4'-O-beta-D-glucopyranoside decreases expression ISO RGD:69147 6480464 spiraeoside results in decreased expression of CASP9 protein CTD PMID:34116102 quinacrine increases cleavage ISO RGD:69147 6480464 Quinacrine results in increased cleavage of CASP9 protein CTD PMID:28867437 ranitidine multiple interactions ISO RGD:69147 6480464 Ranitidine inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] CTD PMID:19723537 reactive oxygen species increases activity ISO RGD:69147 6480464 Reactive Oxygen Species results in increased activity of CASP9 protein CTD PMID:26884717 reactive oxygen species multiple interactions ISO RGD:69147 6480464 [[[[[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein] which results in increased cleavage of BID protein] which results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein more ... CTD PMID:19054763 more ... Rebamipide multiple interactions EXP 6480464 rebamipide inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] CTD PMID:16184425 resveratrol decreases activity ISO RGD:69147 6480464 resveratrol results in decreased activity of CASP9 protein CTD PMID:21505870 resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Fenitrothion results in increased expression of CASP9 mRNA] CTD PMID:34968465 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CASP9 protein modified form CTD PMID:24040416 resveratrol increases cleavage ISO RGD:69147 6480464 resveratrol results in increased cleavage of CASP9 protein CTD PMID:18347188 more ... resveratrol increases expression ISO RGD:62159 6480464 resveratrol results in increased expression of CASP9 protein CTD PMID:25505154 resveratrol increases cleavage ISO RGD:62159 6480464 Resveratrol results in increased cleavage of CASP9 protein CTD PMID:17872969 , PMID:22137261 resveratrol decreases activity ISO RGD:62159 6480464 resveratrol results in decreased activity of CASP9 protein CTD PMID:20940732 resveratrol multiple interactions ISO RGD:62159 6480464 BIRC5 protein affects the reaction [Resveratrol results in increased cleavage of CASP9 protein] more ... CTD PMID:16322078 more ... resveratrol decreases activity EXP 6480464 resveratrol results in decreased activity of CASP9 protein CTD PMID:20861279 resveratrol multiple interactions ISO RGD:69147 6480464 [2 more ... CTD PMID:12902349 more ... resveratrol increases activity ISO RGD:69147 6480464 [Resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein more ... CTD PMID:11406544 more ... Rhein decreases expression ISO RGD:69147 6480464 rhein results in decreased expression of CASP9 protein CTD PMID:31436023 riboflavin increases activity ISO RGD:62159 6480464 Riboflavin analog results in increased activity of CASP9 protein CTD PMID:20688149 Riluzole increases activity ISO RGD:69147 6480464 Riluzole results in increased activity of CASP9 protein CTD PMID:19528481 Risedronate sodium increases activity EXP 6480464 Risedronic Acid results in increased activity of CASP9 protein CTD PMID:19505369 Ro 31-8220 multiple interactions EXP 6480464 Ro 31-8220 inhibits the reaction [Hexachlorocyclohexane results in increased activity of CASP9 protein] CTD PMID:22001173 romidepsin multiple interactions ISO RGD:69147 6480464 Bortezomib promotes the reaction [romidepsin results in increased cleavage of CASP9 protein] CTD PMID:18223231 romidepsin increases cleavage ISO RGD:69147 6480464 romidepsin results in increased cleavage of CASP9 protein CTD PMID:18223231 ropinirole multiple interactions ISO RGD:69147 6480464 ropinirole inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] CTD PMID:18242171 rotenone multiple interactions ISO RGD:69147 6480464 3-Hydroxybutyric Acid inhibits the reaction [Rotenone results in increased activity of CASP9 protein] more ... CTD PMID:16917840 more ... rotenone increases cleavage EXP 6480464 Rotenone results in increased cleavage of CASP9 protein CTD PMID:29174113 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CASP9 mRNA, Rotenone results in increased expression of CASP9 protein CTD PMID:25502462 more ... rotenone increases expression ISO RGD:62159 6480464 Rotenone results in increased expression of CASP9 mRNA CTD PMID:25428620 rotenone increases activity ISO RGD:62159 6480464 Rotenone results in increased activity of CASP9 protein CTD PMID:21216964 rotenone increases activity EXP 6480464 Rotenone results in increased activity of CASP9 protein CTD PMID:25263579 rotenone increases activity ISO RGD:69147 6480464 Rotenone results in increased activity of CASP9 protein CTD PMID:16917840 , PMID:25263579 rotenone multiple interactions ISO RGD:62159 6480464 CASP2 protein affects the reaction [Rotenone results in increased activity of CASP9 protein] more ... CTD PMID:21216964 , PMID:24830863 rotenone increases cleavage ISO RGD:69147 6480464 Rotenone results in increased cleavage of CASP9 protein CTD PMID:18242171 more ... rotenone multiple interactions EXP 6480464 [3-bromo-2-oxopropionic acid co-treated with Rotenone] results in increased expression of CASP9 protein more ... CTD PMID:21664962 more ... rottlerin multiple interactions ISO RGD:62159 6480464 rottlerin inhibits the reaction [Asbestos more ... CTD PMID:12626342 rottlerin increases cleavage ISO RGD:69147 6480464 rottlerin results in increased cleavage of CASP9 protein CTD PMID:22902833 royal jelly multiple interactions EXP 6480464 royal jelly inhibits the reaction [Fluorides results in decreased expression of CASP9 protein] CTD PMID:34227456 rubimaillin increases activity ISO RGD:69147 6480464 rubimaillin results in increased activity of CASP9 protein CTD PMID:19716835 rubimaillin multiple interactions ISO RGD:69147 6480464 BCL2L1 protein inhibits the reaction [rubimaillin results in increased activity of CASP9 protein], benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone affects the reaction [rubimaillin results in increased activity of CASP9 protein] CTD PMID:19716835 rubitecan multiple interactions ISO RGD:69147 6480464 [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CASP9 protein CTD PMID:21695227 rubitecan increases expression ISO RGD:69147 6480464 rubitecan results in increased expression of CASP9 protein CTD PMID:21695227 ruthenium atom multiple interactions ISO RGD:69147 6480464 [Ruthenium binds to Phloretin] which results in decreased expression of and results in increased cleavage of CASP9 protein, Ruthenium results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:17210701 , PMID:34896434 rutin multiple interactions ISO RGD:69147 6480464 Rutin inhibits the reaction [Cisplatin results in decreased expression of CASP9 protein] CTD PMID:29962303 S-(1,2-dichlorovinyl)-L-cysteine increases cleavage ISO RGD:69147 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased cleavage of CASP9 protein CTD PMID:15967204 S-(1,2-dichlorovinyl)-L-cysteine increases activity ISO RGD:69147 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased activity of CASP9 protein CTD PMID:29129777 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:62159 6480464 4-amylcinnamoylanthranilic acid inhibits the reaction [Buthionine Sulfoximine results in increased activity of CASP9 protein], Glutathione inhibits the reaction [Buthionine Sulfoximine results in increased activity of CASP9 protein] CTD PMID:33309544 S-butyl-DL-homocysteine (S,R)-sulfoximine increases activity ISO RGD:62159 6480464 Buthionine Sulfoximine results in increased activity of CASP9 protein CTD PMID:33309544 safrole increases expression ISO RGD:69147 6480464 Safrole results in increased expression of CASP9 mRNA CTD PMID:21591240 safrole increases activity ISO RGD:69147 6480464 Safrole results in increased activity of CASP9 protein CTD PMID:21591240 Salinomycin increases cleavage ISO RGD:69147 6480464 salinomycin results in increased cleavage of CASP9 protein CTD PMID:30273566 Salinomycin increases expression ISO RGD:69147 6480464 salinomycin results in increased expression of CASP9 mRNA CTD PMID:35914560 Salinomycin multiple interactions ISO RGD:69147 6480464 [salinomycin co-treated with Calcitriol] results in increased expression of CASP9 mRNA CTD PMID:35914560 salubrinal multiple interactions ISO RGD:62159 6480464 Acetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein]], salubrinal promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein] CTD PMID:21616140 sanguinarine decreases expression ISO RGD:69147 6480464 sanguinarine results in decreased expression of CASP9 protein alternative form CTD PMID:19135517 sanguinarine multiple interactions ISO RGD:69147 6480464 [sanguinarine results in increased chemical synthesis of Reactive Oxygen Species] which results in increased activity of CASP9 protein CTD PMID:23660334 sanguinarine increases activity ISO RGD:69147 6480464 sanguinarine results in increased activity of CASP9 protein CTD PMID:19346183 , PMID:22215411 sappanchalcone increases activity ISO RGD:69147 6480464 sappanchalcone results in increased activity of CASP9 protein CTD PMID:21963806 sappanchalcone increases cleavage ISO RGD:69147 6480464 sappanchalcone results in increased cleavage of CASP9 protein CTD PMID:32590072 saquinavir increases cleavage ISO RGD:69147 6480464 Saquinavir results in increased cleavage of CASP9 protein CTD PMID:19147209 sarpogrelate multiple interactions ISO RGD:62159 6480464 [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] more ... CTD PMID:34560070 , PMID:35202708 sarpogrelate multiple interactions ISO RGD:69147 6480464 [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] more ... CTD PMID:34560070 , PMID:35202708 SB 203580 multiple interactions ISO RGD:69147 6480464 [Resveratrol co-treated with SB 203580] results in increased activity of CASP9 protein more ... CTD PMID:17237268 more ... SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein], SB 203580 inhibits the reaction [Cocaine results in increased activity of CASP9 protein] CTD PMID:15365088 , PMID:26396915 SB 431542 multiple interactions ISO RGD:69147 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Colistin results in increased activity of CASP9 protein] CTD PMID:35378205 Se-methyl-L-selenocysteine increases expression ISO RGD:69147 6480464 selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form CTD PMID:25321483 Se-methyl-L-selenocysteine multiple interactions ISO RGD:69147 6480464 BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form] CTD PMID:25321483 Se-methylselenocysteine increases expression ISO RGD:69147 6480464 selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form CTD PMID:25321483 Se-methylselenocysteine multiple interactions ISO RGD:69147 6480464 BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form] CTD PMID:25321483 selenium atom multiple interactions ISO RGD:69147 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein]] more ... CTD PMID:17339365 more ... selenium atom multiple interactions EXP 6480464 [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA] more ... CTD PMID:21628957 more ... selenium atom decreases activity ISO RGD:62159 6480464 Selenium results in decreased activity of CASP9 protein CTD PMID:17997286 selenocystine decreases expression ISO RGD:69147 6480464 selenocystine results in decreased expression of CASP9 protein CTD PMID:35863474 senecionine increases activity ISO RGD:69147 6480464 senecionine results in increased activity of CASP9 protein CTD PMID:29458164 Senkirkine increases activity ISO RGD:69147 6480464 senkirkine results in increased activity of CASP9 protein CTD PMID:29458164 sepantronium multiple interactions ISO RGD:69147 6480464 [venetoclax co-treated with sepantronium] results in increased cleavage of CASP9 protein CTD PMID:31837377 sepantronium increases cleavage ISO RGD:69147 6480464 sepantronium results in increased cleavage of CASP9 protein CTD PMID:31837377 serpentine asbestos increases expression ISO RGD:69147 6480464 Asbestos, Serpentine results in increased expression of CASP9 protein CTD PMID:24735948 serpentine asbestos increases cleavage EXP 6480464 Asbestos, Serpentine results in increased cleavage of CASP9 protein CTD PMID:18300051 serpentine asbestos increases cleavage ISO RGD:69147 6480464 Asbestos, Serpentine results in increased cleavage of CASP9 protein CTD PMID:18300051 sertraline multiple interactions ISO RGD:69147 6480464 Sertraline results in increased cleavage of and results in increased activity of CASP9 protein CTD PMID:24194395 Sesamol increases activity ISO RGD:69147 6480464 sesamol results in increased activity of CASP9 protein CTD PMID:27270451 Sesamol multiple interactions ISO RGD:62159 6480464 sesamol inhibits the reaction [Lipopolysaccharides results in increased activity of CASP9 protein], zinc protoporphyrin inhibits the reaction [sesamol inhibits the reaction [Lipopolysaccharides results in increased activity of CASP9 protein]] CTD PMID:30261164 sesquiterpene increases activity ISO RGD:69147 6480464 Sesquiterpenes results in increased activity of CASP9 protein CTD PMID:18070620 sevoflurane multiple interactions EXP 6480464 Nimodipine inhibits the reaction [Sevoflurane results in increased expression of CASP9 protein modified form] CTD PMID:33171207 sevoflurane increases expression EXP 6480464 Sevoflurane results in increased expression of CASP9 protein modified form CTD PMID:33171207 Shikonin multiple interactions ISO RGD:62159 6480464 shikonin inhibits the reaction [Benzene results in increased cleavage of CASP9 protein], shikonin inhibits the reaction [Benzene results in increased expression of CASP9 mRNA] CTD PMID:36306860 sildenafil citrate affects response to substance ISO RGD:69147 6480464 CASP9 protein affects the susceptibility to Sildenafil Citrate CTD PMID:20884855 sildenafil citrate multiple interactions ISO RGD:69147 6480464 CASP9 protein mutant form inhibits the reaction [Sildenafil Citrate results in increased activity of Doxorubicin], Sildenafil Citrate promotes the reaction [Doxorubicin results in increased activity of CASP9 protein] CTD PMID:20884855 silibinin multiple interactions ISO RGD:69147 6480464 benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Silybin results in increased cleavage of and results in increased activity of CASP9 protein] more ... CTD PMID:16777994 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CASP9 protein CTD PMID:26865670 silicon dioxide increases expression ISO RGD:69147 6480464 Silicon Dioxide results in increased expression of CASP9 protein CTD PMID:21766316 silicon dioxide increases expression ISO RGD:62159 6480464 Silicon Dioxide analog results in increased expression of CASP9 mRNA, Silicon Dioxide analog results in increased expression of CASP9 protein CTD PMID:26263183 silicon dioxide multiple interactions EXP 6480464 ZC3H12A affects the reaction [Silicon Dioxide results in increased expression of CASP9 protein] CTD PMID:26865670 silver atom increases activity ISO RGD:69147 6480464 Silver results in increased 
